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GENERAL INTRODUCTION
1
 
Stroke, also known as cerebrovascular accident (CVA) is the sudden death of brain 
cells due to lack of oxygen caused by blockage of blood flow or rupture of an artery to 
the brain [1]. There a two types of stroke, ischemic and hemorrhagic. In ischemic 
stroke, severe disturbance of the blood supply to brain tissue leads to a deprivation of 
oxygen supply to brain tissue and causes neuronal death [2]. A hemorrhagic stroke is 
either a brain aneurism burst or a weakened blood vessel leak. The bleeding may 
cause lesions to migrate and dissect through less-dense white matter and into the 
ventricles, causing swelling and (intracranial) pressure, damaging cells and brain 
tissue [3]. 
 
Worldwide, stroke is the second leading cause of death and the third leading cause of 
disability [4]. Fifteen million people suffer a stroke each year and almost 6 million 
people die from it. During the last four decades, stroke incidence declined by 42% in 
high-income countries [5], likely because of the increased use of specific prevention 
medication such as statins and anti-hypertensives [6]. During this time period, in low-
income countries stroke however, incidence has more than doubled [5]. A further 
increase in the global burden of stroke is expected, mainly due to the increase in 
disability-adjusted life years in developed countries and the ageing population [7, 8]. In 
addition, compared to high-income countries, stroke, on average, occurs 15 years 
earlier in low-and middle income countries and affects individuals at the peak of their 
productive life, thus creating an enormous impact on countries’ socio-economic 
development [1]. In the Netherlands, in 2017, stroke incidence (excluding TIA 
(transient ischemic Attack)) amounted to 38,800, whereas stroke year prevalence was 
341,100 and mortality was 9,180. In 2011, in the Netherlands, costs related to care for 
patients suffering from a stroke amounted to almost 2.3 billion Euro [9].  
 
The most common and widely recognized impairment caused by stroke is motor 
impairment, often stated as a loss or limitation in mobility typically affecting movement 
in the face, arm and leg of one side of the body [10, 11]. Loss of movement in the arm 
and hand is very common after stroke and is often persistent and disabling [12]. About 
33% to 66% of the stroke survivors are left with a severely impaired, non-functional 
arm-hand [13], and, depending on the outcome measures used, only 5% to 20% 
achieve full recovery of arm-hand function at 6 months [13]. Patients, after stroke, rate 
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improving their arm-hand function and incorporating their paretic hand in daily activities 
as a top priority in their rehabilitation [14-16]. 
 
Even when stroke survivors experience some return of arm-hand function, it remains 
a common and significant source of long-term disability [17]. Symptoms like loss of 
strength and sensation, pain and spasticity in the affected arm-hand often lead to 
numerous restrictions in the daily lives of those affected. Their capacity to perform 
basic self-care and household activities and their ability to regain self-confidence in 
participation and taking up societal roles are reduced. Ultimately, this has a negative 
impact on the patient’s emotional and psychological well-being [18, 19], and is 
associated with a poor perception of health-related quality of life [20].  
 
Arm-hand rehabilitation in the post-stroke phase is continuously subject to changes 
and developments from both a research and a clinical perspective [21, 22]. Whereas 
acute treatment options after hemorrhagic stroke remain limited [23], in ischemic brain 
injuries acute stroke therapies such as reperfusion or neuroprotection have been 
developed to limit the severity of the injury [24]. Both existing and novel rehabilitation 
treatments need to take these new developments into account. As rehabilitation 
treatments aim to maximize function in brain areas that survived the stroke, or provide 
compensatory approaches to improve overall function [21], here at least two important 
domains regarding arm-hand recovery and arm-hand interventions in the post-stroke 
phase can be identified, i.e.:  
1. Characterization of arm-hand recovery processes in association with post-
stroke brain plasticity, outcomes of which may support stratification and 
selection of those patients who are likely to positively respond to certain arm-
hand rehabilitation programs [25], and  
2. Development of novel interventions aimed at improving arm-hand performance 
during rehabilitation [7].  
 
Many rehabilitation interventions have been developed over the last decades, aimed 
at maximizing arm-hand recovery in order to improve functional ability and quality of 
life [11, 26-28]. These interventions cover a wide range of different exercises or training 
methods, the use of equipment or techniques, and/or pharmacological interventions 
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targeting neural mechanisms in order to enhance motor recovery [29]. This myriad of 
possibilities, in turn, makes it difficult for clinicians to decide on the most appropriate 
(combination of) therapy elements. In order to aid clinicians in their choices during 
clinical decision making, several authors have provided extensive overviews with 
respect to rehabilitation techniques and interventions aimed at arm-hand improvement 
[30-35]. Yet another difficulty for clinicians lies in the fact that, although arm-hand 
treatment delivered in stroke rehabilitation settings normally consist of a complex array 
of interventions, adjusted to the patient’s individual needs, the set-up of most 
evaluation studies with respect to arm-hand interventions, reported in literature, 
deviates from these real-life arm-hand treatment circumstances. For example, the 
majority of the evaluation studies consist of a single intervention. Often, such 
intervention is firmly protocol-based to serve a narrow band of well-described patients, 
and is less adaptable to accommodate patients with different levels of impairment after 
stroke or patients with specific needs [37, 38] as commonly seen in daily clinical 
practice. A third source of difficulty for clinicians concerns the fact that, although it is 
generally acknowledged that task-specific training should be at the heart of treatment, 
it is still unclear how task-related interventions should be tailored to (reduce the 
consequences of) the specific underlying impairments.  
 
 
Arm - hand rehabilitation in sub-acute stroke patients with a moderately to 
severely affected arm-hand 
 
Whereas in patients with a mildly affected arm-hand improvements in arm-hand 
function (AHF) and arm-hand skill performance (AHSP) occur more quickly, the 
relearning of motor abilities during arm-hand rehabilitation for stroke patients with a 
moderately to severely affected arm-hand is slower, or even absent. 
In 50% of patients with a severe paresis no recovery of the affected arm and hand is 
observed [39], due to the absence in the ipsilesional corticomotor excitability [25]. 
Immediately after admission to rehabilitation, these patients often display a 
combination of no hand function and a low motor ability level due to severe muscle 
weakness [40], while their prospect regarding functional recovery is limited [41, 42].  
12 
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Stroke patients with a moderate to severely affected arm hand often experience co-
morbidities like cognitive deficits [43], depression [44], sensomotor deficits [45], 
shoulder pain [46, 47], spasticity [48] or edema [49] which even further hamper 
progressions in AHF and AHSP. Also, experiencing serious arm-hand capacity 
problems may have a negative impact on a patient’s sense of self-efficacy. A low level 
of self-efficacy may lead to diminished patient’s beliefs and self-perceived performance 
which, in turn, is associated with sub-optimal use of the affected arm-hand, thus 
leading to a vicious circle. Given the above, to both regain and maintain AHF and 
AHSP in patients with a moderately to severely affected hand is challenging.  
In order to re-use the affected arm-hand in task-performance situations, a stepwise 
clinical management procedure must be developed to identify the nature of interacting 
constraints (among others motor control problems) that influence skill acquisition in the 
affected arm-hand [51]. Subsequently, a treatment plan must be developed in order to 
enable the patient to choose the most efficient strategy towards successful task-
performance.  
A small change in AHF may represent a clinically meaningful change in AHSP and/or 
arm-hand performance. For example: being able to use the affected arm-hand for 
simple passive and active stabilization tasks leads to the patient being able to perform 
bimanual activities, like fixating bread while making a sandwich. However, it is quite 
difficult to recognize (subtle) improvements in AHF and AHSP, to encourage 
moderately and severely affected stroke patients to push their boundaries, and to 
create perspectives for these patients to re-use their affected hand more quickly in 
daily tasks outside the rehabilitation setting [52, 53]. For this reason, AHF and/or AHSP 
improvements gained during therapy must be used to stimulate the patients’ beliefs 
about their (growing) ability to influence their level of arm-hand performance. The 
transferability of learned skills to other (non-trained) skills must be enhanced [54, 55] 
and optimal therapy conditions (i.e. sufficient resources, state-of-the-art equipment, 
therapy time and therapy intensity) must be provided [56]. 
The need for comprehensive arm-hand rehabilitation programs, featuring essential 
aspects like adequately well-described content, dose and duration, has been 
acknowledged [38, 58, 59]. These rehabilitation programs should accommodate a 
broad spectrum of hand severity levels, including patients with a moderately to severely 
affected arm-hand, typically seen in daily medical rehabilitation practice. Nevertheless, 
currently, the majority of interventions targeting the affected arm-hand are protocolled 
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interventions targeting stroke patients with a mildly impaired arm-hand using strict 
inclusion criteria. For this reason, these treatment protocols are less applicable in 
heterogeneous patient populations as commonly seen in rehabilitation practice, also 
holding patients with a moderately to severely affected arm-hand. Taking into account 
the abovementioned factors, the decision-making process in order to select the most 
appropriate intervention for a particular patient is challenging for clinicians in day-to-
day clinical practice.  
 
To understand the way in which arm-hand rehabilitation influences the neurobiology of 
the central nervous system regarding therapy content, timing of treatment and intensity 
of treatment is of considerable importance [60]. Knowledge with respect to these 
aspects should be leading in the design of the most appropriate arm-hand rehabilitation 
strategy, fitting the needs of the individual patient. Another important aspect of arm-
hand rehabilitation is to make patients recognise their improved performance, and 
experience successful task performance in daily activities. Recognizing improvements 
may encourage stroke patients to push their boundaries and create perspectives to 
start re-using their affected hand more quickly in daily tasks. Ultimately, patients 
facilitate themselves in creating an optimal retention of how to use the full potential of 
their affected hand by also using the affected hand outside therapeutic situations, i.e. 
in their own daily life pursuits.  
 
 
Changes in arm-hand function, arm-hand skill performance and actual arm-hand 
use during and after rehabilitation  
 
Applying assessments to determine the effectiveness of arm-hand rehabilitation 
treatments and to monitor the patients’ progressions during or after rehabilitation are 
indispensable both in clinical practice and in research. The application of the 
International Classification of Functioning, Disability and Health (ICF) framework [61] 
is supportive in differentiating three levels of human functioning, i.e. function level 
(body structures and function), activity level (task execution) and participation level 
(taking up societal roles). The term Arm Hand Function (AHF), used throughout this 
thesis, refers to the ICF function level. Arm-Hand Skill Performance (AHSP) refers to 
14 
CHAPTER 1
 
the ICF activity level, which is sub-classified into capacity and performance [62]. 
Performance can be sub-classified into perceived performance and actual 
performance. Perceived performance concerns the level of manual skill ability as 
observed by therapists in patients with arm-hand impairments or as perceived by 
patients themselves in daily life situations. Actual performance reflects the patient’s 
objectively detectable level of AHSP as performed in his or her current environment 
[62] and can be subdivided into, a) amount of arm-hand use, i.e. how frequent and/or 
how much the arm-hand is used, and b) the quality with which the arm-hand is used 
during tasks or skills [62]. The application of the ICF model in rehabilitation allows 
clinicians to gain insight into the specific functional profile of each patient. Being able 
to objectively quantify patient’s performance at the level of function, activity and 
participation is essential in identifying the relationships between these three levels and 
to fine-tune each patient’s individual arm-hand rehabilitation treatment [63]. 
 
To improve AHF and AHSP in a therapeutic environment is done in order to achieve 
actual use of the affected hand in daily life performance situations outside the 
rehabilitation setting. Actual use of the affected hand in daily life performance strongly 
depends on the severity of the arm-hand impairment in the initial phase post-stroke 
[31, 64, 65]. Furthermore, it is known that after having been discharged from 
rehabilitation, arm-hand capacity may deteriorate and actual arm-hand use of the 
paretic arm and hand in daily life may decrease [34, 66, 67]. Rand et al. reported that 
in patients with a moderately or severely affected hand, the intensity of arm-hand use 
on the affected side sharply dropped during the rehabilitation phase [68]. De Niet et al. 
and Michielsen et al. found that chronic stroke patients hardly use their affected arm-
hand in daily performance [69, 70]. The rationale behind these findings related to the 
limited and even decreased use of the affected arm-hand is still poorly understood. It 
neither well understood at what rate such deterioration (or improvement) occurs, nor 
in which patient categories, i.e. patients with a certain level of arm-hand severity, this 
is most prominent. Taub and colleagues found substantial improvements on real arm-
hand use outside the clinical setting in chronic stroke patients with a mildly affected 
arm-hand when using a behavioural strategy in combination with an intensive arm-
hand training paradigm [71].  
On may assume that, in order to use the affected hand in performing daily activities 
after rehabilitation, patients need to achieve their maximum motor ability level during 
 15
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rehabilitation. However, as already reported by others, the motor ability levels as 
measured in the clinical setting are considered to be different from the actual real-world 
arm-hand use [72-74]. The lack of information about the proportional improvement or 
deterioration to be expected in stroke survivors in the sub-acute phase after stroke 
may lead to difficulties for clinicians to make decisions about arm-hand treatment 
objectives and concomitant prognostics regarding arm-hand skill performance and 
actual arm-hand use, in particular in patients with a moderately to severely affected 
hand. It would, however, be of great value to have an insight in a more detailed level 
of retention of training effects in the time after cessation of the training, in order to 
assess whether arm-hand performance has stabilized or maybe even improved 
beyond clinical discharge values. Clarification of these issues is essential in order to 
develop more effective arm-hand rehabilitation interventions that may augment and/or 
maintain arm-hand AHF, AHSP and actual arm-hand use levels in stroke patients with 
a moderately to severely affected arm-hand.  
 
 
Evaluation of technological assistive devices and pharmacological interventions 
adjunct to arm-hand rehabilitation therapy in sub-acute stroke patients with a 
moderately to severely affected arm-hand 
 
Both the use and the impact of technological and pharmacological interventions that 
may enhance functional recovery or restoration of arm-hand function and arm-hand 
skill performance are growing [75]. The majority of such interventions is designed in 
order to augment existing therapies delivered by clinicians.  
With respect to arm-hand rehabilitation in post-stroke phase, modest, though 
significant results are found for robotic-assistive arm training on arm function, strength 
and activities of daily living [35]. Regarding pharmacological trials aimed at enhancing 
motor recovery, significant results have been found in the application of selective 
serotonin reuptake inhibitor (SSRI) and L-dopa [29]. However, pharmacological 
interventions like, for instance, the application of botulinum toxin targeting 
improvements on arm-hand use, have not yet been observed [77]. Nevertheless, even 
when new developments are proven effective, clinicians may still experience difficulties 
to implement such new interventions swiftly into current and future therapy regimes 
16 
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[28, 78]. First, it is challenging to keep up with the latest evidence, especially given the 
speed of developments in e.g. technology [79, 80]. 
Secondly, clinicians may face organisational issues when trying to adopt and 
implement new insights into daily clinical practice. New insights and techniques are 
introduced into practice in order to optimize a clinical pathway. However, two aspects 
are important here. Firstly, it is important to determine the added-value of new 
developments before leaving conventional treatment concepts. Secondly, it is 
important to determine the level of efficacy of the conventional therapy performed 
before novel treatment elements are introduced. Data obtained from stroke patients 
who received a well-documented form of therapy-as-usual can then be used as 
reference. 
Most arm-hand rehabilitation programs lack transparency, which makes it difficult to 
determine the actual status of the content and dose of arm-hand training interventions 
delivered and how this influences AHF, AHSP and actual arm-hand use in a 
heterogeneous population typically seen in stroke rehabilitation [58, 76]. To contrast 
newly developed training interventions in the absence of a well-defined form of arm-
hand training is difficult. It may hamper the evaluation of novel developments like, for 
instance, the use of technological assistive devices or pharmacological interventions 
aimed at AHF and AHSP improvement in rehabilitation.  
 
A critical factor contributing to successful rehabilitation of the affected hand after stroke 
is the provision of sufficient training intensity [52, 56, 81] within the limited time window 
of spontaneous recovery [82-84]. Patients with a moderately to severely affected arm-
hand are often unable to generate sufficient voluntary force in order to execute grasp 
movements independently [85, 86]. For this reason they are often not engaged in high-
intensive, task-oriented training programs within the critical window of opportunity [87], 
which may influence improvements in AHF and AHSP negatively, especially in the sub-
acute phase.      
 
Several technological and pharmacological interventions are available in order to 
facilitate grasp and release movements independently in moderately to severely 
affected stroke patients. Though, the application of these interventions in clinical 
practice is limited due to several barriers like costs, questionable superiority over 
standard care, and aspects of usability [80, 88]. Translation of these interventions to 
 17
GENERAL INTRODUCTION
1
 
the clinical setting may also be hampered by the manner in which the intervention has 
been evaluated. The majority of these interventions are investigated using strict 
methodological considerations and results are often expressed in group averages, 
making it more difficult to translate such results to specific individual cases.  
To evaluate the added-value of technological and pharmacological interventions within 
the complex nature of arm-hand rehabilitation could lead to more generalizable and 
translatable findings for the practicing clinician to use.  
In contrast to group-related research, single-case experimental designs (SCED) 
provide an evaluation method that may be more suitable in heterogeneous populations 
like sub-acute stroke patients with a moderately to severely affected hand [89]. The 
application of the SCED, in conjunction with a well-documented form of arm-hand 
therapy used as standardized rehabilitation approach to contrast novel interventions, 
may provide opportunities to systematically investigate such novel interventions.   
 
 
Aim of the thesis 
 
The overall aim of this thesis is to provide a perspective on clinical management of the 
moderately to severely affected arm-hand in a heterogeneous group of sub-acute 
stroke patients commonly seen in stroke rehabilitation.  
 
This thesis is divided in three parts: The first part outlines the Concise Arm and hand 
Rehabilitation Approach in Stroke (CARAS), a practical and evidence-based 
framework developed to support clinicians to structure arm-hand rehabilitation 
interventions in post-stroke phase. The second part reports on a prospective cohort 
study into the systematic evaluation of the proportional improvement or deterioration 
in arm-hand performance during and after rehabilitation in a broad group of stroke 
survivors typically seen in the rehabilitation clinic, who participated to CARAS. The 
third part encompasses three systematic evaluations, two of which focus on the 
(functional) added value of dynamic orthoses, and one on the application of botulinum 
toxin, all adjunct to CARAS provided to patients with a moderately to severely affected 
arm-hand in the sub-acute phase after stroke.   
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Outline of the thesis 
 
Chapter 2 explains the development and rationale of CARAS. In chapter 3 we 
investigated differences in the rate of improvement or deterioration in arm-hand 
function, arm-hand capacity and self-perceived arm-hand skill performance, during the 
rehabilitation period and up till 12 months after patients’ protocolled rehabilitation 
treatment. Furthermore, differentiations in arm-hand function, arm-hand capacity and 
self-perceived arm-hand skill performance between three subgroups of stroke patients, 
i.e. patients with either a severely, moderately or mildly affected functional arm-hand 
have been investigated. In line with chapter 3, chapter 4 reports on the actual use of 
the arm-hand during daily unimanual and bimanual tasks, measured using 
accelerometry and expressed as ‘Intensity-of arm-hand-use’ and ‘Duration-of-arm-
hand-use’. Actual use has been measured during the rehabilitation phase and until one 
year post-discharge in sub-acute stroke patients with a severely, moderately or mildly 
affected arm-hand. Chapter 5 outlines a design protocol comprising three 
methodological approaches in order to assess the rate of improvement in arm-hand 
performance that may be attributable to a spasticity reducing treatment relative to 
‘therapy as usual only’ in sub-acute stroke patients. In Chapter 6 the added-value of 
early spasticity reduction to improve arm-hand skill performance in sub-acute stroke 
patients with a moderately to severely affected hand is evaluated. 
Chapter 7 and chapter 8 describe the usability and the effectiveness of two dynamic 
hand orthoses, adjunct to therapy-as-usual, on functional use of the 
moderately/severely impaired hand in sub-acute stroke patients. Finally, Chapter 9 
summarizes the results of the studies performed, and discusses clinical implications, 
methodological considerations and future perspectives in clinical practice and 
research.   
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Abstract 
 
The volume of information on new treatment techniques supporting the restoration of 
arm-hand function (AHF) and arm-hand skill performance (ASHP) in stroke survivors 
overwhelms therapists in everyday clinical practice when choosing the appropriate 
therapy. 
The Concise Arm and hand Rehabilitation Approach in Stroke (CARAS) is designed 
for paramedical staff to structure and implement training of AHF and AHSP in stroke 
survivors. 
CARAS is based on four constructs: a) stratification according to the severity of arm–
hand impairment (using the Utrecht Arm-hand Test (UAT), b) the individual’s 
rehabilitation goals and concomitant potential rehabilitation outcomes, c) principles of 
self-efficacy, and d) possibilities to systematically incorporate (new) technology and 
new evidence-based training elements swiftly. 
The framework encompasses three programs aimed at treating either the severely 
(UAT 0-1), moderately (UAT 2-3) or mildly (UAT 4-7) impaired arm-hand. Program 
themes are: ‘taking care of the limb and prevention of complications’ (program 1), ‘task-
oriented gross motor grip performance’ (program 2) and ‘functional AHSP training’ 
(program 3).  
Each program is preceded and followed by an assessment. Training modularity 
facilitates rapid interchange/adaptation of sub-elements. Proof-of-principle in clinical 
rehabilitation has been established. CARAS facilitates rapid structured design and 
provision of state-of-the-art AHF and AHSP treatment in stroke patients. 
 
Keywords: arm, hand, self-efficacy, stroke, therapy, task-oriented training 
Running title: Concise arm-hand rehabilitation approach in stroke 
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Introduction 
 
Approximately 50% of stroke survivors experience unilateral motor deficit that leads to 
chronic upper extremity impairment. This results in limited functional use of the affected 
arm as well as reduced engagement in community life [1-5] and a poorer quality of life 
overall [6]. Four years after stroke, 67% of stroke survivors with initial unilateral motor 
deficit still experience nonuse or disuse of the affected arm as a major problem [1]. 
Motor rehabilitation aimed at arm-hand performance after stroke has changed 
substantially over the last decades. Previously, treatment mainly targeted the 
International Classification of Functioning, Disability and Health (ICF) function level [7]. 
Researchers now focus instead on ICF activity and participation level. 
Well-explored training approaches have emerged [8-11] that address paresis and 
impaired motor control [12-14]. These approaches feature training elements such as 
meaningfulness; challenge; specificity; feasibility; and, when some arm-hand dexterity 
emerges, task-oriented and high-intensity training [15]. Further, these treatment 
programs include a wide variety of exercises that stroke survivors may use in 
therapeutic and/or home-based situations [16-21].  
 
Task-oriented training [22-24] and constraint-induced movement therapy [25] focus on 
both the ICF activity level and participation level. In task-oriented approaches, patients 
are trained in specific functional, skill related tasks, preferably using real-life objects 
[26], thereby teaching patients to solve specific problems related to issues such as 
anticipatory locomotor adjustments or cognitive processing by using efficient goal-
oriented movement strategies [27, 28]. The positive transfer of learned skills to other 
(non-trained) skills occurs when similarities with the learned skill are present [29]. 
Functional treatment outcome in task-oriented training approaches is higher than in 
muscle strength training [15]. 
 
The increasing amount of evidence and studies related to arm-hand performance after 
stroke creates a new problem for modern day therapists treating stroke survivors. 
The sheer volume of information on new treatment techniques and technologies that 
could enhance functional recovery or restoration of arm-hand function and arm-hand 
skill performance may overwhelm therapists in day-to-day clinical practice when they 
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have to choose the appropriate therapy for a patient. This potentially leads to the 
implementation of a patchwork of training regimens.  
Translating the latest scientific evidence and results from clinical trials into clinically 
useful treatments is difficult [30-32], and although formal (national) guidelines for 
training exist, these recommendations cannot always keep up with the latest evidence, 
especially given the speed of technological developments [33]. 
 
In order to guide therapists in systematically designing a stroke patient’s arm-hand 
rehabilitation program, the authors address four issues: 
 
• The heterogeneity of the patient population and the associated patterns and 
levels of recovery of arm-hand skill performance [34, 35]. 
• The lack of adequate description and adaptation of treatment protocols for 
stroke survivors experiencing a broad variety of problems in daily life related to 
an impaired arm-hand. 
• The encouragement of patients’ beliefs about their ability to influence their level 
of performance, thus enabling them to train at and maintain a certain skill level. 
This makes the patient the main stakeholder in his or her training [36-38]. 
• The difficulty of swiftly implementing new insights into current and future therapy 
regimes [9, 11]. 
 
Related to these four issues, four potential solutions are proposed: 
 
a) The presence or absence of dexterity in the affected arm-hand is the most 
important variable. When selecting the potentially most effective treatment, the 
recommendation is to stratify persons with an impaired arm-hand into a limited 
number of dexterity levels [11, 35]. 
b) A well-described program offering stepwise, comprehensible procedures may 
facilitate transparency and could lead to outcomes that are more predictable.  
A (modular) program should span the full range of arm-hand impairments and 
related functional problems experienced, from ‘taking care and prevention’ to 
‘high intensity task-oriented training’.   
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c) The patient’s lack of engagement with arm-hand treatment may be overcome 
by using self-efficacy principles, which could also facilitate optimal transfer and 
retention of learning.  
d) To allow for quick adaptations to novel and effective innovations, the content of 
training should be based on simple, easy-to-replace schedules organized into 
time blocks. When necessary, other training methods can replace these 
schedules’ content without having to rearrange treatment planning.  
 
The aim of this paper is to present the Concise Arm and hand Rehabilitation Approach 
in Stroke (CARAS) that therapists can use to structure and implement treatment of 
arm-hand function and arm-hand skill performance in stroke survivors based on a) 
level of arm-hand impairment, b) detailed training descriptions, c) principles of self-
efficacy, and d) swift implementation of interventions. 
 
A:  Level of arm-hand impairment  
 
CARAS encompasses three modular, group-based training programs divided into two 
parts, namely ‘taking care and prevention’ (Part 1) and ‘high intensity, task-oriented 
arm-hand performance training’ (Part 2; see Figure 1). Based on the Utrecht Arm-hand 
Test (UAT) scores [39], patients enrol in one of the training programs, each of which 
consists of well-described and time-delimited building blocks. 
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Figure 1.  Schematic representation of CARAS and its constituent programs. UAT = Utrechtse Arm-hand Test  
Part 1, encompassing program 1, is designed for stroke survivors who, due to the 
severity of the stroke, are not able to use their affected arm-hand for skill performance 
in daily life situations (non-functional arm-hand) because of inactivity, spasticity and/or 
stiffness. Eventually, this disuse can lead to secondary complications, such as pain, 
problems in performing basic activities of daily living, and hygienic issues [8, 40]. 
Therapists can manage these complications by coaching patients on how best to care 
for their impaired arm-hand.
Program 1 targets stroke survivors with an UAT score of 0-1. Interventions are directed 
towards enabling persons to keep the arm-hand in optimal condition, such as feeling 
comfortable in various postures both during resting and while performing daily life 
activities. 
Part 2, encompassing programs 2 and 3, features high intensity, task-oriented arm-
hand training in which patients learn to integrate their affected arm-hand into daily 
occupations to optimise their overall functional abilities in daily situations. In this part, 
a distinction is made between patients who have a moderately affected arm-hand (i.e. 
those who are able to use their affected arm-hand for passive and active stabilisation 
tasks like holding bread while making a sandwich) and patients with a mildly affected
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arm-hand (i.e. those who are able to use their affected arm-hand instantaneously in 
daily situations).
Program 2 targets stroke survivors with an UAT score of 2-3. These persons have to 
cope with a moderately impaired arm-hand and are able to use their affected hand to 
assist the non-paretic arm-hand during bimanual activities in daily life. This program is 
aimed at gross motor grip tasks, i.e. ‘passive and active fixation’ tasks, ‘grasp and 
displace’ tasks and simple bimanual daily life activities.
Program 3 targets stroke survivors with an UAT score of 4-7. These patients have the 
potential or are already able to spread the fingers and make isolated finger movements 
with the affected hand. From the perspective of motor learning, this allows them to use 
their arm-hand in functional tasks in daily life situations immediately from the start of 
rehabilitation. This program is aimed at ‘grasp and displace’ tasks, manipulation tasks 
and complex bimanual activities.
B Training interventions
Figure 2 shows the CARAS time schedule.
Figure 2.      Time schedule of CARAS
In order to manage CARAS’ group-based interventions adequately, groups should be 
limited to six patients. After establishing a baseline via an assessment, patients enrol 
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in one of the three programs and start training for six consecutive weeks, followed by 
a second assessment. Progress is expressed in terms of functional goals reached, 
based on measures gauging performance levels (e.g. ABILHAND)[41] and capacity 
levels (e.g. Action Research Arm Test [42], or the Fugl-Meyer Motor Assessment [43]. 
Depending on these results, it is possible for the patient to choose a second 6-weeks 
period of training. Furthermore, depending on the progress made, a patient can switch 
from program 1 to program 2 when he or she has regained dexterity in the affected 
arm-hand (improving from UAT 1 to 2), or from program 2 to program 3 when he or 
she shows an increase in selectivity in the affected hand, resulting in isolated wrist 
and/or finger movements (UAT 3 to 4). This second 6-week period is followed by a 
(third) assessment. 
 
 
B 1. Training patients with a severely affected arm-hand 
 
The initial level of paresis is generally regarded as the most important predictor for 
motor recovery [35]. When neurophysiological recovery is absent, patients may be left 
with a non-functional arm-hand that cannot be used in daily activities. It is not useful to 
train patients in program 1 under the same practice conditions and as intensively as 
patients in programs 2 and 3.  
 
Patients in program 1 spend about 4.5 hours a week on training. The training consists 
of the following topics: Education about the basic principles of how the affected arm is 
related to the body and mind, and why it is not moving adequately; education and 
exercises on how to position the arm-hand in different circumstances and postures 
(e.g., lying in bed, or in sport or vocational situations); exercises to avoid discomfort, 
maintaining joint mobility and maintaining muscles/tendons in an optimal condition; 
exercises to provoke voluntary movement where possible; learning strategies on what 
to do when discomfort nevertheless arises; and training in the use of supportive tools 
like static or dynamic splints, braces and/or slings. Every day during the 5 days per 
week, one of these topics will be discussed in a group. 
A substantial proportion of patients with a severely affected arm-hand will not regain 
dexterity. The difficulty patients have in dealing with this poor prognosis in the post-
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stroke sub-acute phase may complicate their treatment and deter adherence. 
Diminished therapy adherence will hinder the learning process. Therapist may improve 
adherence by helping the patient to understand his or her reactions and constraints to 
learned skills, having the patient adopt similar strategies used by fellow patients to 
cope with their severely affected arm-hand, and by providing a valid prognosis based 
on the patient’s individual characteristics. Program 1 is based on the Attitude-Social 
influence self-Efficacy (ASE) model [44], which assumes that attitudes, social 
influences and self-efficacy expectations determine intention and behaviour. These 
cognitive aspects are coupled with relevant topics for patients with a severely affected 
arm-hand.  
 
 
B2. Training patients with a moderately or mildly affected arm-hand 
 
Patients following the ‘task-oriented arm-hand performance training’ receive intensive 
exercise training spread across 5 days per week, covering approximately 7 hours per 
week. In contrast to program 1, program 2 and program 3 provide patients with more 
training because they are generally able to work more intensively due to the functional 
capabilities of their affected hand and their overall better condition. In general, the 
recommended duration of arm-hand treatment is about 1 hour per session [4, 45, 46]. 
With respect to general duration and frequency of training, phases of 6 to 12 weeks 
are advocated [47, 48].  
Given the program’s modularity, all interventions are embedded in 60 minute time 
blocks, during which the patient starts with the set-up of the training of a personal goal 
for at least 5 minutes, followed by 40-50 minutes of training exercises, related to the 
personal goal. Immediately after this training session, the patient works for at least 5 
minutes towards the same personal goal again. An example of a personal goal may 
be to handle the garden hose to water the plants.  
 
Programs 2 and 3 target patients with, respectively, a UAT score of 2-3 and a UAT 
score of 4-7. Patients from both these groups are eligible for task-oriented training. 
This involves training in functional (skill-related) tasks with a high level of repetition, 
assuming an interaction between the task or skill, the patient performing the task, and 
the context in which the task is performed [26, 49]. Scientific evidence of task-oriented 
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training being associated with neuroplastic changes is increasing [50, 51], although the 
variety of training content, combined with different durations and intensities reported, 
makes it hard to compare treatment effects between interventions [52]. 
 
Clinical management of motor control problems in task-oriented training uses the 
following five steps: 
1) Perform a task analysis together with the patient and quantify functional abilities.   
2) Check the strategies used to accomplish functional skills. 
3) Consider which underlying sensory, motor, or cognitive factors constrain functional 
movement and which factors might be the most trainable. 
4) Choose a suitable motor learning approach and appropriate practice conditions.   
5) Train as functionally as possible to accomplish well-defined results, based on 
successful transfer of the learned task from a clinical environment to the home 
environment [53].  
The application of these five steps in arm-hand rehabilitation practice is outlined below. 
 
Step 1: task analysis. In the first week of programs 2 and 3 the therapist establishes 
the level of task performance by asking the patient to perform a meaningful and 
attainable functional task. The focus is on whether the patient can do the task and the 
degree of difficulty. 
The therapist determines the degree to which the patient uses the affected arm-hand 
during the task.  
 
Step 2: strategies used to accomplish functional skills. During the execution of the task, 
the therapist analyses the task performance strategies used by the patient. After 
examining the patient’s problem-solving strategy, small adaptations to the task may be 
made. In these situations the therapist examines the underlying mental and physical 
capacities of the patient; the mental, cognitive and motor demands of the task; the 
strategies used by the patient to meet these demands, and their ability to choose the 
most efficient strategy for a given task [53]. 
 
Step 3: constellation of impairments. The multitude of underlying cognitive and/or sensory-
motor deficits that contribute to the ability to use the affected arm-hand in real life activities 
are determined by using the Action Model of Goal-directed Movement [54]. Subsequently, 
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the Hypothesis-Oriented Clinical Practice method [55, 56] is used to establish an adequate 
starting point for the interventions. Specific exercises for the patient will be set up in the 
first week in accordance with the patient’s individual needs and the existing capabilities of 
the paretic arm-hand. 
 
Step 4: practical applications of motor learning. Based on the outcome of the first three 
steps, a suitable learning approach and concomitant practice conditions are chosen, 
taking into account that a) the focus of practice lays on the execution of functional tasks 
[15], b) in most cases retraining motor skills demands large amounts of practice and a 
great deal of time spent on arm-hand therapy [57, 58], and c) the training starts in an early 
phase of rehabilitation, thereby avoiding learned nonuse and the development of 
abnormal movement patterns as well as preventing secondary symptoms [11, 59]. 
 
Step 5: transfer to real life performance. Transferring the goals set during the period of 
training to both a new task and the patient’s situation is vital and strongly influences 
treatment success. Facilitating transfer is done by setting goals that are meaningful and 
feasible from the patient’s perspective. In addition, there must be a need to execute these 
goal-related tasks regularly. This is done by setting up practice conditions that closely 
resemble the demands of the patient’s personal situations in his or her daily environment.  
To further enhance these practice conditions, patients are encouraged to bring their own 
materials and instruments to the program. Homework assignments are listed and 
distributed on Fridays, before going on weekend leave, and evaluated the next Monday, 
thus providing new insights into the operational capabilities of the affected arm-hand in 
home situations. 
 
In programs 2 and 3, the effects of task-specific training may generalize towards other, 
untrained tasks [60]. A way to support this generalization is to stimulate the patient’s 
awareness of the operational capability of the affected hand in a positive way in order to 
increase spontaneous use of this hand in an early phase during rehabilitation [61]. To do 
this, patients are offered and employ a broad variety of frequently used and familiar tasks 
that they face in daily practice in their home environment and, in most cases, also during 
their rehabilitation period. For this purpose, six intervention modules have been 
developed. Each module contains a selection of tasks, specifically addressing personal 
goals (see Figure 3).  
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Figure 3.      Six training modules used in programs 2 and 3 of CARAS
The first module (‘taking care and prevention’) focuses on improving and maintaining 
an optimal condition of the paretic arm-hand. Compared to the version in program 1, 
this module contains different exercises aimed at getting and keeping the affected 
shoulder and arm-hand supple and free of pain, which is also relevant for persons with 
a higher functional arm-hand. The other five modules are aimed at improving arm-hand 
skills performance, targeting reach and grasp tasks, moving objects, opening and 
closing items (e.g. door, drawer, zipper, buttons); handling materials and hand-
operated tools (like screwdrivers, hairdryer) and completing activities of daily living
(e.g. using towel, toothbrush). The tasks are grouped into three levels of difficulty 
(easy, medium and hard) and are based on the stages described in the Fugl-Meyer 
Motor Assessment [43].
C. Self-efficacy
A contemporary method for improving patients’ ability level is promoting their self-
efficacy. Self-efficacy is described as confidence in one’s ability to perform a task or 
exert a specific behaviour [36]. Many interventions that enhance self-efficacy may elicit 
positive effects on peoples’ outcome after stroke [37, 62, 63] as applied in task-oriented 
training methods [64] or group education interventions [65]. Therapists can incorporate 
principles of self-efficacy for improving patients’ empowerment. By extracting and 
defining goals, patients are enabled to work toward their goals, boosting their belief in 
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improvement. This may result in patients integrating their affected hand in daily 
activities. The self-efficacy principles, explained below, are essential to the success of 
Part 2 of CARAS and should be integrated in daily routine practice. 
  
1. Mastery experiences: positive experiences with a task/skill 
2. Vicarious experience: comparison of oneself to other patients 
3. Verbal persuasion: encouragement of the patient during exercising 
4. Physiological feedback: beliefs formed from feedback produced by the patient’s 
own physiologic state [66]. 
 
Mastery experience  
The development of efficacy beliefs through enactive experience creates effective 
performance [66]. Therefore, therapists should strive to creating patient involvement 
and motivation during the therapy programs [67, 68]. Prior to the training program, a 
semi-structured interview is performed to extract three to six activities that are both 
meaningful and challenging to that patient. The important characteristics of these 
activities are that they have to be used frequently and be directly related to home-
based activities in daily life. These activities are converted into attainable and 
meaningful goals and are rated by the patient on a six-point ordinal (Likert) scale 
varying from very easy to perform to very difficult to perform. 
 
Complex skills are often broken down into subskills that are easier to master. These 
subskills (part practice) are subsequently presented in a chronologic sequence to 
acquire or recover the complex skill (whole practice) [66]. Progression towards each 
goal is monitored in a personal training diary, rated by the patient three times a week 
using a quantitative measure such as a visual analogue scale or the time used to 
perform the goal. At the end of each week, progression in goal-attainment is visualised 
graphically. Identifying even small steps made towards the goals is done by patients 
themselves to stimulate confidence and to maintain a positive trend regarding their 
self-perceived ability level [69]. After six weeks, all goals set are re-evaluated and rated 
using a 6-point Likert scale.  
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Vicarious experience  
Observational practice can make unique and important contributions to learning, 
especially when the observation is combined with physical practice [70]. In CARAS’ 
programs 2 and 3, the patient works towards their individual goals in groups of patients 
who experience similar motor impairments. Each individual is able to observe the other 
while exercising. Working on an identical activity level facilitates learning through 
mutual observation and reduces insecurity through role modelling and dyad practices 
[71]. Another way to provide vicarious experiences is to have the patient observe 
himself as a model using video recordings taken during different time epochs, during 
one or more sessions.  
To obtain persuasive model conditions it is important to create certain similarities in 
the training sessions (e.g., two patients who have a similar goal, like eating with knife 
and fork). The third method of providing vicarious experiences is to use the therapist 
as a role model, especially in situations that warrant giving extrinsic feedback as a way 
to increase knowledge of performance [53].  
 
Verbal persuasion  
Feedback that emphasizes successful performance and ignores less successful 
attempts benefits learning and may boost motivation [66]. During training, small 
progressions can be noticed and conveyed as positive feedback to the patient. Patients 
are also taught to identify these small progressions and to provide positive feedback 
to themselves and, when possible, to fellow patients. Positive family and social support 
may improve motivation and functional recovery [72]. CARAS encourages family to 
visit sessions. Furthermore, homework assignments are provided so that in home-
based situations during weekends the family can notice and encourage skills mastered 
by the patient. 
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Physiological feedback   
Somatotopic maps (i.e., body schemes) are not rigid, but are subject to constant 
modification, depending on experience, and are updated during movement [73]. 
Besides the loss of voluntary movement in the affected arm-hand, in the first weeks 
post-stroke the loss of touch detection and proprioception has been noted in a high 
proportion of patients [74]. During this phase, patients often cope with a changed 
perception of the affected arm-hand [75], which influences their own judgement on the 
functional capability of the arm-hand. Enhancing patients’ confidence in performing 
tasks can be achieved by adjusting perceptions [76].  
 
Maintaining or improving these perceptions is done by: a) explaining (physiological) 
mechanisms underlying symptoms like co-contraction, lack of proprioception and/or 
voluntary movements, experienced by the patient during skill performance, b) providing 
interventions in situ fitted to the most relevant problem (e.g., providing additional 
muscle strength training during a functional task training like cutting meat); and c) 
relating progressions made to relevant tasks. 
 
 
D The swift implementation of interventions 
 
In order to keep up with the state-of-the-art evidence and to test new developments, 
CARAS can be easily adapted without having to resort to major (systemic) alterations like 
the time of treatment or the (chronological) content of treatment.  
CARAS consists of time blocks in which the type of training is defined. Other blocks with 
different content can easily replace parts of these blocks and their content. However, 
starting with setting personal goals and evaluating these goals again after a period of 
training should be maintained. Working in time blocks makes it easier to respond quickly 
to new developments, like the use of aids. Removing a single training component and 
replacing it by another component provides valuable insight into the added value of that 
component. Effectiveness of the newly implemented component can be evaluated by 
using the assessments on performance level and capacity level (presented in Section B), 
and the quantitative self-evaluation method (outlined in Section C). 
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Discussion 
 
The aim of this paper was to present a modular and clinically manageable arm-hand 
rehabilitation framework (called: CARAS) that can be used by paramedical staff to 
structure and implement their treatment of arm-hand function and arm-hand skill 
performance problems in stroke survivors. Four common problems clinicians face during 
the rehabilitation of stroke are tackled: the heterogeneity in dexterity of the affected arm-
hand, the lack of the patient’s engagement with therapy, the non-transparency of 
procedures, and the slow response to innovations [11, 20, 77, 78].To provide answers to 
these problems, self-efficacy principles and task-oriented training methods have been 
merged into in a modular program, stratified for level of arm-hand impairment, and 
designed to be easily adaptable in response to innovations. 
 
CARAS induces at least three changes in the rehabilitation of stroke survivors. First, 
different patterns of recovery of arm-hand function imply that individual patients will have 
different rehabilitation needs [79]. With respect to the heterogeneity among these recovery 
patterns, the use of dexterity levels (based on UAT scores) is helpful for therapists to target 
specific (motor) problems related to the paretic arm-hand [11]. Stratification, based on the 
presence of dexterity and corresponding functional possibilities, facilitates a better focus 
and tailored therapy delivery.  
 
Second, to create an optimal state of readiness in patients, self-efficacy principles are 
embedded in CARAS. The effectiveness of self-efficacy principles, however, is not clear 
[80]. In line with several other studies [65, 81], four sources of self-efficacy are applied in 
the three programs constituting CARAS. However, when adapting these sources of self-
efficacy during training, it is vital to keep in mind that some patients may not able to 
understand all aspects of self-efficacy. As a result of their stroke, patients may experience 
cognitive and/or mood disorders. Mood states can bias attention and can affect how 
events are interpreted, cognitively organized and retrieved from memory [82, 83]. 
Cognitive disorders are a major exclusion criterion for most studies in which self-efficacy 
or self-management interventions are examined [80]. In CARAS, patients with cognitive 
disorders are included.  
Mastery experiences is the most important source of efficacy information because 
successes build a robust belief in one’s personal efficacy[36]. Therefore, this source is 
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used constantly, independent of problems perceived and exercises performed. The other 
three sources - vicarious experience, verbal persuasion and physiological feedback - are 
used more intermittently, depending on the patient’s cognitive status and mood status.  
 
Third, the task-oriented training method combined with the self-efficacy principles used in 
Part 2 of CARAS lead to a condensed organisational structure that resolves several 
logistical issues. Patients commit themselves to be present during a minimum of three 
sessions weekly for six consecutive weeks and, in line with task-oriented training, a 
minimum of 40-50 minutes of training should be provided during each session. CARAS’ 
modular structure, coupled with its clear timing and concomitant assessments, provides 
the patient, his or her family or partner, and the therapist with valuable insight into any 
progress made, the prognosis of the impaired arm-hand and (additional) therapy 
requirements. 
 
Finally, following the implementation criteria for using technology in rehabilitation [84] 
facilitates the use of technology in CARAS. Its modular structure allows for quick 
implementation of new interventions. Stratification of patients into three groups (severely, 
moderately and mildly impaired) makes it easier to match quickly new technologies to 
patients’ needs [85]. The added value of new technologies may be evaluated in the clinical 
setting by using standard, objective measures in the assessment phases.  
 
There is a variety of existing arm-hand programs, each tackling one or more of the 
aforementioned problems. For example, the ICARE protocol [86] and the task-specific 
training method of [16] both provide a structured framework and customized therapy with 
challenging activities related to the real-world tasks chosen by the patient. The amount of 
training time in the BATRAC bilateral arm training [87] shows similarities with the training 
intensity of CARAS’ programs 2 and 3. The upper extremity treatment program of Wallace 
[88] contains training blocks and a stratification of patients with a mildly affected arm-hand 
into three levels, thereby accommodating graded functional training. McDonnell et al., 
(2013) incorporated a hypothetico-deductive framework in their arm-hand program [20].  
To our knowledge, however, there is no program that targets all four problems and their 
concomitant solutions as presented above. CARAS merges experience-based clinical 
treatment with evidence-based interventions, targeting clearly defined populations and 
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covering a substantial part of the stroke population with an affected arm-hand. Its 
theoretical framework makes it easier to identify clear targets or goals toward which the 
patients can train. CARAS provides a systematic approach to therapy and accommodates 
appropriate evaluation methods for evaluating novel developments to be implemented. 
 
 
Considerations 
 
Some considerations regarding this framework should be mentioned. Although the 
initial results relating to progressions made during and after therapy are hopeful, the 
added value of CARAS, compared to other existing arm-hand programs, has not yet 
been evaluated. It has, however, been successfully implemented at Adelante 
Rehabilitation Centre.  
The second limitation is that the program requires a certain number of therapy hours 
for six consecutive weeks. This six-week schedule demands regular timing in a 
patient’s therapy schedule, which may sometimes conflict with other therapy related to 
stroke rehabilitation in the sub-acute phase.  
 
 
Future Research 
 
Future research will focus on a) evaluating the outcomes of CARAS, comparing it to 
other arm-hand treatment programs in stroke, b) implementation in additional centres, 
and c) further optimisation of CARAS regarding the dose-response relationship and 
the optimization of the number of hours involved in ‘face-to-face’ therapy delivery.  
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Abstract 
 
Background: Arm-hand rehabilitation programs applied in stroke rehabilitation 
frequently target specific populations and thus are less applicable in heterogeneous 
patient populations. Besides, changes in arm-hand function (AHF) and arm-hand skill 
performance (AHSP) during and after a specific and well-described rehabilitation 
treatment are often not well evaluated. 
 
Method: This single-armed prospective cohort study featured three subgroups of 
stroke patients with either a severely, moderately or mildly impaired AHF. 
Rehabilitation treatment consisted of a Concise Arm and hand Rehabilitation Approach 
in Stroke (CARAS). Measurements at function and activity level were performed at 
admission, clinical discharge, 3, 6, 9 and 12 months after clinical discharge.  
 
Results: Eighty-nine stroke patients (M/F:63/23; mean age:57.6yr (+/-10.6); post-
stroke time:29.8 days (+/-20.1)) participated. All patients improved on AHF and arm-
hand capacity during and after rehabilitation, except on grip strength in the severely 
affected subgroup. Largest gains occurred in patients with a moderately affected AHF. 
As to self-perceived AHSP, on average, all subgroups improved over time. A small 
percentage of patients declined regarding self-perceived AHSP post-rehabilitation. 
 
Conclusion: A majority of stroke patients across the whole arm-hand impairment 
severity spectrum significantly improved on AHF, arm-hand capacity and self-
perceived AHSP. These were maintained up to one year post-rehabilitation. Results 
may serve as a control condition in future studies. 
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Introduction 
 
One of the most common deficits following stroke is a persistent impairment of the arm 
and hand due to a hemiparesis, which has a significant impact on performance in daily 
life activities [1]. Recovery of arm-hand function and skills is a major rehabilitation and 
health care challenge. Motor rehabilitation approaches for arm-hand performance after 
stroke has been changing substantially over the last decades. However, an integral 
arm-hand skill training approach, accommodating both the heterogeneity of the patient 
population and its associated patterns and levels of recovery directly post-stroke 
seems to be absent. A large number of well-explored and well-investigated examples 
of training approaches in specific (sub) populations have been identified [2] like, for 
instance, task-oriented training [3], mental practice [4] and constraint-induced 
movement therapy (CIMT) [5]. In task-oriented approaches specific functional, skill-
related tasks are trained. This is done preferably by using real-life objects [6], thereby 
teaching patients to solve specific problems related to, e.g., anticipatory motor 
adjustments or cognitive processing by using efficient goal-oriented movement 
strategies [7, 8].  
 
Existing task-oriented arm-hand programs (e.g. [9-16]) are valuable contributions to 
rehabilitation practice and may offer a stable point of departure for clinicians to select 
the most appropriate therapy for a particular patient.  
However, several aspects make it difficult for clinicians to choose the most appropriate 
arm-hand therapy intervention(s) for a particular patient: 1) Most studies or programs 
target specific populations (in particular those with some preservation of wrist and/or 
finger extension) and thus are less applicable for patients with a more severely affected 
arm-hand as seen in the heterogeneous populations of many rehabilitation centres 
[17]. 2) Programs are focused on either the arm or the hand alone. 3) Most of the 
current studies in research projects feature strictly protocolled interventions, which 
cannot be easily adopted in the clinicians’ daily practice. 4) The lack of information 
about the proportional improvement or deterioration to be expected in stroke survivors 
in the sub-acute phase after stroke may lead to difficulties for clinicians to make 
decisions about arm-hand treatment objectives and concomitant prognostics regarding 
arm-hand skill performance. 
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In order to overcome these four drawbacks a Concise Arm and hand Rehabilitation 
Approach in Stroke (acronym: CARAS) [18] was developed in order to guide clinicians, 
during their daily practice, in systematically designing a patient’s optimal arm-hand 
rehabilitation program. CARAS is based on four constructs: a) stratification of the 
patient population is based on the severity of arm–hand impairment for which the 
Utrecht Arm-hand Test (UAT) is used [19], b) clear focus on the individual’s 
rehabilitation goals and concomitant potential rehabilitation treatment outcomes, c) 
principles of self-efficacy, and d) possibility to systematically incorporate (new) 
technology and new evidence-based training elements swiftly. CARAS has proven to 
be feasible in a number of stroke units of rehabilitation centres throughout the 
Netherlands. 
 
In the present study, the term ‘arm –hand function’ (AHF) refers to the ICF ‘body 
function and structures level’. The term ‘arm-hand skilled performance’ (AHSP) refers 
to the ICF activity level, covering both capacity and performance [20].  
 
The present paper focusses on two aspects.  
Firstly, during rehabilitation AHF and AHSP may improve to a certain level. However, 
once a stroke patient has left the rehabilitation program, his arm-hand capacity and 
performance may deteriorate [21]. Whereas stroke patients with mild to moderate initial 
impairments show an almost fixed amount of recovery after stroke, ranging up to 70% 
[22, 23], stroke patients with a more severely affected arm-hand, i.e. absence of finger 
extension combined with large motor impairments, strongly lag behind this recovery 
percentage.  
Four years after stroke, 67% of stroke survivors still experience non-use or disuse of 
the moderately or severely affected arm–hand [24].  
However, it is neither well understood at what rate such deterioration (or improvement) 
occurs, nor in which patient categories, i.e. patients with a certain level of arm-hand 
severity, this is most prominent. Answers to these questions are essential for the 
development of more adequate, personalised and cost-effective interventions that may 
augment and/or maintain arm-hand skill performance (AHSP) levels in stroke patients 
living in their home environment.  
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Secondly, the risk of losing the opportunity to clearly define ‘therapy-as-usual’ (TAU) 
is becoming a problem in AHSP research in stroke patients. In the myriad of studies 
evaluating newly developed training protocols aimed at improving AHF and/or AHSP, 
each of these new training approaches is contrasted to some kind of TAU, the latter of 
which may vary widely between clinics and institutes. Even worse, often TAU is not 
clearly defined at all.  
As the implementation of many of the tested experimental treatments progresses, the 
concept of ‘therapy-as-usual’ inevitably will be lost.  
 
The aim of the present study was to evaluate the course AHF and AHSP take in a 
broad range of sub-acute stroke patients during and after rehabilitation involving a 
therapy-as-usual (i.e. CARAS) [18].   
Three subgroups, i.e. a subgroup of patients with a severely affected arm-hand, a 
subgroup of patients with a moderately affected arm-hand and a subgroup of patients 
with a mildly affected arm-hand, were formed.  
 
The research questions were: 
1) To what extent do arm-hand function and arm-hand skill performance in stroke 
patients change during and after their rehabilitation involving therapy-as-usual? 
2) To what extent does the rate of improvement or deterioration (over time) of arm-
hand function and arm-hand skill performance differ between three subgroups of 
stroke patients, i.e. patients with either a severely, moderately or mildly affected 
functional arm-hand, during and after their rehabilitation involving CARAS? 
 
 
Methods 
 
Design 
This study is a single-armed prospective cohort study conducted between February 
2011 and May 2015. Stroke patients who experienced AHF loss and (concomitantly) 
AHSP loss were assessed during and up till 12 months after their protocolled 
rehabilitation treatment.  
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This investigation has been conducted according to the principles expressed in the 
Declaration of Helsinki. This project was approved by the Medical Ethics Committee of 
Maastricht University Medical Centre in the Netherlands (dossier number NL35681.068.11).  
 
Written informed consent was obtained from all participants prior to the start of their 
participation in this study. 
 
Population 
The study population consisted of a broad range of sub-acute stroke patients admitted 
to an inpatient stroke ward of the Adelante Rehabilitation Centre. Identification of 
potential participants was done by the rehabilitation specialists of the stroke unit, based 
on the inclusion and exclusion criteria as mentioned below. Inclusion criteria were kept 
to a minimum: age ≥18 years; clinically diagnosed with central paresis of the arm/hand 
at entry in the study; ability to control sitting posture; a fair cognitive level, i.e. being 
able to understand the questionnaires and measurement instructions. Exclusion 
criteria were: additional complaints that may interfere with the execution of the 
measurements; no informed consent. 
In this study the primary outcome measure to assess arm-hand use on the hemiparetic 
side in stroke patients was the ARAT [25].Given a mean difference of at least 10% 
between baseline values and post-intervention values, an expected standard deviation 
of the difference of 15%, a two-sided test in a repeated-measures design, an alpha of 
0.05, a power of 0.90, and a loss to follow-up of 10%, at least 29 participants per group 
needed to be included in the study. For three groups 87 participants were needed. 
 
Procedures 
 
Therapy-as-usual 
All participants followed the Concise Arm and hand Rehabilitation Approach in Stroke 
(CARAS) [18] as provided by the medical and paramedical staff of Adelante 
rehabilitation centre. CARAS spans the full range of arm-hand impairments considered 
for this patient group. This approach consists of a well-described program offering 
stepwise, transparent and comprehensible procedures, tailored to specific needs of 
the individual patient.  
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Based on the UAT score (0 – 7) [19], patients were allocated to one of the three 
subgroups (i.e. subgroup 1 = severely affected, subgroup 2 =  moderately affected and 
subgroup 3 = mildly affected) and were allocated to one of three training programs 
within CARAS. Subgroup 1 followed program 1 which targets stroke survivors with an 
UAT score of 0 to 1, and is titled ‘taking care and prevention’. It is designed for stroke 
survivors who are not able to use their affected arm and hand for skill performance in 
daily life situations (non-functional arm-hand). This program contains different topics 
aimed at getting and keeping the affected shoulder and arm-hand in an optimal 
condition and learning strategies on what to do when discomfort arises. Subgroup 2 
(UAT score 2-3) was admitted to program 2 and subgroup 3 (UAT score 4-7) followed 
program 3. Both programs are high intensity, task-oriented arm-hand performance 
training programs in which patients learn to integrate their affected arm and hand in 
daily occupations, thus optimizing their overall functional abilities in daily situations. 
Patients in subgroup 2 will work on becoming more able to use their affected arm and 
hand for passive and active stabilisation tasks, like fixating bread while making a 
sandwich. Patients from subgroup 3 are already able to use their affected arm and 
hand instantaneously in daily situations. They will work more towards complex (bi-
)manual activities. Patients in program 1 spend 4.5 hours on training spread across 
each week. Patients following program 2 or 3 receive an intensive exercise training of 
6 hours spread across each week. A more detailed description of the therapy content 
and basic assumptions of CARAS have been described by Franck and co-workers [18].  
 
After baseline measurements, patients enrolled in one of the three programs and 
started training for six consecutive weeks. After six weeks the patient left the program 
and entered the second assessment. Progression made, was expressed in terms of 
functional goals reached, based on performance and capacity levels exceeding certain 
minimal clinically important thresholds as captured by outcome measurements. 
Depending on these results it was possible for the patient to choose for a second (and 
final) six weeks period of training, which was then also evaluated. 
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Outcome measures 
The following measurements, covering both the ‘function’ and ‘activities’ domain of the 
International Classification of Function, Disability and Health (ICF) (World Health 
Organization, 2001), were performed.  
 
At function level, the Fugl-Meyer Motor Assessment (FMA) and dynamometry (gauging 
grip strength) were used. The upper extremity section of the FMA is a reliable and valid 
test for the assessment of arm-hand function in stroke patients at function level [26, 
27]. Its score ranges from 0 to 66. The minimal clinical important difference (MCID) for 
the FMA upper extremity section is 9 points (for both the affected dominant and 
affected non-dominant arm-hand) [28]. 
Grip strength of the hand was measured using the JAMAR hand dynamometer [29].  
Grip strength (in N) was measured three times and the mean score was used. The 
MCID for grip strength were 50 N (affected dominant hand) and 62 N (affected non-
dominant hand) [30]. 
 
At activity level, encompassing both capacity and perceived performance, the Action 
Research Arm test (ARAT) and ABILHAND were used. The ARAT has been proven to 
be reliable, valid and sensitive to change in measuring upper limb capacity at activity 
level in patients with stroke [31-34]. It consists of four subtests comprising 16 grasp 
movements and three reaching movements to be performed by the patient. Items are 
scored on a 4-point scale, its sum score ranging from 0 to 57. The MCID of the ARAT 
were 12 points (affected dominant arm-hand) and 17 points (affected non-dominant 
arm-hand) [30].  
The ABILHAND is a Rasch-evaluated test to assess the manual ability in terms of the 
difficulty perceived by patients with hand impairments in their daily life [35]. It focuses 
on 23 representative unimanual or bimanual activities [36, 37]. The test is administered 
as a semi-structured interview, using a 3-level ordinal rating scale: impossible (0), 
difficult (1), and easy (2) to perform. The ABILHAND is valid, responsive and clinically 
useful [35, 36]. The MCID of the ABILHAND is within a range of 0.26 to 0.35 [38]. 
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Finally, one single question was used every two weeks to gauge the occurrence of any 
major event (for example ‘flu’, ‘falls’, etc.) that might have affected the use of the arms 
or hands of the patient over the past two weeks. (“Has there been any major problem 
during the last 2 weeks preventing you from using one or both hands?(yes/no). If so, 
please indicate (from a short list) which event(s).”). This question was merely used as 
an indicator in case of any unexplainable data shift in a patient’s time series occurring. 
This indicator was not used in the statistical analyses. 
In clinical practice and in randomized clinical trials an improvement of 10% or more on 
the primary outcome measure is often considered being clinically relevant (e.g. 
Kwakkel et al [39] [40]). As to deterioration on a primary outcome measure, no clear 
guidelines are available. In our study we therefore decided to use a conservative 
threshold of 5% in identifying any deterioration, thus making sure that even a small 
reduction in the outcome would be considered being a deterioration. 
 
Measurement dates 
As soon as possible after admission to the rehabilitation centre the aforementioned 
measurements were performed (baseline measurement (TBL)). Furthermore, at five 
additional points in time, interspaced by three months, measurements were performed, 
starting one week prior to discharge from the clinical and outpatient rehabilitation 
program (TCD), followed by T3m (=TCD + 3 months) through T12m (=TCD + 12 months). In 
Figure 1 an overview of the measurement dates is given. 
 
 
Figure 1.    Overview of measurement timing. T = time; BL = baseline; CD = clinical discharge; m = month. 
 
Rehabilitation phase Post rehabilitation phase
Admission Clinical discharge
6
weeks
6
weeks
TBL TCD T3m T6m T9m T12m
3
months
3
months
3
months
3
months
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Data processing and statistical analysis 
 
For data representation, boxplots were used. As to the methodological handling of 
missing values in this study, four decision rules, formulated prior to the start of the 
study, were applied (consecutively). 
1. When the baseline value was missing, its value was estimated using the mean 
baseline value of the (sub-)group.  
2. When the T12m value was missing, the ‘last observation carried forward’ procedure 
[41] was used.  
3. When 1 or 2 (temporally adjacent) value(s), not being the baseline value or the T12m 
value, were missing, these missing value(s) were estimated by linear interpolation 
using the two valid adjacent values in the time series.  
4. In case of 3 or more missing values, the whole case was discarded.  
 
The MCID threshold values, as used in this study, were corrected for hand dominance. 
Per subgroup, the number of patients whose outcome scores exceeded these MCID 
thresholds were ascertained. These numbers were then converted into a percentage 
of the total number of persons within a subgroup.  
In order to assess whether data were normally distributed or not, multiple Shapiro-Wilk 
tests were performed. As, eventually, nearly all data turned out to be non-normally 
distributed, data were statistically analysed using non-parametric statistics. Alpha was 
set at 0.05. The ‘intention-to-treat’ principle was used, i.e. patients were analysed 
according to the program in which they originally started. Friedman two-way analysis 
of variance by ranks was used for the data of each subgroup to determine whether 
patients improved over time, i.e. between all measurement dates from TBL up till T12m 
regarding the FMA, grip strength, ARAT, and ABILHAND. Subsequent multiple 
comparisons between TBL and TCD data (to ascertain any changes in AHF and AHSP 
during the rehabilitation phase) as well as between TCD and T12M data (representing 
changes the one year follow-up), included Wilcoxon signed ranks tests. A Bonferroni 
approach was used to control for spurious false positive findings. 
For ascertaining any possible differences between subgroups as to the rate of 
improvement in arm-hand performance during rehabilitation and during the 12 months 
follow-up, Kruskal-Wallis tests were applied. Here, multiple comparisons included 
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Mann-Whitney U-tests in a Bonferroni approach. Data were analysed using SPSS 
software (version 23.0, IBM Corp., New York). 
 
 
Results 
 
Error analysis  
In total 89 patients entered the study. Three patients dropped out due to a recurring 
stroke during the study. Two patients prematurely left the study after the TCD 
measurement because of personal reasons. Six patient cases were discarded 
following the procedures we used regarding missing values (rule number 4), i.e. when 
data from three or more measurement dates were missing. No significant differences 
in patient characteristics existed between the patients who dropped out and the 
remaining patients.  
Shapiro-Wilk tests revealed that the majority of data were not normally distributed. 
Therefore, data were analyzed using non-parametric statistics as described earlier.  
 
Patient characteristics 
The characteristics of the 89 patients included in the study are shown in Table 1. 
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Table 1.   Patient characteristics upon inclusion in the study. 
Characteristics 
Whole 
group 
Subgroups 
1 2 3 
Total number (n) 89 28 28 33 
Age (y), mean (sd) 57.6 (10.6) 56.2 (11.0) 57.9 (12.5) 58.5 (8.5) 
Gender (n, %)     
Male 63 (70.8%) 15 (53.6%) 24 (85.7%) 24 (72.7%) 
Female 26 (29.2%) 13 (46.4%) 4 (14.3%) 9 (27.3%) 
Side of lesion (n, %)     
Left 53 (59.6%) 13 (46.4%) 18 (64.3%) 22 (66.7%) 
Right 36 (40.4%) 15 (53.6%) 10 (35.7%) 11 (33.3%) 
Stroke Type (n, %)     
Haemorrhagic 17 (19.1%) 5 (17.9%) 5 (17.9%) 7 (21.2%) 
Ischemic 72 (80.9%) 23 (82.1%) 23 (82.1%) 26 (78.8%) 
Lesion site as diagnosed (n)     
Basal ganglia 7 1 2 4 
Brainstem 2   2 
Capsula interna 1   1 
Cerebellum 2   2 
Frontal area 2  1 1 
Frontoparietal area 1 1   
Frontotemporal area 2 1 1  
Parietal area 1   1 
Parietotemporal area 1 1   
Posterior area 1   1 
Temporal area 1   1 
Temporal area & thalamus 1   1 
Thalamus 4 1 1 2 
Pontine 1   1 
Hemisphere 54 22 20 12 
Lacunar 5  3 2 
Medulla oblong. & cerebellum 1   1 
Nucleus caudatus  2 1  1 
Time post stroke (days),  
mean (sd) 
29.8 (20.1) 40 (27.5) 27 (14.5) 23.4 (12.6) 
Affected hand (n)     
Dominant 50 11 17 22 
Non-dominant 39 17 11 11 
n = number; sd = standard deviation. 
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Improvement over time within each subgroup  
 
Fugl-Meyer Motor Assessment 
In Figure 2A - C the boxplots of the FMA data per measurement moment for each of 
the three groups are presented. 
  
Figure 2.     Boxplots of the FMA data per measurement moment for each of the three groups.  
FMA = Fugl Meyer Motor Assessment;TBL = Baseline; TCD = clinical discharge; T3m = (=TCD + 3 months); T6m (=TCD 
+ 6 months); T9m (=TCD + 9 months);T12m (=TCD + 12 months). Circle = outlier value; Asterisk = far out value. 
 
Overall, patients of the three subgroups improved over time between TBL and T12m on 
the FMA (p<=0.000). Multiple comparison analyses revealed that in subgroup 1 the 
FMA improved between TBL and TCD (p=0.003) and between TCD and T12m  (p=0.009). 
In subgroup 2 significant improvements between TBL and TCD (p<=0.000) and between 
TCD and T12m (p=0.004) were found. Similarly, in subgroup 3 improvements between 
TBL and TCD (p<=0.000) and TCD and T12m (p=0.002) were found regarding the FMA 
scores.  
 
Grip strength 
In Figures 3A - C the boxplots of the grip strength data per measurement moment for 
each of the three groups are presented. 
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Figure 3.     Boxplots of the grip strength data per measurement moment for each of the three groups.  
TBL = Baseline;  TCD = Clinical Discharge; T3m = (=TCD + 3 months); T6m (=TCD + 6 months); T9m (=TCD + 9 
months);T12m (=TCD + 12 months). Circles = outlier value; Asterisk = far out value. 
 
In general, patients of the three subgroups improved on grip strength between TBL and 
T12m (p<=0.000). In subgroup 1 no significant changes between TBL and TCD (p=0.066) 
were found, in contrast to the follow-up period, i.e. between TCD and T12m, in which 
substantial improvements were found (p=0.001). Subgroup 2 and subgroup 3 showed 
a significant improvement as to grip strength between TBL and TCD (p<=0.000), and, 
similarly, in the follow-up period between TCD and T12m (p<=0.000). 
  
Action Research Arm Test 
In Figures 4A - C the boxplots of the ARAT data per measurement moment for each of 
the three groups are presented. 
 
Figure 4.     Boxplots of the ARAT data per measurement moment for each of the three groups.  
ARAT = Action Research Arm Test; TBL = Baseline; TCD = Clinical Discharge; T3m = (=TCD + 3 months); T6m (=TCD + 
6 months); T9m (=TCD + 9 months);T12m (=TCD + 12 months). Circles = outlier value; Asterisk = far out value.  
Overall, patients of the three subgroups improved on the ARAT over time between TBL and  
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T12m (p<=0.000). Subgroup 1 progressed on the ARAT between TBL and TCD (p=0.018) 
and in the follow-up period between TCD and T12m (p=0.007). In subgroup 2 progression 
was found between TBL and TCD (P<=0.000), and between TCD and T12m (p=0.001). 
Subgroup 3 improved on the ARAT between TBL and TCD (p<=0.000). However, in the 
latter group, no significant changes on the ARAT were found between TCD and T12m 
(p=0.071).  
 
ABILHAND 
In Figures 5A - C the boxplots of the ABILHAND data per measurement moment for 
each of the three groups are presented. 
 
Figure 5.     Boxplots of the ABILHAND results per measurement moment for each of the three groups.  
TBL = Baseline; TCD = Clinical Discharge; T3m = (=TCD + 3 months); T6m (=TCD + 6 months); T9m (=TCD + 9 months);T12m 
(=TCD + 12 months). Circles = outlier value; Asterisk = far out value. 
 
Generally speaking, patients of subgroup 1, 2 and 3 improved on the ABILHAND over 
time (p<=0.000). Subgroup 1 significantly progressed on the ABILHAND between TBL 
and TCD (p=0.014), and between TCD and T12m (p<=0.000). In subgroup 2 improvements 
on the ABILHAND were found between TBL and TCD (p<=0.000), but not between TCD 
and T12m (p=0.044). Subgroup 3 improved on the ABILHAND between TBL and TCD 
(p<=0.000), but not between TCD and T12m (p=0.040).  
 
Deterioration of arm-hand function, capacity and performance post-rehabilitation 
 
In Table 2 the number and percentage of patients per subgroup whose arm-hand 
function, arm-hand capacity and/or performance either deteriorated (more than 5% 
relative to clinical discharge performance), or remained equal or improved during the 
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post-rehabilitation phase, are presented. Deterioration of arm-hand function, as 
measured with the FMA, occurred in 19.2% of the persons with a severely affected 
arm-hand. In persons with a moderately or mildly impaired arm-hand this occurred in 
19.0% and 3.2%, respectively. Deterioration of grip strength occurred in 0% of the 
severely affected subgroup patients, in 9.5% of the moderately impaired subgroup and 
in 3.2% of the mildly affected subgroup patients. Arm-hand capacity, as measured with 
ARAT, showed a deterioration of 0% in the severely affected group, 9.5% in the 
moderately affected subgroup and 3.2% in the mildly affected subgroup. Deterioration 
of perceived performance, as measured with the ABILHAND, occurred in 56.0% of 
persons with a severely affected arm-hand, in 23.8% and 29.0% of the moderately and 
mildly impaired persons, respectively. 
 
Table 2.   Number (and %) of patients per subgroup whose arm-hand capacity and/or performance either 
deteriorated (more than 5% relative to clinical discharge performance), or remained equal or improved 
during the post-rehabilitation phase  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FMA = Fugl Meyer Motor Assessment; ARAT = Action Research Arm Test; Asterisk = one data point in 1 patient 
(P10) regarding the ABILHAND is missing for Tcd. 
 
  
Test  
Worse or 
Equal / 
better 
 
 
 
Subgroups 
 
 
1 2 3 
(n=26) (n=21) (n=31) 
FMA         
  worse  5 (19.2%)  4 (19.0%)  1 (3.2%) 
  equal / better  21 (80.8%)  17 (81.0%)  30 (96.8%) 
Grip strength         
  worse  0 (0.0%)  2 (9.5%)  1 (3.2%) 
  equal / better  26 (100%)  19 (90.5%)  30 (96.8%) 
ARAT         
  worse  0 (0.0%)  2 (9.5%)  1 (3.2%) 
  equal / better  26 (100%)  19 (90.5%)  30 (96.8%) 
ABILHAND         
  worse  14 (53.8%)  5 (23.8%)  9 (29.0%) 
  equal / better  *11 (46.2%)  16 (76.2%)  22 (71.0%) 
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Differences in rate of improvement over time between subgroups 
 
In Table 3 the rates of improvement over time of subgroups regarding the FMA, grip 
strength, ARAT and ABILHAND are presented. 
 
Fugl-Meyer Motor Assessment 
Overall, the rate of improvement on the FMA between TBL and TCD differed between 
groups (p<=0.000). Furthermore, FMA rate of improvement between TBL and TCD 
differed between group 1 and 2 (p<=0.000), between group 2 and 3 (p<=0.000) but not 
between group 1 and 3 (p=0.064).   
In general, no significant differences between groups regarding the rate at which FMA 
scores changed between TCD and T12m were found (p=0.177).  
 
Grip strength 
Overall, changes in grip strength between TBL and TCD differed between the three 
subgroups (p<=0.000). More specifically, the rate of grip strength improvement differed 
significantly between group 1 and 2 (p<=0.000), group 2 and 3 (p=0.029) and between 
group 1 and 3 (p<=0.000).  
 
With respect to the TCD and T12m measurement period, overall, differences as to the 
rate at which grip strength improved were found between the groups (p=0.009). 
Multiple comparisons revealed a significant difference in the rate of improvement 
between group 1 and 2 (p=0.005). However, no significant differences in the rate of 
improvement on grip strength were found between group 1 and 3 (p=0.050) or group 
2 and 3 (p=0.078) 
 
Action Research Arm Test 
Overall, the rate at which the ARAT improved between TBL and TCD differed among the 
three groups (p<=0.000). Multiple comparisons revealed these differences to be 
present between all (three) combinations of subgroups (p<=0.000).  
Also, overall significant differences between the rate of improvement on the ARAT 
were found between the three subgroups (p=0.004) regarding TCD and T12m. Further 
analysis showed statistically significant differences in improvement on the ARAT 
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between group 1 and 2 (p=0.008), group 2 and 3 (p=0.001), but not between group 1 
and 3 (p=0.684). 
 
ABILHAND 
Overall, differences in the rate at which patients improved on the ABILHAND between 
TBL and TCD were not statistically significant between groups (p=0.056). Regarding the 
TCD and T12m follow-up phase, patients from the three subgroups also did not 
significantly differ as to their rate of improvement on the ABILHAND over time 
(p=0.567).  
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Percentages of patients whose outcome scores exceeded the MCID thresholds 
 
In Table 4, for the FMA, grip strength, ARAT and ABILHAND, the number of patients 
whose outcome scores exceeded the MCID thresholds, expressed as the percentage 
of the total number of persons within each subgroup, are presented. 
 
 
Table 4:  Number of patients whose outcome scores exceeded the MCID thresholds, expressed as the 
percentage of the total number of persons within a subgroup, for FMA, grip strength, ARAT and ABILHAND 
 
Test 
 
Time phase  
  Subgroups  
1 2 3 
FMA  Tbl - Tcd  28% 86% 84% 
  Tcd - T12m  16% 38% 16% 
       
Grip strength  Tbl - Tcd  4% 81% 61% 
  Tcd - T12m  38% 76% 68% 
       
ARAT  Tbl - Tcd  4 % 81 % 57% 
  Tcd - T12m  8% 24% 3% 
       
ABILHAND  Tbl - Tcd  66% 81% 97% 
  Tcd - T12m  66% 62% 65% 
 
FMA = Fugl Meyer Motor Assessment; ARAT = Action Research Arm Test; T.. = time; bl = baseline; cd = clinical 
discharge; 12m = 12 months follow-up time 
 
 
Discussion 
 
The aim of the present study was to investigate a) to what extent arm-hand function 
(AHF) and arm-hand skill performance (AHSP) in subacute stroke patients change 
during and after their rehabilitation involving a well-described ‘therapy-as-usual’, and 
b) to what extent the rate of improvement or deterioration (over time) of AHF and AHSP 
differs between three subgroups of stroke patients. These patients are grouped 
according to their initial level of arm-hand impairment, i.e. severe (UAT 0-1), moderate 
(UAT 2-3) and mild (UAT 4-7) impairment. This study has been performed in a large 
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stroke patient group typically seen in daily medical rehabilitation practice, i.e. only few 
inclusion and exclusion criteria were used, covering a broad spectrum of arm-hand 
problem severity levels, thus enhancing clinical generalisability of our results. 
 
Within-group results 
With respect to the first research question: On average, patients in all three subgroups, 
i.e. suffering from either a severely, moderately or mildly impaired arm-hand, improved 
over time regarding their arm-hand function and capacity as measured with the FMA, 
JAMAR and ARAT. More specifically, both during and after the rehabilitation phase, 
improvement on arm-hand capacity was observed in all three subgroups, except for 
the grip strength in the severely impaired group, which remained low during the 
rehabilitation phase, but did improve slightly during the 12 months post-rehabilitation. 
Given the late onset of the latter, it is very unlikely that this improvement of grip strength 
was caused by spontaneous recovery, whereas an increase in using the affected hand 
in assistance during daily living activities might explain this finding. Alternatively, as 
seen in many cases, the slight improvement in grip strength in the low functional group 
may have been caused by upcoming associated reactions, i.e. spasticity, in a later 
phase after stroke. This slight improvement in grip strength can be used by patients in 
their daily hand performance, although in most cases the functional benefits are 
minimal due to the negative side effects of associated reactions limiting the working 
range of the arm and hand. 
 
During the rehabilitation phase, patients with an initially mildly or moderately affected 
arm-hand (subgroup 2 and 3) improved considerably as to arm-hand capacity and arm-
hand function. Both groups were able to maintain these high levels during the post-
rehabilitation phase. It should, however, be noted that, for both the FMA and ARAT, 
patient scores in the mildly impaired subgroup related to the post-rehabilitation phase 
converged towards the maximum of the scale, thus constituting ceiling effects. 
Whether or not some of these patients may have further improved their arm-hand 
function and capacity beyond the scales’ ranges during the post-rehabilitation phase 
is unclear, especially given the fact that grip strength and perceived arm-hand 
performance did significantly increase in these patients during this phase.  
 
CHAPTER 3
74 
 
 
Remarkably, seven patients who were diagnosed with an UAT score of 0-1 at baseline 
improved considerably as to their arm-hand capacity during and after the rehabilitation 
phase. These patients appear to represent a clinically meaningful subpopulation, 
distinctly different to the majority of patients across the low functional subgroup. Also 
the significant progressions observed at AHF and AHSP level between TBL and TCD 
within the moderately impaired group (group 2) leads to further questions concerning 
possible compensation and recovery mechanisms occurring at brain level in the sub-
acute phase post-stroke. Improvements made regarding voluntary movement during 
and after the rehabilitation phase may be related to a substantial recovery of the 
corticospinal tract [42]. FMA outcome (arm-hand part) is said to be associated with 
cortico-spinal tract integrity and may be used in predicting recovery from motor 
impairment after stroke [43, 44]. The progressions measured with the FMA between 
TBL and TCD within this moderately impaired group suggests that a certain degree of 
recovery of the cortico-spinal tract may have taken place. They underpin the 
observation that especially persons who are classified as ‘moderately impaired’ may 
go through a considerable recovery process regarding their affected arm and hand 
.This means that patients who lack any dexterity, i.e. finger extension at the start of 
program 2,  still have an ability to generate and maintain significant progressions in 
AHF and AHSP. In terms of optimization of personalized arm-hand treatment and 
outcome, assessment should be focused on early detection of these patients among 
the population of patients with an initially low-functioning arm-hand.  
 
In order to identify persons who initially show no recovery of hand movements, 
transcranial magnetic stimulation (TMS) [45] and diffusion tensor imaging (DTI) [46] 
are upcoming techniques to accurately predict arm-hand recovery. These techniques 
could be especially useful in the early phase of the rehabilitation process in assisting 
in deciding on rehabilitation goals and concomitant therapies.  
 
As to self-perceived AHSP measured with the ABILHAND, as gauged using the ‘5% 
threshold’ criterion, on average, all three groups improved over time. Whereas the 
severely impaired subgroup improved during both the rehabilitation phase and the 
post-rehabilitation phase, patients with an initially moderately or mildly impaired arm-
hand function improved only significantly during the rehabilitation phase. During the 
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post rehabilitation phase they were, again on average, able to maintain this self-
perceived ability level, but did not increase any further. However, a more in-depth 
analysis of the post-rehabilitation data revealed that in 5 to 14% of all cases self-
perceived AHSP deteriorated between clinical discharge and one-year follow-up, 
especially in the low functional group. However, when using the minimally clinically 
important difference (MCID) criterion in evaluating the ABILHAND data, a somewhat 
higher percentage of patients from subgroup 1 indicate having improved post-clinically. 
The self-perceived deterioration of AHSP by these patients is not in line with the results 
from more objectively quantified performance measures on capacity (ARAT) and 
function level (grip strength), which, for the larger part, remained at the same level or 
improved during the post-rehabilitation phase. One should, however, keep in mind that 
both ARAT and grip strength at clinical discharge were still low in a number of patients, 
especially in the (initially) low functioning group, and thus may have constituted so-
called ‘floor effects’. 
 
Between-group results 
With respect to the second research question: As to the potential differences in the 
rate of improvement between subgroups, there seems to be a non-linear, inverse U-
shaped relation between the rate of improvement at the level of AHF and AHSP on the 
one hand, and the severity of the loss of arm-hand function directly post-stroke. The 
largest gains as to AHF and AHSP, both during and after the rehabilitation phase, are 
seen in patients with an initially moderately affected arm-hand due to a stroke (UAT 
score 2-3), which is consistent with studies reported by Winters [23], Prabhakaran [22], 
Duncan [47] and Mirbagheri [48]. However, one should keep in mind that the majority 
of the patients with a moderately impaired arm-hand (in contrast to persons with a 
severely or mild impaired arm-hand) received a second six weeks period of training.  
 
Furthermore, in contrast to patients with a moderately affected arm-hand, patients with 
an initially severely (UAT score 0-1) or mildly (UAT score 4-7) affected arm-hand 
showed a limited rate of improvement regarding the FMA and ARAT. In the latter group, 
however, ceiling effects in these measures as mentioned previously, might be 
responsible for this finding. 
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In contrast to the progressions made at function level and capacity level, no significant 
differences between the rate of improvement at self-perceived performance level 
between subgroups were found, neither during nor after the rehabilitation phase. 
Nevertheless, what becomes clear from our data is that, across all subgroups, changes 
in self-perceived performance regarding arm-hand skills do not correlate well with 
changes in a patient’s arm-hand skill capacity. Regarding the patients whose self-
perceived performance decreases, the specific question arises what may have caused 
this deterioration in the post-rehabilitation phase. The answer to this question may be 
two-fold. First, one could argue that some patients’ frame of reference regarding their 
perception and cognitions as to their daily skill performance may (negatively) change 
over time. This seems plausible as patients, once they are back in their own home 
environment, face daily reality and daily routine and may have difficulties to cope with 
this. Once in post-rehabilitation, i.e. chronic phase, patients may undergo a growing 
awareness as to their (in)ability in arm-hand performance. However, this topic should 
be investigated in-depth before a more definitive explanation can be provided. Finally, 
the ABILHAND, gauges a patient’s performance on 23 fixed (bi)manual skills, not all of 
which each patient will perform in his daily routines. However, in the rehabilitation 
phase the patient seems to perceive his own performance more positively, in contrast 
to the post-rehabilitation phase in which he experiences more difficulties in the daily 
life circumstances. This will inevitably yield low sub-scores on some skills being 
encoded as having become more difficult. A possible solution to this problem may be 
to further personalize the list of skills to better fit the patient’s changing needs and skill 
ambitions across time, which currently is beyond the scope of the ABILHAND.  
 
Strength and limitations of this study 
 
Most evidence-based therapies that have been shown to be effective for arm-hand 
performance in the post-stroke phase, are based on the testing of a single experimental 
intervention relative to various shapes of ‘therapy-as-usual’ in a group of preselected 
patients with at least some residual arm-hand function, predominantly focussing on 
persons with a mildly affected arm and hand. However, research studying the 
performance of patients with an unfavourable prognosis and/or a non-functional hand 
(i.e. UAT score 0-1 and 2-3) are scarce in literature [21, 49, 50]. The present study was 
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explicitly designed to monitor the development of arm-hand use and skill performance 
in a broad range of stroke patients across the full stroke severity range who received 
a well-described ‘therapy-as-usual’, i.e. CARAS [18]. Next to evidence that a large 
majority of patients improved as to their AHF and AHSP, our study also provides 
evidence that, in a minority of patients, AHF and self-perceived AHSP deteriorate once 
they have left the active clinical rehabilitation setting.  
The latter especially holds for patients with an initially moderately or severely affected 
arm-hand function (subgroup 1 and 2).  
With respect to the results achieved in all groups the following remarks have to be 
made. First, the majority of the patients with a moderately impaired arm-hand (in 
contrast to persons with a severely or mild impaired arm-hand) received a second six 
weeks period of training. This particular group of patients do have the possibility to use 
their affected hand again in daily performance. However, due to their moderately 
impaired arm-hand they need a second 6-week during period of training. Second, 
patients in program 1 spend 4.5 hours per week on training, while patients in program 
2 and 3 spend six hours per week of training. When neurophysiological recovery is 
absent, patients may be left with a non-functional arm-hand, which cannot be used in 
daily activities. Therefore, from a clinical point of view it is not useful to train patients in 
program 1 (severely affected) according the same practice conditions and as 
intensively as patients in program 2 and 3 (i.e. moderately and mildly affected patients).  
In contemporary clinical trials investigating effects of new therapy approaches patients 
with a moderately to severely affected hand are very often excluded. It is our firm 
opinion that these patient sub-groups deserve more scientific research attention 
regarding the exploration of the possibilities in sensorimotor training methods, 
especially at an early stage post-stoke. 
 
The frame of reference of patients regarding the outcomes at the level of self-perceived 
AHSP may be influenced because they may reflect on their arm-hand abilities as how 
they were previously before the stroke occurred. The use of proxy-measurement has 
been considered. However, proxy-measurement might lead to other difficulties. First, 
regarding perceived performance it is difficult to avoid unreliable outcomes from 
relatives who also are familiar with the patients’ former AHSP level. Second, the 
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measures as used in this study are not designed to be used as proxy-measurement 
instruments. 
 
CARAS has not been proven to be superior to other arm-hand therapy approaches as 
described by e.g. Winstein [9], Combs [10], Arya [11], Wallace [12], McDonnell [13], 
Platz [14], Morris [15], and Harris [16]. As Pollock et al., [51] already highlighted, clinical 
decision making procedures and the clinical application of arm-hand interventions have 
to be tailored to the patient’s individual needs. CARAS is a clearly defined ‘therapy-as-
usual’, which provides practical solutions based on the presence of dexterity and 
corresponding functional possibilities which facilitates a better focus and tailored 
therapy delivery. It provides instructions how to empower patients by using principles 
of self-efficacy, and allows for the systematic incorporation of (new) technology and 
new evidence-based training elements swiftly [18], specifically adapted to the severity 
of the arm-hand impairment.  
 
 
Conclusion 
The present study has yielded a comprehensive longitudinal database on the 
development of AHF and AHSP in a broad range of stroke patients suffering from arm-
hand impairments, who received well-documented ‘therapy-as-usual’, which may be 
used in future research as a reference database to contrast newly developed training 
interventions. 
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Abstract 
 
Introduction: Improvement of arm-hand function and arm-hand skill performance in stroke 
patients is reported by many authors. However, therapy content often is poorly described, 
data on actual arm-hand use are scarce, and, as follow-up time often is very short, little 
information on patients’ mid- and long-term progression is available. Also, outcome data 
mainly stem from either a general patient group, unstratified for the severity of arm-hand 
impairment, or a very specific patient group.  
 
Objectives: To investigate to what extent the rate of improvement or deterioration of actual 
arm-hand use differs between stroke patients with either a severely, moderately or mildly 
affected arm-hand, during and after rehabilitation involving a well-defined rehabilitation 
program. 
 
Methods: Design: single–armed prospective cohort study. Outcome measure: affected 
arm-hand use during daily tasks (accelerometry), expressed as ‘Intensity-of arm-hand-use’ 
and ‘Duration-of-arm-hand-use’ during waking hours. Measurement dates: at admission, 
clinical discharge and 3, 6, 9 and12 months post-discharge. Statistics:2-way repeated 
measures ANOVAs. 
 
Results: Seventy-six patients (63 males); mean age: 57.6 years (sd:10.6); post-stroke time: 
29.8 days (sd:20.1) participated. Between baseline and 1-year follow-up, Intensity-of-arm-
hand-use on the affected side increased by 51%, 114% and 14% (p<.000) in the mildly, 
moderately and severely affected patients, respectively. Similarly, Duration-of-arm-hand-
use increased by 26%, 220% and 161% (p<.000). Regarding bimanual arm-hand use: 
Intensity-of-arm-hand-use increased by 44%, 74% and 30% (p<.000), whereas Duration-
of-arm-hand-use increased by 10%, 22% and 16% (p<.000). 
 
Conclusion: Stroke survivors with a severely, moderately or mildly affected arm-hand 
showed different, though (clinically) important, improvements in actual arm-hand use during 
the rehabilitation phase. Intensity-of-arm-hand-use and Duration-of-arm-hand-use 
significantly improved in both unimanual and bimanual tasks/skills. These improvements 
were maintained until at least 1 year post-discharge. 
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Introduction 
 
After stroke, the majority of stroke survivors experiences significant arm-hand impairments 
[1, 2] and a decreased use of the paretic arm and hand in daily life [3]. The actual use of 
the affected hand in daily life performance depends on the severity of the arm-hand 
impairment [4-6] and is associated with perceived limitations in participation [7, 8]. Severity 
of arm-hand impairment is also associated with a decrease of health-related quality of life 
[9],  restricted social participation [10], and subjective well-being [11, 12].   
Numerous interventions and arm-hand rehabilitation programs have been developed in 
order to resolve arm-hand impairments in stroke patients [6, 13]. In the Netherlands, a 
number of stroke units in rehabilitation centres implemented a well-described ‘therapy-as-
usual’ arm-hand rehabilitation program, called CARAS (acronym for: Concise Arm and 
hand Rehabilitation Approach in Stroke)[14], serving a broad spectrum of stroke patients 
across the full stroke severity range of arm-hand impairments. The arm-hand rehabilitation 
program has been developed to guide clinicians in systematically designing arm-hand 
rehabilitation, tailored towards the individual patient’s characteristics while keeping control 
over the overall heterogeneity of this population typically seen in stroke rehabilitation 
centres. A vast majority of stroke patients who participated in CARAS improved on arm-
hand function (AHF), on arm-hand skilled performance (AHSP) capacity and on (self-) 
perceived performance, both during and after clinical rehabilitation [15]. The term ‘arm-
hand function’ (AHF) refers to the International Classification of Functioning (ICF) [16] 
‘body function and structures level’. The term ‘arm-hand skilled performance’ (AHSP) 
refers to the ICF ‘activity level’, covering capacity as well as both perceived performance 
and actual arm-hand use [17]. 
Improved AHF and/or AHSP capacity do not automatically lead to an increase in actual 
arm-hand use and do not guarantee an increase of performing functional activities in daily 
life  [18-20]. Improvements at function level, i.e. regaining selectivity, (grip) strength and/or 
grip performance, do not automatically lead to improvements experienced in real life task 
performance of persons in the post-stroke phase who live at home [18, 21]. Next to 
outcome measures regarding AHF, AHSP capacity and (self-) perceived AHSP, which are 
typically measured in controlled conditions, objective assessment of functional activity and 
actual arm-hand use outside the testing situation is warranted [22, 23]. 
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Accelerometry can be used to reliably and objectively assess actual arm-hand use 
during daily task performance [24-32] and has been used in several studies to detect 
arm-hand movements and evaluate arm-hand use in the post-stroke phase [20, 33-
35]. Previous studies have demonstrated that, in stroke patients, movement counts, as 
measured with accelerometers, are associated with the use of the affected arm-hand 
(Motor Activity Log score) [36, 37] and, at function level, with the Fugl-Meyer Motor 
Assessment [38]. Next to quantifying paretic arm-hand use, accelerometers have also 
been used to provide feedback to further enhance the use of the affected hand in 
home-based situations [39]. Most studies consist of relatively small [27, 30, 40-44] and 
highly selected study populations [45] with short time intervals between baseline and 
follow-up measurements. As to our knowledge, only a few studies monitored arm-hand 
use in stroke patients for a longer period, i.e. between time of discharge to a home 
situation or till 6 to 12 months after stroke [19, 44, 46]. However, they used a relatively 
small study sample and their intervention aimed at arm-hand rehabilitation was 
undefined. Both studies of Connell et al. and Uswatte et al. describe a well-defined arm 
hand intervention where accelerometry data were used as an outcome measure [27, 
47]. However, the study population described by Connell et al. consisted of a relative 
small and a relative mildly impaired group of chronic stroke survivors. The study 
population described by Uswatte et al. consisted of a large group of sub-acute stroke 
patients within strict inclusion criteria ranges [37], who, due to significant spontaneous 
neurologic recovery within this sub-acute phase, had a mildly impaired arm and hand 
[48, 49]. This means that the group lacked persons with a moderately to severely 
affected arm-hand, who are commonly treated in the daily rehabilitation setting. 
The course of AHF and AHSP of a broad range of sub-acute stroke patients during 
and after rehabilitation involving a well-defined arm-hand rehabilitation program (i.e. 
CARAS) [14] has been reported by Franck et al. [15]. The present paper provides data 
concerning actual arm-hand use in the same study population, and focuses on two 
objectives. The first aim is to investigate changes in actual arm-hand use across time, 
i.e. during and after clinical rehabilitation, within a stroke patient group typically seen 
in daily medical rehabilitation practice, i.e. covering a broad spectrum of arm-hand 
problem severity levels, who followed a well-described arm-hand treatment regime. 
The second aim is to investigate to what extent improvement (or deterioration) 
regarding the use of the affected arm-hand in daily life situations differs between 
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patient categories, i.e. patients with either a severely, moderately or mildly impaired 
arm-hand, during and after their rehabilitation, involving a well-defined arm-hand 
rehabilitation program. 
 
 
Methods 
 
Design 
 
This study is a single-armed prospective cohort study conducted between February 
2011 and May 2015. Stroke patients who experienced AHF impairments were 
assessed during and up till 12 months after their protocolled rehabilitation treatment. 
This study meets the principles as stated in the Declaration of Helsinki and was 
approved by the Medical Ethics Committee of Maastricht University Medical Centre in 
the Netherlands (dossier number NL35681.068.11). 
Written informed consent was obtained from all participants prior to the start of their 
participation in this study. 
 
Population 
The study population consisted of a broad range of sub-acute stroke patients admitted 
to the inpatient stroke ward of Adelante Rehabilitation Centre in Hoensbroek, the 
Netherlands. Inclusion criteria were kept to a minimum, i.e.: age ≥18 years; clinically 
diagnosed with central paresis of the arm/hand at entry in the study; ability to control 
sitting posture; a fair cognitive level, i.e. being able to understand the questionnaires 
and measurement instructions. Exclusion criteria were: additional complaints that may 
interfere with the execution of the measurements; no informed consent. 
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Procedures 
 
Therapy-as-usual   
After having been admitted to the Concise Arm and hand Rehabilitation Approach in 
Stroke (CARAS) [14], all participants were coached in arm-hand training, how to cope 
with their affected hand and to (re-)explore how to use their arm-hand in daily life 
activities or, in case dexterity was lacking completely, how to learn to keep and 
maintain the affected arm-hand in an optimal condition. CARAS targets a broad 
spectrum of arm-hand impairments typically seen in a heterogeneous stroke 
rehabilitation population. This approach consists of a well-described program offering 
stepwise, transparent and comprehensible procedures, tailored to specific needs of 
the individual patient.  
Based on the severity of arm–hand impairment, for which the Utrecht Arm-hand Test 
(UAT) was used [50], patients were stratified into three subgroups, i.e. subgroup 1 
(severely affected arm-hand (UAT score 0-1)), subgroup 2 (moderately affected arm-
hand (UAT score 2-3)), and subgroup 3 (mildly affected arm-hand (UAT score 4-7)). 
All patients followed one of three training programs within CARAS. Subgroup 1 
followed program 1, titled ‘taking care and prevention’. These patients are unable to 
use their affected arm and hand for skill performance in daily life situations (non-
functional arm-hand). Program 1 contains different topics aimed at getting and keeping 
the affected shoulder and arm-hand in an optimal condition and learning strategies on 
what to do when discomfort arises. Patients in subgroup 2 (UAT score 2-3) were 
admitted to program 2, whereas patients in subgroup 3 (UAT score 4-7) followed 
program 3. Both program 2 and 3 incorporate (high) intensive, task-oriented training 
components aimed at optimal integration of the affected arm and hand in daily 
occupations. Patients in subgroup 2 work on passive and active stabilisation tasks in 
order to become able to use their affected arm and hand for, e.g., holding vegetables 
on a table while cutting them with a knife held in the non-affected hand. Patients from 
subgroup 3 relearn their abilities to use their affected arm and hand instantaneously in 
daily situations in which more complex (bi-)manual activities are necessary. Patients 
in program 1 spend 4.5 hours per week on training during a period of six weeks. 
Patients in program 2 spend six hours of training per week during 12 weeks and 
patients in program 3 spend six hours of training during each week for 6 weeks. In this 
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study CARAS is considered as ‘therapy-as-usual’ i.e. the standard rehabilitation 
approach for patients who cope with arm-hand deficits due to stroke occurrence. A 
more detailed description of the therapy content and the basic assumptions of CARAS 
have been presented elsewhere by Franck and co-workers [14].  
 
After baseline assessment, patients enrolled in one of the three programs and started 
training for six consecutive weeks. After six weeks the patient left the program and entered 
the second assessment.  Progress made, was expressed in terms of functional goals 
reached, based on capacity and performance levels exceeding certain minimal clinically 
important thresholds, as captured by the outcome measures at function level and activity 
level. Depending on these results, it was possible for the patient to choose for a second 
(and final) six weeks period of training, which was then also evaluated [14]. 
 
Outcome measures 
At the start of the study the following demographic data and characteristics of 
participants were recorded: Gender, age, time post-stroke, stroke localisation, affected 
side, hand dominance, and status of the affected arm and hand expressed in terms of 
dexterity (severely, moderately or mildly affected), based on the UAT score [50].  
 
Every two weeks a short question was posed in order to establish the occurrence of any 
major event that may have prevented the participant from using one or both arms or 
hands. The questions posed, was: “Has there been any major problem during the last two 
weeks preventing you from using one or both hands?  (yes/no).  If so, please indicate 
(from a short list) which problem(s).”This information is important as it may be used in 
explaining changes in data trends due to non-therapy-related events (e.g. sudden 
reduction in arm-hand use because the patient became ill and was confined to bed). 
 
At each measurement time point the amount of arm-hand use (on both the affected 
and non-affected side) was monitored for 3 consecutive days, using watch-like 
accelerometers  
(Actiwatches (Actiwatch AW7, CamNtech, UK)). Accelerations were recorded and 
converted into digital signals with a sample frequency of 32 Hz and a quantization 
range between  -128 and +128. Accelerations between -5g and +5g can be recorded 
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by the system. The threshold of movement detection (=system sensitivity) is 0.05g. 
[36]. Per measurement session, two Actiwatches had to be worn, one on each wrist. 
Both Actiwatches were held in place using a nylon strap on the wrist, i.e. at the distal 
part of the radius, with the device facing the dorsal side of the forearm.   
 
Measurement dates 
 
This study included six measurements. After admission to the rehabilitation centre and 
prior to the start in CARAS a baseline measurement (TBL) was performed, followed by 
a measurement at clinical discharge (TCD). After discharge, measurements were 
performed at four additional points in time, interspaced by three months: T3m (=TCD + 3 
months) through T12m (=TCD + 12 months).  Per measurement session, the participants 
wore both Actiwatches for a period of three consecutive days in which the amount of 
arm-hand use was recorded continuously. Figure 1 presents an overview of the 
measurement dates. 
 
 
Figure 1.     Overview of measurement timing. T = time; BL = baseline; CD = clinical discharge; M = month. 
  
Rehabilitation phase Post rehabilitation phase
Admission Clinical discharge
6
weeks
6
weeks
TBL TCD T3m T6m T9m T12m
3
months
3
months
3
months
3
months
CHANGES IN ACTUAL ARM-HAND USE IN SUB-ACUTE STROKE PATIENTS
4
 93
 
 
Signal processing 
Accelerations caused by arm-hand movement were recorded as analogue signals 
which were subsequently converted into a digital signal. The highest amplitude per 1-
second period, representing peak intensity, was registered as a “count”. Every two 
seconds the two peak intensity values identified, were summed into a single number. 
This 2-second period was called an epoch [32, 51]. In this study the duration of the 
epoch was set per 2 seconds. This number then became a single data point in the final 
outcome signal or ‘count’ time series [36].  
 
Figure 2 provides an example of a ‘count’ time series of three consecutive days of 
accelerometry data from a participant suffering from a paresis of the arm/hand.  
Figure 2:  Figure 2A represents data from the non-affected arm-hand, whereas Figure 
2B represents data from the affected arm-hand. Figure 2C represents the zero time-
lag low pass filtered signal of the non-affected arm-hand (dotted time series), the 
affected arm-hand (dashed-dotted time series) and the cumulative signal of the data 
of both hands (solid time series). 
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Figure 2.     Accelerometer data ‘count’ time series of three consecutive days. 
A = ‘count’ time series from the non-affected arm; B = count’ time series from the affected arm; Dotted time series 
in Figure 2C = zero time-lag filtered signal from non-affected arm; Dashed-dotted time series in Figure 2C= zero 
time-lag filtered signal from affected arm; Solid time series in Figure 2C = cumulative signal representing both 
filtered signals; vertical dashed-dotted lines = start and end of the so-called ‘uptime’ per day. 
 
First, both ‘count’ time series, from the non-affected and the affected arm (‘A’ and ‘B’ 
respectively in Figure 2), were filtered using a zero time-lag second-order Butterworth filter 
(cut-off frequency: 0.0025 Hz) (dotted time series and dashed-dotted time series in Figure 
2C) and subsequently cumulated into one signal (solid line in Figure 2C). From the latter 
signal, representing the arm-hand activity of both sides, the start and end of the so-called 
‘uptime’ per day was identified (delimited by the vertical dashed-dotted lines on the time 
axis in Figure 2), using a predefined threshold. In order to avoid small resting periods 
during the uptime, in which neither arm-hand was used, to be falsely detected as ‘night 
time’, night time was a-priori defined as being longer than four consecutive hours. Minimal 
uptime length was defined as, at least, 10 consecutive hours per day. Night time data were 
discarded. 
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Next, for each uptime, the average sum of ‘counts’ per minute was calculated for each of 
the two devices, i.e. for both arm-hands separately. This average sum of ‘counts’ per 
minute represents ‘Intensity-of-arm-hand-use’ of each arm-hand during the uptime period 
per minute [36, 51]. ‘Duration-of-arm-hand-use’ was calculated as the total amount of time 
(in seconds) in which there was activity of one or both hands exceeding a minimal 
threshold of signal intensity during the uptime.  
Subsequently, more specific information on Intensity-of-arm-hand-use and on Duration-
of-arm-hand-use of both the affected and non-affected arm-hand was extracted from the 
‘count’ time series data collected during uptime. First, the time (during uptime) in which 
the affected arm-hand was used unimanually, the time in which the non-affected arm-hand 
was used unimanually, the time both hands were used and the time none of the hands 
were used, was calculated, based on signal intensity crossing a predefined threshold. 
Next, for each of the aforementioned times the Intensity-of-arm-hand-use was calculated. 
Finally, in order to compare the Intensity-of-arm-hand-use of the affected arm-hand to that 
of the non-affected arm-hand, the ratio between the sum of counts of the affected arm 
(numerator) and the unaffected arm (denominator) was calculated. To avoid 
underestimation of the non-impaired arm-hand counts (denominator), compared to the 
impaired arm-hand (numerator), this ratio was log-transformed before (sub-)group 
averages were calculated [36]. Similarly, this procedure was done for the Duration-of-arm-
hand-use data.  
All accelerometry data were analyzed using MATLAB software version R2016a (The 
MathWorks Inc, Natick, MA, USA) and Microsoft Excel software version 2010 
(Microsoft Corporation, Redmond, Washington, USA).  
 
Handling of missing values 
In order to handle missing data we used the following four decision rules, formulated 
prior to the start of the study; 
1. When the baseline value was missing, this value was estimated using the mean 
baseline value of the subgroup the patient was allocated to.  
2. When the T12m value was missing, the ‘last observation carried forward’ 
procedure was used [52]. 
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3. When 1 or 2 (temporally adjacent) value(s), not being the baseline value or the 
T12m value, were missing, these missing value(s) were estimated by linear 
interpolation using the two valid adjacent values in the time series. 
4. In case of 3 or more missing values, the whole case was discarded. 
 
Statistical analyses 
 
The statistical analysis was performed using the intention-to-treat approach, following 
up all participants as originally allocated to a particular subgroup (1, 2 or 3) of CARAS.  
Statistical analyses included two-way repeated measures Analysis of Variance 
(ANOVA) (within-subject factor: Time, between-subject factor: AHF status). To test for 
normal distribution, the Shapiro-Wilk test was used [53]. Subsequently, multiple 
comparison was done using a Bonferroni approach to control for spurious false positive 
findings, involving two combinations of data sets, i.e. TBL vs. TCD and TCD vs. T12m, 
representing the clinical rehabilitation phase, and the post-rehabilitation phase, 
respectively. Alpha was set at 0.05.  Data were analyzed using SPSS software (version 
24.0) (IBM Inc. Armonk, NY). 
In the results section below, accelerometry data with respect to both Intensity-of-arm-
hand-use and Duration-of arm-hand-use are reported in the following order: First, 
results regarding the affected arm-hand are presented. Second, the results of the use 
of the affected arm-hand during unimanual activities, are presented. Third, results 
regarding the use of both hands, while performing a task bimanually, are presented. 
And four, data regarding the ratio of Intensity-of-arm-hand-use of the affected hand 
and for both hands are presented. 
 
Results 
Patient characteristics and error analysis 
A total of 89 patients entered the study. As a result of the application of the four 
previously stated decision rules, the data of 13 participants were discarded (rule 
number 4), leading to a remaining group of 76 participants used in the statistical 
analysis. For 16 (out of 380) measurement points, data were interpolated in 
accordance with rules 2 and 3.  
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Patient characteristics are presented in Table 1. 
 
Table 1.  Overview of patient characteristics at baseline. 
Characteristics  Whole group                                                                                                                       Subgroups   
          Gr1                          Gr2                       Gr3   
Total number: (n)  89  28 28 33 
Age (years)  
(mean  +/-sd) 
  
57.6  +/-10.6 
  
56.2  +/-11.0 
 
57.9 +/- 12.5 
 
58.5 +/- 8.5 
Gender            
• Male      (n (%)) 
• Female  (n (%)) 
  
63   (70.8%) 
26   (29.2%) 
  
15   (53.6%) 
13   (46.4%) 
 
24   (85.7%) 
  4   (14.3%) 
 
24   (72.7%) 
  9   (27.3%) 
Lesion side     
• Left   (n (%)) 
• Right (n (%)) 
  
53   (59.6 %) 
36   (40.4 %) 
  
13   (46.4%) 
15   (53.6%) 
 
18   (64.3%) 
10   (35.7%) 
 
22   (66.7%) 
11   (33.3%) 
• Stroke Type  
Haemorrhagic      
(n (%)) 
• Ischemic (n (%)) 
             
 
 
17   (19.1 %) 
72   (80.9 %) 
 
 
  5   (17.9 %) 
23   (82.1 %) 
  
 5   (17.9%) 
23   (82.1%) 
   
7   (21.2 %) 
26   (78.8 %) 
Time post stroke 
(days) (mean +/-sd) 
 
29.8  +/-20.1 
 
40  +/-27.5 27  +/-14.5 23.4  +/-12.6 
• Affected hand: 
dominant (n(%)) 
• non-dominant  
(n (%)) 
 
 
  50  (56.2%) 
  39  (43.8%) 
 
 
11 (39.3%) 
17 (60.7%) 
 
17 (60.7%) 
11 (39.3%) 
 
22 (66.6%) 
11 (33.3%) 
Lesion site (n) 
 
 
 
 
Basal ganglia (7), Brainstem (2), Capsula interna (1), Cerebellum (2), Frontal 
area (2), Frontoparietal area (1), Frontotemporal area (2), Parietal area (1), 
Parietotemporal area (1), Posterior area (1), Temporal area (1), Temporal area & 
thalamus (1), Thalamus (4), Pontine (1), Hemispheric (not specified) (54), 
Lacunar (5), Medulla oblongata & cerebellum (1), Nucleus caudatus (2). 
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Intensity-of-arm-hand-use on the affected side during (overall) uptime
Mean values for Intensity-of-arm-hand-use during (overall) uptime for subgroups 1, 2 
and 3 are displayed in Figure 3. The corresponding statistics are presented in Table 2.
From Tbl across to T12m main significant effects for ‘Time’, ‘AHF status’ and ‘Time’ x 
‘AHF status’ were found. Furthermore, whereas, on average, all 3 subgroups showed 
improvement between baseline and clinical discharge regarding Intensity-of-arm-
hand-use on the affected side during uptime, participants from subgroup 2 seem to 
even further improve between discharge  (TCD) and 12 months after clinical discharge 
(T12m). Participants admitted to subgroup 3 improved the most between baseline (TBL) 
and clinical discharge (TCD). 
  
Figure 3.     Mean values for Intensity-of-arm-hand-use during uptime for subgroups 1,2 and 3. T = time; bl = 
baseline; cd = clinical discharge; m = month; Solid line = subgroup 1; Dotted line = subgroup 2; Dashed line = 
subgroup 3.
Intensity-of-arm-hand-use on the affected side
During uptime
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Intensity-of-arm-hand-use on the affected side during unimanual activities
Mean values for Intensity-of-arm-hand-use on the affected side during unimanual 
activities for subgroups 1, 2 and 3 are displayed in Figure 4A. The corresponding 
statistics are presented in Table 2.
Figure 4A.     Mean values for Intensity-of-arm-hand-use on the affected side during unimanual activities for 
subgroups 1, 2 and 3. 
Figure 4B.     Mean values for Intensity-of-arm-hand-use on the affected side during bimanual activities for 
subgroups 1, 2 and 3. T = time; bl = baseline; cd = clinical discharge; m = month. Solid line = subgroup 1; Dotted 
line = subgroup 2; Dashed line = subgroup 3.
The main findings were that, on average, the Intensity-of-arm-hand-use on the affected 
side during unimanual activities decreased in subgroup 1 and 2, and, although not 
statistically significant, to a lesser extent, in subgroup 3, between TBL and TCD.  
Regarding results from TCD and T12m, no further change in Intensity-of-arm-hand-use 
on the affected side during unimanual activities was observed.
Intensity-of-arm-hand-use on the affected side during bimanual activities 
Mean values for Intensity-of-arm-hand-use on the affected side during bimanual 
activities for subgroups 1, 2 and 3 are displayed in Figure 4B. The corresponding 
statistics are presented in Table 2. 
Intensity-of-arm-hand-use on the affected side
Unimanual activities Bimanual activitiesA B
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During bimanual task performance Intensity-of-arm-hand-use on the affected side 
improved in all three subgroups across time, i.e. between TBL and T12m. However, in 
subgroup 2 improvement between TBL and T12m was relatively larger compared to 
subgroup 1 and, though to a lesser extent, to subgroup 3.  At baseline, participants 
from subgroup 2 used their affected arm-hand approximately equally to participants 
from subgroup 1 during bimanual activities.
Duration-of-arm-hand-use on the affected side during unimanual activities 
Mean values for Duration-of-arm-hand-use on the affected side during unimanual 
activities for subgroups 1, 2 and 3 are displayed in Figure 5A . The corresponding 
statistics are presented in Table 3.
Figure 5A.     Mean values for Duration-of-arm-hand-use on the affected side during unimanual activities. 
Figure 5B.     Mean values for Duration-of-arm-hand-use on the affected side during bimanual activities for subgroups 1, 
2 and 3.  T = time; bl = baseline; cd = clinical discharge; m = month. Solid line = subgroup 1; Dotted line = subgroup 2; 
Dashed line = subgroup 3.
Duration-of-arm-hand-use on the affected side
Unimanual activities Bimanual activitiesA B
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Although between TBL and TCD, and also from TBL across to T12m main significant effects 
for ‘Time’ and ‘AHF status’ were found regarding Duration-of-arm-hand-use on the 
affected side during unimanual activities, differences were rather small. Most distinct 
differences between subgroups at all points in time were found between subgroup 1 
and 3. 
 
 
Duration-of-arm-hand-use on the affected side during bimanual activities  
 
Mean values for Duration-of-arm-hand-use on the affected side during bimanual 
activities for subgroups 1, 2 and 3 are also displayed in Figure 5B. The corresponding 
statistics are presented in Table 3. 
 
Significant main effects for ‘Time’ and for ‘AHF status’ regarding Duration-of-arm-hand-
use on the affected side during bimanual activities were found for the phase between 
TBL and TCD as well as for the phase between TBL and T12m. Subgroup differences were 
most prominent between subgroup 1 and 3. 
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Mean ratios regarding Intensity of arm-hand use between the affected and the non-
affected arm-hand during uptime
Mean ratios regarding Intensity of arm-hand use between the affected and the non-
affected arm-hand during uptime for subgroups 1, 2 and 3 are displayed in Figure 6A. 
The corresponding statistics are presented in Table 4.
Figure 6A.     Mean ratios regarding Intensity of arm-hand use between the affected and the non-affected arm-hand 
during uptime for subgroups 1, 2 and 3. 
Figure 6B.     Mean ratios regarding Intensity of arm-hand use between the affected and the non-affected arm-hand during 
bimanual activities for subgroups 1, 2 and 3. T = time; bl = baseline; cd = clinical discharge; m = month; A = affected side; 
NA = non-affected side. Solid line = subgroup 1; Dotted line = subgroup 2; Dashed line = subgroup 3.
During uptime the ratio of Intensity-of-arm-hand-use between the affected and non-
affected side increased in all subgroups across the clinical and post-clinical period, 
with major gains observed between TBL and TCD. Also a main effect for ‘AHF status’, 
but no ‘Time’ x ‘AHF status’ interaction related to Intensity-of-arm-hand-use between 
the affected and non-affected side during uptime was found throughout the 
rehabilitation phase and post-clinical phase.
Mean ratios regarding Intensity of arm-hand use between affected and non-affected side
During uptime During bimanual activitiesA B
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Mean ratios regarding Intensity of arm-hand use between the affected and the non-
affected arm-hand during bimanual activities 
 
Mean ratios regarding Intensity of arm-hand use between the affected and the non-
affected arm-hand during bimanual activities for subgroups 1, 2 and 3 are displayed in 
Figure 6B. The corresponding statistics are presented in Table 4. 
As to the ratio of Intensity-of-arm-hand-use between the affected and non-affected side 
during bimanual activities, similar results were observed as described by the uptime-
related ratios above. 
 
Discussion 
 
The aim of the present study was to assess a) possible improvement or deterioration 
in actual arm-hand use of sub-acute stroke patients during and after clinical 
rehabilitation involving a well-defined therapy approach, and b) to what extent actual 
arm-hand use differs between three subgroups of stroke patients, i.e. patients with 
either a severely, moderately or mildly affected arm-hand, within this time period. The 
majority of the study population significantly improved as to Intensity-of-arm-and-hand-
use during waking hours (or so-called ‘uptime’). However, when differentiating between 
unimanual and bimanual task conditions, during the rehabilitation period, i.e. between 
baseline and clinical discharge, Intensity-of-arm-and-hand-use on the affected side 
during unimanual activities sharply dropped. In contrast, in the exact same period of 
time bimanual activities the Intensity-of-arm-and-hand-use on the affected side 
increased. This indicates that the patients learn to co-use their affected arm-hand more 
during bimanual skill performance.
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Duration-of-arm-hand-use on the affected side during bilateral activities improved, 
especially during the rehabilitation phase, and remained at this higher level during the 
post-clinical phase. In contrast, Duration-of-arm-hand-use on the affected side during 
unilateral activities remained at nearly identical levels throughout the rehabilitation and 
post-rehabilitation phase. These results on actual arm-hand use are in line with 
improvements observed on both function level and capacity level in the same group as 
presented by Franck et al. [15]. 
 
Use of the affected hand unimanually  
 
Intensity-of-arm-hand-use 
In moderately or severely affected patients, the intensity of unimanual arm-hand use 
on the affected side sharply dropped during the rehabilitation phase, as was also 
reported by Rand et al. [18]. This phenomenon was less in the mildly affected group.  
This may have been due to the fact that, during arm-hand treatment, especially the 
moderately impaired patients are vigorously encouraged to use their affected arm-
hand in bimanual activities during their training period in program 2. The mildly 
impaired patients, are, due to their initial state of impairment , already inclined to work 
bimanually, using their affected hand less unimanually. A small scale study by Urbin et 
al. [30] reported similar results in a group of patients in sub-acute phase comparable 
with the moderately and mildly affected group as presented in this study. During the 
post-clinical phase, the intensity of unilateral arm-hand use on the affected side 
remains low. One year after discharge, patients with a moderately affected arm-hand 
function achieved and maintained a certain level of intensity of use of the affected hand 
in unimanual conditions. In contrast, De Niet et al. and Michielsen et al. [54, 55], found 
that chronic stroke patients hardly use their affected arm-hand unimanually.   
Despite a difference in absolute values regarding the Intensity-of-arm-hand-use, 
relative progressions gained in the moderately affected group in the post-rehabilitation 
phase did not differ significantly from those in mildly impaired patients. This is 
interesting, because, in contrast to persons with a mildly impaired arm-hand, patients 
with a moderately impaired arm-hand first had to regain a substantial level of dexterity 
as a prerequisite before being able to actually use their affected arm-hand in daily task 
performance. 
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Duration-of-arm-hand-use 
Whereas Intensity-of-arm-hand-use during unimanual activities showed a significant 
decline during the rehabilitation phase, especially in persons with a mildly and 
moderately affected hand, Duration-of-arm-hand-use of the affected hand improved in 
both groups during the exact same period of time.  Results achieved during the 
rehabilitation phase were maintained across the post-rehabilitation phase, which is 
interesting in particular regarding the moderately impaired group, in which a substantial 
part of the patients started with no dexterity at all [15]. These results may probably be 
a consequence of the patient’s learning process to reintegrate the affected hand during 
skill performance tasks [56]. From the perspective of a patient with a moderately 
affected hand, gaining confidence in task performance is a powerful issue that may 
lead to a more positive belief in his/her own capabilities to achieve levels of arm-hand 
performance previously set out for during goal setting, and may even lead to inter-task 
transfer of learning towards other, untrained functional tasks [57].  
 
Use of the affected arm-hand bimanually 
 
Intensity-of-arm-hand-use 
Regarding bimanual activities, patients with a moderately or mildly impaired hand 
learned to use their affected hand more frequently and more intensively during the 
rehabilitation phase and maintained that level till one year after discharge. Similar 
results were found by Michielsen et al. [55].   
Despite an absolute difference in the values regarding Intensity-of-arm-hand-use as 
measured between the mildly and moderately affected group, the latter group showed 
a similar pattern of progression in bimanual arm-hand use, both during and after the 
rehabilitation phase.  
To improve and to maintain a certain level of Intensity-of-arm-hand-use in the 
moderately affected hand used during bimanual task performance is challenging for 
these patients. They suffer from no or almost no dexterity at the start of the arm-hand 
rehabilitation process [15]. For these patients it takes courage to use their affected 
hand in bimanual activities and become satisfied about how activities are performed 
and accomplished [58].  
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The majority of patients with a severely impaired hand remained unable to use their 
hand during bimanual performance of tasks in this same period. Progressions 
observed regarding Intensity-of-arm-hand-use may be explained by: 1) an increase of 
voluntary movements in flexion synergy in the proximal and/or distal part of the arm; 
2) associated movements while moving or performing activities with the non-affected 
hand or during walking; and 3) performing bimanual exercises as learned to maintain 
the severely affected arm-hand supple and pain free. However, in contrast to the 
majority of patients mentioned above who followed program 1, six patients in the 
severely affected group did show considerable (early) arm-hand improvement. This 
may be associated with spontaneous recovery. This improvement made them eligible 
for training in CARAS program 2, whereas all data from the severely impaired patient 
subgroup were analyzed according to the intention-to-treat principle. A per-protocol 
analysis of the data (not reported here) leaving out these six patients, showed that in 
the severely affected group neither Intensity-of-arm-hand-use nor Duration-of-arm-
hand-use on the affected side improved significantly across time.    
 
The differences in Intensity-of-arm-hand-use, as observed between the three groups, 
may be interpreted as follows: 1) In contrast to severely and moderately affected 
patients, mildly affected patients display voluntary wrist and finger movements at the 
initial phase of the arm-hand rehabilitation program, associated with a certain degree 
of cortico-spinal tract integrity [59, 60]. Due to this substantial spontaneous recovery 
episode, mildly impaired patients become enabled to integrate their affected hand 
relative more quickly in (bimanual) tasks compared to moderately/severely affected 
patients. 2) The course of arm-hand rehabilitation of the mildly affected group is less 
interrupted by problems more commonly seen in the other two groups, like, for 
instance, presence of cognitive deficits, which could influence motor (re)learning 
negatively [61]; the appearance of weakness i.e. loss of strength and change in muscle 
condition [62]; the change in the paretic shoulder’s physical and kinematic properties 
which results in a less than optimal scapular joint alignment [63]; or swelling or edema 
of the post-stroke hand [64]. Patients with a moderately affected hand, admitted to 
CARAS, program 2, went through a considerable development process from not being 
able to use the affected hand during daily activities at the start of the arm-hand training 
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[15], towards displaying dexterity and a concomitant higher level of Intensity-of-arm-
hand-use during rehabilitation and in daily life performance after rehabilitation.  
 
Regarding the moderately and mildly affected group, Uswatte et al. Taub et al. and 
Liao et al. reported similar findings i.e. a significant increase of Intensity-of-arm-hand-
use in sub-acute and chronic stroke patients with a moderately or mildly affected arm-
hand who participated in a constrained-induced therapy program [44, 65]. Liao et al. 
combined functional training with robot practice in mildly impaired chronic stroke 
patients [66]. However, in contrast to the present study, these studies included relative 
small study populations with strict inclusion criteria, thus reducing generalizability.   
No significant difference were reported by Doman et al. and Rand et al. regarding 
Intensity-of arm-hand-use in sub-acute stroke patients with a moderately to mildly 
affected hand, who received arm-hand training [18, 43]. Waddel et al. reported no 
significant differences in Intensity-of-arm-hand-use in moderately and mildly impaired 
chronic (≥ 6 months) stroke patients after the rehabilitation phase who participated in 
a high repetitive, task-specific arm-hand regime [67].  
 
Duration-of-arm-hand-use 
In moderately and mildly impaired patients improvement in the Duration-of-arm-hand-
use of the affected hand during bimanual task performance was observed. However, 
relative to the non-affected arm-hand, the affected arm-hand continued to play a limited 
role, which is in line with the studies of Bailey and Michielsen [29, 55].  
 
In mildly impaired patients in the post-rehabilitation period, the non-affected hand is 
used about one and a half times more than the affected hand. In this same period, 
patients with a moderately affected hand used their non-affected hand about two and 
a half times more than their affected hand. Thrane et al. (2011) found a difference in 
this ratio of up to two and a half times in a group of sub-acute stroke patients with a 
mildly impaired arm-hand who are comparable with the mildly impaired group as 
presented in the present study [68]. In contrast, healthy older adults of approximately 
the same age as the study participants display a more equal Intensity-of-use between 
both hands [55, 69-71]. Regarding the mildly impaired group the reduction in bilateral 
arm-hand activity might be due to (a combination of) a lack of motor capability, patient 
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motivation, a shift in routine performance tasks, or a direct result of so-called learned 
non-use [20, 72].  
The moderately affected group as presented in the present study demonstrated far 
less motor capabilities at the initial start of the rehabilitation phase compared to the 
mildly affected group [15], which may explain the lower level of bimanual performance 
in the moderately affected group. Despite this low level, data obtained from the present 
study suggests that these patients re-learn to use their the affected arm-hand during 
(bi)manual task performance during their rehabilitation period. Within this early, sub-
acute phase these patients become enabled to perform a vast number of bimanual 
tasks in their daily life situation, as learned within program 2 of CARAS. These findings 
differ from the study of Waddel et al. [67], who reported no improvements in arm hand 
use in daily performance, after completing an eight-week intensive task-specific arm-
hand program. However, their study population consisted of chronic (≥ 6 months post-
injury) stroke patients with, on average, a level of arm-hand capacity similar to our 
moderately affected group measured at clinical discharge. In the post-stroke phase, 
the moderately affected hand is used in bimanual activities, but still proportionally less 
than the non-affected hand. The ratio between the affected and non-affected arm-hand 
remained more or less unchanged during the post-clinical phase. This suggests that 
patients may have become accustomed to use their affected hand regularly in skill 
performance in daily situations, a phenomenon also described by other authors [18, 
55, 67]. 
 
Clinically speaking, sub-acute stroke patients who followed an arm-hand training 
featuring CARAS, program 2 and program 3, improved on Intensity-of-use and 
Duration-of-use of their moderately or mildly affected arm-hand.   
 
 
Considerations 
 
This study is not without limitations. First, the inability to differentiate between signals 
stemming from task-specific (e.g. reaching or grasping) or non-task-specific arm-hand 
movement may limit the interpretation of results regarding any qualitative aspect of 
arm-hand motor behavior [30]. Wrist accelerometry is a valid and reliable 
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measurement method [20, 31]. However, it measures ‘use’ and not ‘purposeful 
use’[25], and does not provide information about movement quality or specific activities 
that were performed during the wearing period. Therefore, data on actual arm-hand 
use provided in this study have to be interpreted with some care when translating these 
results towards real arm-hand skill performance. Techniques to identify (the quality of) 
specific among multiple activities using body worn sensors are upcoming and are 
promising tools to further improve actual arm-hand skill performance measurement 
[73].  
 
Secondly, data on actual arm-hand use, based on accelerometry, depend on the way 
how arm-hand use has been defined, and on how data are collected and processed 
[20]. The term ‘counts’, as a measure of ‘amount of use’ [23, 74], is often used. 
However, the calculation of ‘counts’ is not always the same across studies. Therefore, 
in order to be able to compare our results with other studies,  in the present study it is 
explicitly formulated how the ‘amount of use’ metric was calculated, based on the raw 
accelerometer data of the Actiwatches used. This makes careful comparisons with 
other studies regarding the use and interpretation of accelerometry data possible. 
 
Thirdly, in the present study an intention-to-treat analysis has been performed, which 
may have resulted in substantial larger within-group variances in the three subgroups.  
In the severely affected group some patients showed substantial large progressions 
regarding Intensity-of-arm-hand-use during the clinical rehabilitation phase, and were 
transferred from CARAS program 1 to CARAS program 2 during the rehabilitation 
phase. These improvements in a subpopulation in the severely affected subgroup 
could explain the statistically significant differences being found. A per-protocol 
analysis of the data (data not reported in this paper) revealed that in the remainder of 
participants in subgroup 1 neither a statistical nor a clinically relevant improvement in 
actual arm-hand use was found.   
 
Fourthly, contrary to participants from subgroup 1 and 3, patients with a moderately 
affected arm-hand received a second six weeks period of training in order to 
experience functionally meaningful progressions in the use of their affected hand and 
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the possibility to use their affected arm-hand more purposefully in bimanual skill 
performance.  
 
Fifthly, in the present study a distinctly low proportion of female participants 
participated (see Table 1), especially in subgroup 2 and 3. This may have influenced 
our results. In general,  most instrumental activity of daily living (IADL) tasks which 
require arm-hand usage are traditionally done by women. Though physically capable 
to perform IADL tasks, men often rely on their spouses performing  IADL tasks like 
cooking and laundry [75].  However, despite this unequal representation of gender 
across both groups, group results indicate progression in both ‘intensity-of-arm-hand-
use’ and ‘duration-of-arm-hand-use’. Subgroup 1 contained proportionally more female 
participants compared to subgroup 2 and subgroup 3. Therefore, gender differences 
most likely had even less influence on study results regarding the latter group. 
  
Sixthly, the average post-stroke time at point of admission to the study of patients of 
subgroup 1 differed from the average post-stroke time in patients admitted to subgroup 
2 and 3 (see Table 1). This is a phenomenon typically seen in clinical situations in the 
sub-acute phase after stroke. In contrast to moderately and mildly impaired patients, 
who were trained to increase intensity and duration of use of their affected hand, 
patients of subgroup 1 were encouraged to keep their severely affected arm in good 
condition instead of being stimulated, to no avail, to regain arm-hand use [14]. This 
has led to patients from different groups to improve at a different rate, leading to 
between-group differences. Another source of between-group differences is, of 
course, the aforementioned difference in stroke severity at entry into the study. 
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Abstract 
Background: Focal spasticity management in patients in the sub-acute phase after a 
stroke is mainly based on expert opinion. Evidence for the optimal type and intensity 
of multidisciplinary rehabilitation programs is scarce. This study will investigate the 
added-value of reduction of early signs of spasticity in the sub-acute phase after stroke 
on arm-hand rehabilitation outcome involving a well-described rehabilitation 
intervention. Reduction of early signs of spasticity will be done using abobotulinum 
toxin-A. 
Methods / design: This study comprises three methodological approaches, i.e.: i) a 
(multiple baseline) single case experimental design involving 10 individuals; ii) a meta-
analysis of the data of all single cases (= single armed group design); iii) non-
randomised double armed group design, i.e. a case-matched control design in which 
each patient receiving early post-stroke spasticity reduction treatment will be matched 
(according to arm-hand capacity, spasticity level, age, gender, and Utrecht Arm-hand 
Test scores) to a case from a prospective cohort study on changes in arm-hand status 
in 89 stroke patients performed previously. 
Improvement of arm-hand skill performance will be gauged using a) the Action 
Research Arm Test, gauging functional capacity; b) the ABILHAND, gauging perceived 
level of arm-hand skill proficiency; and c) bilateral arm accelerometry, gauging actual 
arm-hand skill performance in daily life. Furthermore, arm-hand function will be 
measured using a) Fugl-Meyer Motor Assessment; b) hand-held dynamometry (grip 
strength); c) Motricity Index (functional strength); and d) Modified Ashworth Scale 
(spasticity levels in the upper extremity). 
Statistical analyses include permutation tests involving the time series of each subject 
separately, Kruskal-Wallis tests and Mann-Whitney U-tests. 
Discussion: Results of this study will provide evidence on the added-value of 
reduction of early signs of spasticity in the upper extremity on functional arm-hand skill 
performance in sub-acute stroke patients with either a severely or moderately affected 
arm-hand and moderate to severe grades of spasticity.  
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Introduction 
In stroke survivors, the presence or absence of voluntary motor activity in the affected 
arm and hand is the most important predictor of dexterity outcome and the level of 
performance regarding daily activities. In order to select the potentially most effective 
treatment, it is advocated to stratify persons with an impaired arm and hand into a 
limited number of arm-hand function strata [1, 2]. 
A Concise Arm and hand Rehabilitation Approach in Stroke (CARAS) [3] has been 
developed to structure and implement the treatment of arm-hand function (AHF) and 
arm-hand skill performance (AHSP) in stroke survivors. CARAS is based on: A) level 
of arm-hand impairment, B) detailed training descriptions captured in different training 
modules, C) principles of self-efficacy [4-6], and D) the swift implementation of 
innovations. Based on the UAT (Utrecht Arm-hand Test) [7] scores, patients are 
allocated to one of three training programs, i.e. CARAS program 1, aimed at the 
severely impaired AHF subgroup (UAT 0-1), CARAS program 2 aimed at the 
moderately impaired AHF subgroup (UAT 2-3) and CARAS program 3, aimed at the 
mildly impaired AHF subgroup (UAT 4-7). Program 1 is titled ‘taking care and 
prevention’. It is designed for stroke survivors who are not able to use their affected 
arm and hand for skill performance in daily life situations (non-functional arm-hand). 
Program 2 and 3 are high intensity, task-oriented arm-hand performance training 
programs in which patients learn to integrate their affected arm and hand in daily 
occupations to optimize their overall functional abilities in daily situations. In this part a 
distinction is made between persons who have a moderately affected arm and hand, 
i.e. those who are able to use their affected arm and hand for passive and active 
stabilization tasks, like fixating bread while making a sandwich; and persons with a 
mildly affected arm and hand, who are able to use their affected arm and hand 
instantaneously in daily situations. Currently, CARAS has been implemented in 
everyday stroke rehabilitation practice in a number of rehabilitation centres throughout 
the Netherlands. 
In order to monitor the development, i.e. either progression or deterioration, of both 
AHF and AHSP during and after rehabilitation, a single-arm prospective cohort study 
has been performed, involving 89 patients who participated in CARAS. This study, 
called AMUSE (Activity Monitoring of Upper extremity use in Stroke patients during 
and after rEhabilitation (CCMO code: NL35681.068.11)), involved data collection at all 
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levels of the ICF (International Classification of Function, disability and health [8]) at 
the start of rehabilitation (baseline), at clinical discharge, and at 3, 6, 9 and 12 months 
post discharge, thus providing a time series per patient [9]. 
 
In a number of stroke patients with a moderate to severely affected arm and hand, 
moderate to severe grades of spasticity (Modified Ashworth Scale (MAS) scores 1+ to 
3) may occur already in an early, sub-acute phase post-stroke. This may seriously 
hinder AHF and AHSP treatment, leading to a slowing down of the patient’s functional 
recovery. The problems caused by spasticity can occur at the level of impairment (e.g. 
restricted joint range of movement, pain and involuntary movement), and at the level 
of activity and participation (i.e. inability to perform daily activities, and limitations in 
taking up societal roles like work, family roles and leisure activities) [10].  
 
There is a myriad of literature on the benefits of reducing spasticity on rehabilitation 
training effects regarding AHF and AHSP in chronic stroke patients (e.g. [11-18]). 
However, thus far little evidence is available on the added-value of early spasticity 
reduction during rehabilitation training on the improvement of AHF and AHSP in sub-
acute stroke patients. In a large study (n >300), Shaw et al. [19] recruited stroke 
patients in the sub-acute phase, but this study could not demonstrate improved active 
function. Foley et al. [15] reported small benefits as to improved passive AHF. Baker 
et al found modest but significant results for active AHF, although evidence quality was 
reported as low to very low [20]. A number of  studies explored the added value of arm 
- hand rehabilitation directly after the injection of botulinum toxin. Prazeres et al. [21] 
and Wolf et al. [22] did not find botulinum toxin plus rehabilitation to be superior to 
placebo plus rehabilitation with respect to AHF. Takekawa et al. [23] and Devier et al. 
[24] demonstrates improved AHF in stroke patients with a moderately to mildly 
impaired arm-hand who received botulinum toxin in combination with a tailored arm-
hand rehabilitation program. Reducing the influence of the spastic component 
demands a holistic multidisciplinary approach to combine spasticity management and 
rehabilitation to optimise the likelihood of positive treatment effects [12, 25-30].                     
In most cases, a delay between spasticity reduction and improvement of AHF exists, 
suggesting that motor relearning continues as muscle tone is returning to baseline. 
The optimal types (modalities, therapy approaches, settings) and intensities of therapy 
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for improving activity (active and passive function) in adults with post-stroke spasticity, 
in the short and longer term, however, are still unclear [31].  
 
To date, evidence for the optimal type and intensity of multidisciplinary rehabilitation 
programs following focal spasticity management are based on expert opinion only. The 
present study will investigate the added-value of reduction of early signs of spasticity in 
the sub-acute phase after stroke on arm-hand rehabilitation treatment outcome involving 
a well-described rehabilitation intervention (‘treatment-as-usual’), i.e. CARAS. This 
reduction of early signs of spasticity will be done using abobotulinum toxin-A. It is assumed 
that reduction of spasticity in the upper extremity at an early, sub-acute, stage after stroke 
may enable the patient to a) exercise more independently at an earlier stage and b) 
exercise in a wider variety of therapy conditions also featuring more exercise challenges. 
This, in turn, may lead to better treatment outcome at the ICF (International Classification 
of Functioning, activity and participation) [8] function level and activity level.   
 
Aims 
The aim of the present study is to investigate the added-value of reduction of early 
signs of spasticity in the upper extremity on improving functional arm-hand skill 
performance in sub-acute stroke patients with either a severely or moderately affected 
arm-hand (Utrecht Arm-hand Test (UAT) [7] score 1-3) and moderate to severe grades 
of spasticity, i.e. Modified Ashworth Scale (MAS) [32] score 1+  to 3. Therapy-as-usual, 
involving a regular, well-documented, concise arm-hand rehabilitation treatment 
(called CARAS) [3] will be provided during each patient’s rehabilitation program. 
 
The general research question is:  
To what extent does reduction of spasticity in the shoulder, arm and hand muscles, 
adjuvant to a concise arm-hand rehabilitation approach (CARAS), improve functional arm-
hand skill performance in sub-acute post-stroke patients with a moderately to severely 
affected arm-hand (UAT score 1-3) and moderate to severe grades of spasticity? 
This general research question is subdivided in to three specific sub-questions, to be 
analysed and answered using 3 design approaches. Each design approach is 
explained in-depth below. 
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• Sub-question 1 (necessitating a single case experimental design):  
Which relation exists between the time the spasticity reducing treatment was 
started in the sub-acute phase after stroke in subject X and any changes in the 
time series’ trend regarding each patient’s arm-hand function and arm-hand skill 
performance? 
 
• Sub-question 2 (necessitating a single arm group design):  
To what extent does the rate of improvement as to arm-hand function and arm-
hand skill performance change after baseline as a result of the spasticity 
reducing treatment in sub-acute stroke patients? 
 
• Sub-question 3 (necessitating a non-randomised double arm group design):  
To what extent do sub-acute stroke patients receiving spasticity-reducing 
therapy adjunct to CARAS improve more as to their arm hand function and arm-
hand skill performance than patients who only received CARAS (i.e. patients 
from the AMUSE study [9])? 
 
Methods / Design 
 
This study (version: V2, dated June 16th, 2016) has received ethical approval by the 
Medical Ethics Committee of Maxima Medical Centre in Veldhoven, the Netherlands 
(METC reference number: W16.027; CCMO code: 56494.015.16). This study will be 
conducted according to the principles of the Declaration of Helsinki (version October 
2013) and in accordance with the Dutch Medical Research Involving Human Subjects 
Act (Wet medisch-wetenschappelijk onderzoek met mensen (WMO) [33]). 
 
Design & duration 
The current interventional study gauges the added-value of early post-stroke spasticity 
reduction in the upper extremity during ‘therapy as usual’, on AHF and AHSP levels in 
sub-acute stroke patients using three methodological approaches, i.e.:  
i) A (multiple baseline) single case experimental design [34] involving 10 
individuals; 
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ii) A meta-analysis of the data of all single cases (= single arm group design); 
iii) Non-randomised double arm group design, i.e. a case-matched control design 
in which each patient receiving early post-stroke spasticity reduction treatment  
will be matched (according to arm-hand capacity, spasticity level, age, gender, 
UAT score) to a case from the AMUSE study [9]. 
 
After patient’s eligibility screening and written informed consent, both primary and 
secondary outcome measures will be taken at baseline, followed by measurements at 
1-week intervals during the 2 x 6 weeks (total 12 weeks, i.e. CARAS training episode 
1 and CARAS training episode 2) CARAS treatment and at 2-weeks intervals during 
the ensuing 3 months follow up, resulting in a time series per patient per outcome 
measure. (Figure 1). Blinding of participants, therapists or data analysts as to the 
intervention provided is not possible in this study. 
Figure 1.     Measurement points in time 
ABoNt-A = application of ABoNt-A. Vertical red solid lines: measurement dates. Vertical dotted lines = delineation of 
multiple baseline, i.e. the time window in which ABoNt-A is applied. Horizontal lines = level of (postulated / expected) arm-
hand skill performance. CARAS-1 = CARAS training episode 1. CARAS-2 = CARAS training episode 2. 
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Generic explanation of the study designs used 
 
i) Multiple baseline single case experimental design:  
In single case experimental design studies time series, consisting of many 
sequential observations (= measurements), are recorded for each individual subject. 
After a baseline period an experimental stimulus or intervention is applied. In the 
subsequent time phase the effect of this experimental stimulus or intervention on 
primary and secondary outcome measures relative to baseline values is 
investigated. The length of the baseline phase may be constant between 
participants (e.g. measurements may be taken weekly for 5 weeks) or may vary 
between participants (e.g. in subject A baseline measurements may be taken 
weekly for 4 weeks, whereas for subject B baseline measurements may be taken 
weekly for 5 weeks, and for subject C for 6 weeks). The latter approach, featuring 
different starting moments of the experimental stimulus or intervention across 
participants in a study, is called ‘multiple baseline across subjects’.  
Using a ‘multiple baseline’ design in single case experimental research, as is done 
in the present study, strengthens the design [34], because it reduces the chance of 
any changes in the outcome parameters after the experimental stimulus of 
intervention being attributable to other factors than the experimental stimulus or 
intervention applied. In other words: If changes in outcome parameters occur ONLY 
AFTER the application of the experimental stimulus or intervention, the chance of 
this change being caused by a chance factor is reduced. We can (statistically) relate 
the ‘position on the time axis’ of the occurrence of the intervention to the ‘position 
on the time axis’ of the occurrence of any effect (=outcome measure time series 
trend changes). In Figure 2  an example of a multiple baseline design across 
subjects is depicted.  
 
ADDED-VALUE OF EARLY POST-STROKE SPASTICITY REDUCTION IN ARM-HAND REHABILITATION
5
 129 
 
Figure 2.      Example of a multiple baseline design across subjects. Dotted line: experimental stimulus or intervention. 
Dark dots: measurements of outcome variable X. P..: participants 
 
Since the subjects in the proposed study are patients in the sub-acute phase after 
stroke, it is likely that their performance will improve due to e.g. spontaneous recovery 
and the therapy they receive, especially in the early phase post-stroke. On the other 
hand, the occurrence of spasticity in this sub-acute phase may slow down or hamper 
improvement in voluntary movements. The baseline data (i.e. the baseline time series 
representing changes in the outcome measures during baseline phase) thus may 
reflect effects of spontaneous recovery and/or effects of ‘therapy as usual’ (in our case 
CARAS). These baseline data may show a trend (e.g. towards gradual improvement 
of arm-hand parameter outcome over time, or e.g. a non-improvement of arm-hand 
parameter outcome due to spasticity starting to develop).  
If, at some point, a spasticity-reducing treatment is applied, the trend of arm-hand 
parameter outcome observed in the prior phase (baseline phase) may change (the 
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patient may become proficient more rapidly regarding outcome measure X or Y). An 
example of this concept is given in Figure 3. 
 
 
Figure 3.     Example of change in time series trend. Dotted line: experimental stimulus or intervention. Dark dots: 
measurements of outcome variable X. P1: participant 1. Solid lines: baseline trend and post-intervention trend. (For 
simplicity reasons a linear trend line is depicted here. Other, higher order trend lines may be used.) 
 
ii) Meta-analysis of the data of all single cases (= single arm group design) 
First, each time series of each subject will be ‘de-trended’ for any baseline trends, 
similar to the approach reported by Franck et al [35]. This will result in a ‘detrended’ 
time series for each subject, data of which are rendered mutually independent by 
this de-trending technique. The latter is important in view of the ensuing statistics to 
be used. Next, for each subject, mean values of the residuals from the baseline 
phase and the post-intervention phase will be calculated. Subsequently, for each of 
the (two) phases, these data will be pooled across subjects, after which non-
parametric statistical analyses will be performed on the pooled dataset. 
 
iii) Case-matched control design (= non-randomised double arm group design) 
In this design, for each of the participants in the present study, a case-matched 
control subject from the database of the AMUSE study will be sought. All stroke 
patients suffering from arm-hand problems, who are admitted to Adelante 
rehabilitation centre, receive CARAS treatment.  
In the (previously performed) AMUSE study 89 sub-acute stroke patients who 
entered Adelante rehabilitation centre and who suffered from arm-hand problems 
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due to the stroke, were monitored during their rehabilitation phase and up to 12 
months post-discharge [9].  
As to the frequency of measurements / assessment, in the AMUSE study arm-hand 
assessments at ICF function level and at activity level were performed at baseline 
(i.e. before arm-hand treatment started), at 6 weeks into the CARAS arm-hand 
training program, immediately after the CARAS training program (i.e. at 12 weeks 
post-baseline), at clinical discharge, and at 3, 6, 9 and 12 months post-discharge. 
Measures at ICF participation level were done at baseline, clinical discharge and at 
12 months post-discharge. In order to compare data from the AMUSE study and the 
present study measurement, we will use data of the present study that are collected 
at the same time points during the AMUSE study. In Figure 4 an overview of the 
‘synchronous’ measurement dates for both the AMUSE study and the present study 
are depicted. 
 
 
 
Figure 4.     Measurement dates for both the AMUSE study and the present study. ABoNt-A = application of ABoNt-
A. CARAS-1 = CARAS training episode 1. CARAS-2 = CARAS training episode 2. T = Measurement moment at 3, 
6, 9 and 12 months after clinical discharge. 
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The AMUSE study and the present single case experimental design study share 5 
similar measurement dates.  
• AMUSE: baseline (Tbl) 
The time at which baseline measurements are performed in the AMUSE study 
is identical to the time at which the first baseline measurement of the present 
study is performed. (Figure 4, first vertical dotted line.) 
• AMUSE: mid-CARAS & end-CARAS (T6w & T12w) 
Similarly, after the initial 6 weeks of CARAS training an arm-hand assessment 
has been performed in the AMUSE study (T6w or Tmid-CARAS). This 
measurement time is identical to one of the present study measurement dates. 
This also applies to the AMUSE measurement date immediately after CARAS 
has finished, i.e. after 12 weeks of CARAS training (T12w or T_end-of-CARAS). 
• AMUSE: clinical discharge 
In the AMUSE study arm-hand assessments are also performed at clinical 
discharge (Tcd). Again, this measurement time is identical to one of the present 
study measurement dates. (Figure 4, fourth vertical dotted line.) 
• Last measurement date of the present study 
In the AMUSE study no exact measurement date as counterpart of the last 
measurement of the present study is available. However, a good approximation 
of data from the AMUSE study at a similar time point may be performed by 
linearly interpolating the AMUSE data using data from Tcd and T3m, taking into 
account the time difference between Tcd and the time at which the last 
measurement of the present study was taken. (Figure 4, X-mark.) 
 
Setting 
All patients in the present study will be identified among the sub-acute stoke patient 
population of Adelante rehabilitation centre in Hoensbroek, the Netherlands. The 
present study will be performed at Adelante in Hoensbroek. All patients who, in the 
past, have participated in the AMUSE study (anonymous database data of which will 
be used in the case-matched control design part of the present study) were patients 
from Adelante rehabilitation centre. 
  
ADDED-VALUE OF EARLY POST-STROKE SPASTICITY REDUCTION IN ARM-HAND REHABILITATION
5
 133 
Study population 
The present study focusses on adult sub-acute stroke patients with either a severely 
or moderately affected arm-hand (Utrecht Arm-hand Test (UAT) [7] score 1-3) and 
moderate to severe grades of spasticity, i.e. Modified Ashworth Scale (MAS) score 1+ 
to 3.These patients will be recruited from the patient population of the department of 
brain injury rehabilitation of the Adelante rehabilitation centre in Hoensbroek, The 
Netherlands. This study will include 10 patients who develop (early signs of) spasticity 
in the upper extremity during the sub-acute phase after stroke.  
Stroke patients who have a severe paretic arm and hand (UAT score 1-3) at admission 
to the rehabilitation centre will be asked to participate (by letter from their rehabilitation 
physician (KR)) as soon as possible after admission to the rehabilitation centre. After 
giving written informed consent, collected by the researcher (JAF), measurements will 
start according to the protocol described.  
Patients, who develop early signs of spasticity in the arm and/or hand, i.e. within 5 
weeks after start of arm-hand treatment (CARAS), will remain in the study. In patients 
who have a severe paretic arm and hand (UAT score 1-3) at admission to the 
rehabilitation centre, but who do not develop early signs of spasticity within 5 weeks 
after start of arm-hand treatment (thereby not being in the target group), measurements 
to be used in the study will cease. Their rehabilitation treatment will follow ‘therapy-as-
usual’ as will their regular therapy-related clinimetrics. Any research data of the latter 
patient group recorded for the sole purpose of the research will be discarded/erased. 
 
Inclusion criteria 
In order to be eligible to participate in this study, a subject must meet all of the following 
criteria: 
- Age >=18 years; 
- Supratentorial stroke, i.e. arteria cerebri media infarction; 
- Sub acute phase after stroke, i.e. between 2 weeks and 3 months post-stroke; 
- Severe paretic arm and hand: UAT score 1-3; 
- Functional disabling spasticity in the upper extremity: Modified Ashworth Scale 
(MAS) score 1+  to 3 (developing within 5 weeks after the start of CARAS); 
- Eligible to participate in CARAS for a period of 12 weeks;  
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- Being able to understand the questionnaires and measurement instructions. 
As to functional disabling spasticity in the upper extremity, patients developing 
spasticity in the early sub-acute phase after stroke (i.e. within 5 weeks after the start 
of CARAS) with a  Modified Ashworth Scale (MAS) score of 1+  to 3 will continue to 
participate in the study. 
 
Exclusion criteria 
A potential subject who meets any of the following criteria will be excluded from 
participation in this study: 
- severe non-stroke related co-morbidity that may interfere with arm-hand 
function; 
- additional complaints that may interfere with the execution of the 
measurements; 
- no informed consent. 
 
Sample size calculation 
As to the single case experimental design (SCED), by definition these studies involve 
1 person. Despite this, a sample size calculation is needed given the group-wise 
analyses of the second and third part of the present study, i.e. the meta-analysis of the 
data of all single cases (= single arm group design) and the case-matched control 
design (= non-randomised double arm group design). 
The sample size calculation is based on data from the AMUSE cohort study (see also 
Introduction paragraph), i.e. on the improvement on the main outcome measure used 
in the present study (ARAT) as observed in patients with an UAT score of 1-3 who did 
(Group A) or did not (Group B) develop signs of spasticity in the upper extremity within 
the AMUSE study. In the present study the ARAT is the primary outcome measure. 
Mean improvement on the ARAT after 12 weeks of CARAS was 17.3 points (sd: 12.2) 
for Group A and 38.3 points (sd: 19.2) for group B. Given a two-sample method, a 
double-sided statistical test, a power of 80% and an alpha of 0.05, a loss to follow-up 
of 10%, 10 participants per group are needed. 
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It is expected from clinical experience, our experiences with the AMUSE cohort study, 
and recent influx numbers of patients in Adelante rehabilitation centre that the number 
of 10 patients meeting the inclusion criteria within a reasonable time span (i.e. 16 
months) is well-feasible. The data of 10 case-matched control subjects will be extracted 
from the AMUSE database. Therefore, in total, data of 20 patients will be used. 
 
Interventions 
CARAS 
Arm-hand rehabilitation treatment will be provided according to the CARAS approach 
as described by Franck et al. [3]. In Adelante rehabilitation centre and multiple other 
rehabilitation centres in the Netherlands, CARAS is ‘therapy-as-usual’. After a standard 
initial clinical assessment, patients will receive arm-hand rehabilitation treatment for 2x 
6 weeks. Based on the UAT scores, patients are allocated to one of three training 
programs, i.e.: 
• CARAS program 1; severely impaired AHF subgroup (UAT=0-1).  
• CARAS program 2; moderately impaired AHF subgroup (UAT=2-3).   
• CARAS program 3; mildly impaired AHF subgroup (UAT=4-7).  
Program 1 is titled ‘taking care and prevention’. It is designed for stroke survivors who, 
due to the severity of the stroke, are not able to use their affected arm and hand for skill 
performance in daily life situations (non-functional arm-hand). Program 2 and 3 are high 
intensity, task-oriented arm-hand performance training programs in which patients learn 
to integrate their affected arm and hand in daily occupations to optimize their overall 
functional abilities in daily situations. In this part a distinction is made between persons 
who have a moderately affected arm and hand, i.e. those who are able to use their affected 
arm and hand for passive and active stabilisation tasks, like fixating bread while making a 
sandwich; and persons with a mildly affected arm and hand, who are able to use their 
affected arm and hand instantaneously in daily situations. 
CARAS is the standard therapy (therapy-as-usual) provided by physiotherapists and 
occupational therapists to all stroke patients with arm-hand problems who are admitted to 
Adelante rehabilitation centre for treatment. This means that the decision to apply CARAS 
is taken before inclusion of the patient in the study. 
The present study focusses on patients with initial UAT scores of 1-3. 
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Spasticity-reducing treatment 
In order to reduce spasticity, abobotulinum toxin-A (ABoNt-A) will be administered 
once, i.e. directly following the sequence of baseline measurements in each patient 
who is developing (early signs of) spasticity in the upper extremity.  
In the present study abobotulinum toxin-A (ABoNt-A) is a non-investigational product. 
abobotulinum toxin selectively targets cholinergic nerve endings via binding to ecto-
acceptors to block acetylcholine release at the neuromuscular junction thereby 
abolishing the motor end-plate potential. This causes prolonged muscle weakness. 
Original nerve terminals regain function 12 weeks after ABoNt-A injection with full 
recovery of nerve-evoked muscle contraction [36]. In clinical practice reduced muscle 
tone is seen up to 24 week in the sub-acute phase in patients with early post-stroke 
spasticity [37, 38].  
ABoNt-A will be administered by a senior rehabilitation physician at Adelante 
rehabilitation centre. Patients will receive ABoNt-A injected according to clinical 
judgement into the dominant spastic muscles of the arm and/or forearm. The total 
maximum dose for the upper limb will be 1000U [39]. ABoNt-A dosage for individual 
muscles will be in line with the dose ranges reported by Dashtipour et al. [40], and 
Gracies et al. [39]. Muscles will be identified using electro stimulation or echography 
according to the normal practice of the clinician.  
The decision to use ABoNt-A is entirely based on clinical necessity, i.e. when a patient 
is developing spasticity in the upper limb muscles on the affected side (MAS score 1+ 
to 3), as established by the rehabilitation physician. After the first finding of this 
increased MAS score, the decision to apply ABoNt-A will be taken by the rehabilitation 
physician and the application itself will be done within 1 week. 
Patients in the target group, i.e. those who have a severe paretic arm and hand (UAT 
score 1-3) at admission to the rehabilitation centre, will be asked to participate as soon 
as possible after admission to the rehabilitation centre. After giving informed consent, 
measurements will start according to the protocol described. Therapy adherence will 
be monitored, based on regular clinimetric assessment, as part of the regular daily 
clinical practice. 
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Data collection & measures used 
At the patient’s entry into the study, i.e. after the eligibility screening and patient’s 
written informed consent, the following socio-demographic variables will be recorded: 
age, gender, educational level and the patient’s living situation. Furthermore, medical 
variables, obtained from medical files of the referring consultant in rehabilitation 
medicine, include: stroke type (haemorrhagic or ischemic), lesion site, time since 
stroke, paresis level, co-morbidity, hand dominance prior to the stroke, and arm- hand 
function status (UAT score). During the informed consent procedure, patients will be 
asked for permission to use this information of their medical file. 
Data collection started on October 10th, 2016 when the first patient was included. 
Currently, patients are being recruited and enrolled. 
As to the primary outcome measures, improvement of the patients’ functional arm-hand 
skill performance capacity will be gauged by using the Action Research Arm Test (ARAT) 
[41-44]. The ARAT is reliable, valid and sensitive to change in patients after stroke [42, 
44-46]. It consists of four subtests comprising 16 grasp movements and three reaching 
movements. Items are scored on a 4-point scale, with a max score of 57. 
Secondary outcome measures include: 
- ABILHAND [47, 48], gauging perceived level of arm-hand skill/activity 
proficiency. The ABILHAND is a semi-structured interview, using a 3-level 
ordinal rating scale: impossible (0), difficult (1), and easy (2) to perform. The 
ABILHAND is valid, responsive and clinically useful [47, 49]. 
 - Bilateral arm activity monitoring [50, 51]: As to actual arm-hand skill 
performance, bilateral activity monitors (3D accelerometry, AX3, Axivity Ltd) will 
be worn around both wrists for a period of 4 consecutive days. 
- Fugl-Meyer Motor Assessment (FMA) [44], gauging arm-hand function level. 
The upper extremity section of the FMA is a reliable and valid test for measuring 
changes in arm-hand-function in stroke patients [52, 53]. Its score ranges from 
0 to 66. 
- JAMAR strength test [54], gauging muscle strength, expressed in Newton. 
- Motricity Index (MI) [55], gauging functional strength measurement during 
performance of daily tasks. 
- Modified Ashworth Scale (MAS) [32] gauging spasticity levels in the upper 
extremity.  
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During the first 12 weeks measurements involving the ARAT, ABILHAND, FMA, 
JAMAR, MI and MAS will be performed weekly. In the ensuing 3 months these 
measures will be administered every 2 weeks. The accelerometry 
measurements will be performed once every 3 weeks. 
 
Data storage & safety 
Data collected will be stored in an electronic trial master file on a secured network drive 
of the Adelante network. All data will be coded immediately during measurement. 
Coding will be done using a combination of numeric and alphanumeric characters, 
which are not related to the participant and cannot be used to trace/identify the 
participant. Non-coded data (e.g. participant’s name) will be recorded separately. 
HAMS is the person who has sole access to the coding key. The non-coded data will 
solely be accessible to two persons, i.e. JAF and HAMS. The anonymised data will be 
accessible to JAF, RJEMS, and HAMS. 
Four years after the project has finished all identifiable data will be destroyed, 
preventing any further link between the results and participants. All data will be 
destroyed and/or deleted after 15 years.  
 
Data processing & statistical analysis 
General 
For graphical data presentation, time series per subject and boxplots (for grouped data) 
will be used.  
From the accelerometer data mean ‘activity counts’ during waking hours will be 
calculated for both hands. A ‘count’ is an occasion at which the accelerometer signal 
exceeds a predefined threshold, indicating an (arm-hand) activity intensity. An example 
of identifying waking hours (or ‘uptime’) is given in Figure 5. 
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Figure 5.      Identifying uptime from accelerometer signals. 
 
For each ‘uptime’ the amount of time a patient used both hands, no hands, his affected 
hand and his unaffected hand will be calculated. Similarly, the number of ‘counts’ at 
occasions where a patient used both hands, no hands, his affected hand and his 
unaffected hand will be calculated. These data will each be averaged across the 
number of days the accelerometers were worn. 
 
Handling of missing values 
When 1 or 2 (temporally adjacent) value(s) are missing, these missing value(s) will be 
estimated by linear interpolation using the two valid adjacent values in the time series. 
In case of the final time series observation missing, the ‘last-observation-carried-
forward’ principle will be used. In case of 3 or more consecutive missing values, the 
whole case (for the measure at hand) will be discarded. 
 
First design procedure: Single case experimental design  
Statistics regarding ARAT, ABILHAND, FMA, JAMAR and MI will encompass 
permutation tests involving the time series of each subject separately. The length of 
the baseline epoch will vary between 4-6 weeks between subjects. This procedure will 
provide an answer to the question whether there is a relation between the time the 
spasticity reducing treatment was started in subject X and any changes in the time 
series’ trend regarding each patient’s arm-hand capacity (ARAT), each patient’s arm-
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hand perceived performance (ABILHAND), as well as arm-hand function (FMA), grip 
strength (JAMAR) and functional arm-hand strength (MI). (Figure 3.) Here, data are 
analyzed for each subject separately. MAS results will be reported descriptively by 
plotting the time series of each subject. 
 
Second design procedure: Meta-analysis of the data (= single arm group design) 
Regarding ARAT, linear detrending for any baseline trends per subject, using a least 
squares method, to (partially) compensate for improvements caused by e.g. 
spontaneous recovery and/or other treatment received, will be calculated. The time 
series of these residuals (data of which thus having been rendered mutually 
independent) of the whole group, will be further processed and analysed.  
Per subject, mean residuals data of ARAT will be calculated for the baseline phase 
(Phase A), for the treatment phase after application of the spasticity reducing therapy 
(Phase B), and for the post-treatment up to 3 months post-CARAS (Phase C), thus 
resulting in 3 mean values per subject per measure. 
These mean residuals per phase will be statistically tested using non-parametric 
Kruskal-Wallis tests in a group design. Next, multiple comparison analysis, involving 
Mann-Whitney U-tests between phase A & C and phase B & C will be performed using 
a Bonferroni correction in order to avoid spurious false positive findings. This procedure 
will provide an answer to the question whether, at a group level, patients improved as 
to their arm-hand capacity (ARAT) faster after baseline as a result of the spasticity 
reducing treatment.  
Data processing and statistical analysis for the ABILHAND, mean ‘activity counts’, 
FMA, JAMAR, and MI will be similar to the procedures described for the ARAT. MAS 
results will be reported descriptively. 
 
Third design procedure: Case-matched control design (= non-randomised double arm 
group design) 
Finally, per subject, differences between baseline means and follow-up means will be 
calculated. The latter values will then be contrasted with similar values from a matched 
group of patients from the AMUSE study (see earlier). In this design, for each of the 
participants in the present study, a case-matched control subject from the database of 
the AMUSE study will be sought. 
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In order to compare data from the AMUSE study and data from the present study 
measurement dates from the present study that are synchronous to the measurement 
dates of the AMUSE study will be identified. In Figure 4 an overview of the 
‘synchronous’ measurement dates for both the AMUSE study and the present study 
are depicted. 
Each subject from the SCED study part will be matched with a person from the AMUSE 
study according to the following procedure: Upon entry in the SCED study (baseline 
phase) each patient will be assessed (identical to the assessment performed in the 
AMUSE study subjects) in which his/her UAT score will be identified. Based on this 
UAT score of the SCED study subject we will search our AMUSE database for persons 
with an equal UAT score. Next, a match will be sought regarding the age, gender and 
(baseline) ARAT scores. Matching cases for spasticity level will be done when subjects 
first show signs of spasticity occurring, i.e. within the first 5 weeks after the start of 
CARAS. As an indication: About 50% of patients who have suffered an arteria cerebri 
media infarction and who were admitted to Adelante rehabilitation centre developed a 
functional limiting form of spasticity within 3-5 weeks after the start of the arm-hand 
training program (CARAS). 
Statistical analyses of the primary outcome variable (ARAT) will include Mann-Whitney 
U-tests. This procedure will yield whether or not patients receiving spasticity-reducing 
therapy adjunct to CARAS have improved more as to their arm-hand capacity than 
patients who only received CARAS (i.e. patients from the AMUSE study). 
Again, data processing and statistical analysis for the ABILHAND, mean ‘activity 
counts’, FMA, JAMAR, and MI will be similar to the procedures described for the ARAT. 
MAS results will be reported descriptively. 
 
Data reporting 
The investigators, without restrictions, will report the general, anonymous results of 
this study in scientific papers, and at international congresses. For all scientific 
reporting the guidelines of the International Committee of Medical Journal Editors 
(ICMJE) [56] will be adhered to. 
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Auditing and annual progress report 
The sponsor/investigator will submit a summary of the progress of the trial to the 
accredited Medical Ethics Committee (METC) once a year. Information will be provided 
on the date of inclusion of the first subject, numbers of subjects included and numbers 
of subjects that have completed the trial, serious adverse events / serious adverse 
reactions, other problems, and amendments. The METC exempted this study from 
instating a data monitoring committee. Furthermore, the sponsor/investigator adheres 
to Dutch law concerning any possible independent audit , at any time, by 
representatives of the competent national authorities.  
 
Temporary halt and (prematurely) end of study report 
The investigator/sponsor will notify the accredited METC of the end of the study within 
a period of 8 weeks. The end of the study is defined as the last patient’s last visit. The 
sponsor will notify the METC immediately of a temporary halt of the study, including 
the reason of such an action. In case the study is ended prematurely, the sponsor will 
notify the accredited METC within 15 days, including the reasons for the premature 
termination. Within one year after the end of the study, the investigator/sponsor will 
submit a final study report with the results of the study, including any 
publications/abstracts of the study, to the accredited METC.  
 
Safety reporting 
Temporary halt for reasons of subject safety 
In accordance to section 10, subsection 4, of the Dutch Person-related Research Act 
(WMO), the sponsor will suspend the study if there is sufficient ground that continuation 
of the study will jeopardise subject health or safety. The sponsor will notify the 
accredited METC without undue delay of a temporary halt including the reason for such 
an action. The study will be suspended pending a further positive decision by the 
accredited METC. The investigator will take care that all subjects are kept informed.  
 
Adverse events (AEs) 
Adverse events are defined as any undesirable experience occurring to a subject 
during the study, whether or not considered related to CARAS and/or the application 
of abobotulinum toxin-A. All adverse events reported spontaneously by the subject or 
observed by the investigator or his staff will be recorded. 
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Serious adverse events (SAEs) 
A serious adverse event is any untoward medical occurrence or effect that: 
- Results in death. 
- Is life threatening (at the time of the event). 
- Requires hospitalisation or prolongation of existing inpatients’ hospitalisation. 
- Results in persistent or significant disability or incapacity. 
- Is a congenital anomaly or birth defect. 
- Any other important medical event that did not result in any of the outcomes 
listed above due to medical or surgical intervention but could have been based 
upon appropriate judgement by the investigator. 
An elective hospital admission will not be considered as a serious adverse event. The 
investigator will report all SAEs to the sponsor without undue delay after obtaining 
knowledge of the events. The sponsor will report the SAEs through the web portal 
ToetsingOnline to the accredited METC that approved the protocol, within 7 days of 
first knowledge for SAEs that result in death or are life threatening followed by a period 
of maximum of 8 days to complete the initial preliminary report. All other SAEs will be 
reported within a period of maximum 15 days after the sponsor has first knowledge of 
the serious adverse events. 
 
Follow-up of adverse events 
All AEs will be followed until they have abated, or until a stable situation has been 
reached. Depending on the event, follow up may require additional tests or medical 
procedures as indicated, and/or referral to the general physician or a medical 
specialist. SAEs need to be reported till end of study within the Netherlands, as defined 
in the protocol. 
 
Amendments  
Amendments are changes made to the research after a favourable opinion by the 
accredited METC has been given. All amendments will be notified to the METC that 
gave a favourable opinion. All substantial amendments will be notified to the METC 
and to the competent authority. Non-substantial amendments will not be notified to the 
accredited METC and the competent authority, but will be recorded and filed by the 
sponsor. 
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Result and Discussion 
 
Given the specific research (sub-)questions, a number of issues have been taken into 
account in setting up this study protocol, leading to a combination of three 
methodological designs. 
Firstly, we proposed time series analyses, i.e. a (multiple baseline) single case 
experimental design, in order to more individually control for spontaneous recovery 
and effects of therapy as usual in the sub-acute stage after stroke, which may vary 
considerably between patients. Modelling spontaneous recovery and effects of therapy 
as usual during baseline measurements has two advantages: a) the time series may 
be detrended for baseline trends, making any underlying mechanism to be investigated 
more pronounced, and b) the residuals obtained after the detrending procedure are 
mutually independent, thus making them eligible for statistical analyses aimed at the 
possible relation between the time the spasticity reducing treatment was started in the 
sub-acute phase after stroke in a single subject and any changes in the time series’ 
trend regarding this patient’s level of arm-hand function and arm-hand skill 
performance. 
Secondly, pooling the averaged, baseline-detrended data of all subjects, enables 
group-wise data analyses gauging the (average) rate of improvement in arm-hand 
performance. 
Thirdly, in our previous single-armed prospective cohort study, i.e. the AMUSE study 
[9], we obtained longitudinal data on changes in arm-hand function and arm-hand skill 
performance in a large group of stroke patients’ typically seen in daily clinical practice. 
By matching patients who have received a spasticity reducing treatment with patients 
from the aforementioned cohort study, we can assess the added value regarding the 
rate of improvement in arm-hand performance that may be attributable to the spasticity 
reducing treatment relative to ‘therapy as usual only’ in sub-acute stroke patients. 
The results of this study will provide evidence on the added-value of reduction of early 
signs of spasticity in the upper extremity on improving functional arm-hand skill 
performance in sub-acute stroke patients with either a severely or moderately affected 
arm-hand and moderate to severe grades of spasticity. 
The information may lead to changes in therapy service delivery necessitating therapist 
to reconsider their currently used training programs. Furthermore, it may lead to further 
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optimization of treatment and systematic treatment monitoring, potentially leading to 
better outcome of arm-hand treatment in sub-acute stroke patients. 
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Abstract 
 
Introduction: Spasticity is a hindrance when trying to elicit the full training potential of the 
affected arm-hand during rehabilitation in stroke patients with a moderately to severely 
affected hand. To assess to what extent arm-hand function (AHF) and arm-hand-skill-
performance (AHSP) may improve by reducing early signs of spasticity in sub-acute stroke 
patients. 
 
Methods: Ten sub-acute stroke patients (UAT:1-2, MAS:1+ to 3). Multiple baseline 
single-case-experimental-design and meta-analysis, involving 10 single cases. 
Training: 2x6 weeks of a well-described arm-hand regime, i.e. CARAS, including 
gross-motor-grip arm-hand rehabilitation. BoNT-A: administered once within the first 5 
weeks. Measurement dates: weekly within the first 12 weeks; every 2-weeks during 
the ensuing 12 weeks. Measures: ARAT, ABILHAND, Fugl Meyer Motor Assessment, 
grip-strength, Motricity Index. 
 
Results: At group level, after linear detrending, added-value of BoNT-A on AHF and 
AHSP could not be confirmed. Not detrended data revealed that patients improved 
significantly over time on AHF and AHSP on all measurements (p≤0.037) due to the 
combination of BoNT-A and CARAS. 
At individual level, after baseline trend correction, adjusting for spontaneous recovery 
and therapy-as-usual effects, 7/10 patients improved on AHF: FM (N=4) (p≤0.019), 
grip-strength (N=3) (p≤0.014) and MI (N=4) (p≤0.002), whereas 6/10 patients improved 
on AHSP: ARAT (N=3) (p≤0.042), ABILHAND (N=5) (p≤0.034).  
 
Conclusion: In a number, though not all, individual patients, application of BoNT-A 
may have an added value in reducing early signs of spasticity. To combine a well-
defined therapy-as-usual with early post-stroke spasticity reduction may improve arm-
hand performance in sub-acute stroke patients suffering from spasticity, and who 
display no dexterity at the point of therapy admission.   
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Introduction 
 
The presence of spasticity in (sub-acute) stroke survivors is acknowledged as a 
hindrance in eliciting voluntary movement in the affected arm and hand, and may 
impede both arm-hand function and arm-hand skill performance enhancing 
interventions [1, 2]. In the present study, the term ‘arm-hand function’ (AHF) refers to 
the International Classification of Function, Disability and Health (ICF) ‘body function 
and structures level’. The term ‘arm-hand skilled performance’ (AHSP) refers to the 
ICF activity level, covering both capacity and performance [3, 4].  
Patients with a mildly impaired arm-hand have the potential or are already able to 
perform isolated wrist and finger movements with the affected hand and may use their 
affected arm-hand instantaneously in daily situations. Patients who cope with a 
moderately to severely affected hand at point of admission to rehabilitation show 
minimal abilities to generate selective arm-and hand movements. During rehabilitation, 
a substantial part of these patients regain a sufficient level of dexterity in order to 
perform gross motor grip tasks and assist the non-paretic hand during simple bimanual 
activities in daily life [5, 6]. However, occurrence of moderate to severe grades of 
spasticity (Modified Ashworth Scale (MAS) scores 1+ to 3 [7, 8]) in the sub-acute phase 
post-stroke occur more frequently in patients with a moderately to severely affected 
hand in contrast to patients with a mildly impaired hand [9-11].  
Due to a combination of muscle weakness and spasticity in the affected arm and hand, 
sub-acute stroke patients with a moderately to severely affected arm-hand may be 
unable to attend functional rehabilitation training programs, which may lead to a delay 
in their  functional recovery, or in failure to achieve specific treatment goals in arm hand 
rehabilitation  [12, 13]. 
 
A large body of evidence on the negative influence of post-stroke spasticity on 
movement functions, activity performance and pain exists [14-17]. At function level, 
post-stroke spasticity in the affected part of the trunk, shoulder, arm and hand is 
associated with physiological disturbances like restricted range of joint movement, 
involuntary movement, a disturbed body image [1] and pain [9, 18, 19]. Problems 
occurring at the level of activity and participation concern, for example, hand hygiene, 
the application of a splint [13, 20], dressing, feeding, and sleeping. Furthermore, 
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limitations in taking up societal roles, like work, family roles and leisure activities [13], 
as well as an increased burden on caregivers, are frequently reported [21].  
 
Spasticity occurring in the affected arm and hand can be reduced by using botulinum 
toxin (BoNT) injections [2, 22]. In the past, BoNT injections were often applied as a 
single (pharmacological) intervention. However, effective management of reducing 
spasticity and enhancing hand function demands a holistic, interdisciplinary approach 
in which spasticity management interventions are integrated in an overall rehabilitation 
program [1, 20, 22-27]. Nowadays, BoNT is more frequently applied in combination 
with other forms of therapy, like, for instance, physical or occupational therapy [22, 26, 
28]. When, adjunct to arm-hand rehabilitation interventions, BoNT is applied, one may 
first observe a decrease of spasticity well before improvement of AHF. During this time 
frame, based on motor relearning principles, patients are trained to learn how to use 
their upper limb muscles with reduced muscle tone within arm-hand function and arm-
hand skill performance tasks [29]. 
In the past decade, a substantial number of therapy approaches were developed in 
which botulinum toxin was provided adjunct to therapy targeting deficits in AHF and 
AHSP [13, 22, 26, 28, 30-32]. However, reports on the effects of these approaches 
have been ambiguous [1, 18, 22-24, 28, 33, 34]. Significant though modest results 
regarding active AHF after arm-hand rehabilitation combined with BoNT were reported 
in the systematic reviews by Foley et al. (2013) and Baker et al. (2015). The systematic 
review of Foley et al. (2013) contains studies featuring chronic stroke patients. The 
majority of studies Baker and colleagues included in their systematic review targeted 
sub-acute stroke populations [1, 33]. Also Takekawa et al. [25] and Devier et al. [26] 
demonstrated improved AHF in chronic stroke patients with a moderately to mildly 
impaired arm-hand who received botulinum toxin in combination with a tailored arm-
hand rehabilitation program. However, Shaw et al. [14], Prazeres et al. [23] and Wolf 
et al. [24] found no added value of the injection of BoNT versus placebo both 
immediately followed by an arm-hand rehabilitation program with respect to AHF in 
chronic stroke patients. Furthermore, a recently published meta-analysis of Andringa 
and colleagues reported lack of effects of BoNT on arm-hand capacity [35]. The 
majority of the studies selected in this meta-analysis focussed on chronic stroke 
patients. 
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The following factors may explain the ambiguity regarding the demonstration of 
functional improvements in AHF and AHSP after the application of arm-hand 
rehabilitation combined with botulinum toxin:  
First, the diversity regarding (often undefined) therapy type and therapy intensity 
applied in conjunction with botulinum toxin across the studies [13, 33]. Sufficient details 
with respect to the content of additional therapy or concurrent therapy, applied in either 
the intervention or the control group have rarely been described in detail. Furthermore, 
in many cases no control group was used or the control group did not receive additional 
(arm-hand) therapy. For example, the control group of the study of Devier et al. did not 
participate in arm-hand interventions [26], and the study performed by Takakawa and 
colleagues did not include a control group [25]. Studies of interventions combined with 
botulinum toxin have tended to focus on single treatment modalities as for instance the 
application of electrical stimulation [36], constraint-induced movement therapy (CIMT) 
[37], and task-specific practice [38]. The set-up of these studies deviates from arm-
hand interventions delivered in day-to-day arm-hand rehabilitation settings which 
normally consist of a complex array of interventions, adjusted to the patient’s individual 
needs. This leads to the question whether a single intervention, combined with 
botulinum toxin, may be sufficient to attain relevant improvements regarding AHF and 
AHSP. 
Secondly, the diversity in patient characteristics like post-stroke time and stroke 
location [9, 39, 40]: The majority of the studies published, included chronic stroke 
patients with a mildly to moderately affected arm-hand. One could argue that the 
application of an intensive arm-hand rehabilitation regime in chronic patients with a 
mildly impaired arm-hand may always lead to progressions. Offering a combination of 
intensive therapy and botulinum toxin may also lead to progressions. Demonstrating 
the added-value of botulinum toxin becomes even more complicated when the study 
population consist of sub-acute patients. In such cases it will be difficult to demonstrate 
the singular added-value of botulinum toxin. One way to solve the latter problem is to 
methodologically use a study design including a baseline trend correction, i.e. linear 
detrending of a time series using baseline values measured, thus correcting for both 
therapy-as-usual effects and spontaneous recovery effects often seen in the sub-acute 
phase post-stroke. 
Thirdly: the different pathophysiological mechanisms leading to spasticity and how the 
latter affects neuromuscular control [41]. Given their biomechanical properties, 
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muscles need time to change after having been injected with botulinum toxin. For 
example, fast glycolytic fibers often convert to slow oxidative fibers in the presence of 
hypertonia and time is needed for the conversion to their original glycolytic form [42]. 
Ultimately, this phenomenon will influence skill acquisition during arm-hand training 
aimed at improving daily task performance [43], and one may assume that the course 
of this process differs between subjects. 
The most effective combination of therapy approaches, to be applied in conjunction 
with the application of BoNT, has not been identified yet [13, 28]. This especially holds 
in sub-acute stroke patients with a moderately to severely affected arm-hand. 
Considering the severity of the disability that has to be overcome and in order to 
achieve a clinically important change in AHF and ASHP, it is essential to evaluate the 
patient’s full potential within the limited time-window of recovery. However, the optimal 
type (approach, setting and modalities) and intensity of therapy to improve AHF and 
AHSP in this particular group of stroke patients is unclear and is often based on expert 
opinion only. 
 
To structure and facilitate AHF and AHSP training in stroke survivors with a mildly 
affected arm-hand, but also for stroke survivors with a moderately or severely affected 
hand, a well-described arm and hand rehabilitation approach in stroke, called CARAS 
(acronym for: Concise Arm and hand Rehabilitation Approach in Stroke) [44], has been 
developed. Classified according to the UAT (Utrecht Arm-hand Test) scores [45], 
patients are allocated to one of three training programs. Program 1 is for persons with 
a severely impaired AHF (UAT 0-1), whereas program 2 exists out of a ‘gross motor 
grip performance training’, designed for persons with a moderately impaired AHF (UAT 
2-3). Program 3 targets stroke patients with a mildly impaired AHF (UAT 4-7). Program 
1 and program 3 cover a training period of six consecutive weeks. Due to their 
moderate level of arm-hand impairment at the initial phase of their rehabilitation period, 
patients admitted to program 2 participate in a 12-week during training period, 
consisting of 2 x 6 consecutive weeks, called ‘training episode 1’ and ‘training episode 
2’, graphically presented in Figure 1.  
CARAS’ task-oriented training paradigm is based on stepwise clinical management 
procedures to elicit and define motor control problems. After having identified the motor 
control problems, therapists subsequently establish the most adequate set-up of 
exercises and motor learning approaches for the training. If done adequately, already 
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in the first week of training patients may use a more efficient problem-solving strategy, 
leading to an easier performance of a given task.  
Self-efficacy-enhancing interventions incorporated in CARAS assist patients in 
recognizing and monitoring improved performance, leading to successful experience, 
improved patient’s self-efficacy, and, ultimately, improved arm-hand performance in 
daily activities. In CARAS, patients work towards their individual goals in groups of 
patients who experience similar motor impairments. 
 
The CARAS approach provides clinicians clear rationales to assist a broad range of 
sub-acute stroke patients who cope with hand dexterity problems towards attaining a 
certain level of AHF and AHSP [44]. The development of AHF, AHSP and actual arm-
hand use of patients who were admitted to CARAS has been well-documented and 
can be used as reference data [5, 46].  
 
Patients with a moderately to severely affected hand show an uncertain, non-linear 
trend regarding arm-hand recovery [47, 48]. In some of these patients improvements 
in AHF and AHSP is observed due to e.g. spontaneous recovery and the therapy they 
receive, especially in the early phase post-stroke [5, 6]. Often, they undergo an arm-
hand rehabilitation regime in order to improve on AHF and AHSP, with a limited 
likelihood to improve on functional tasks [1, 22]. The occurrence of spasticity during 
this phase limits the development of voluntary movements in the affected arm and 
hand. Eventually, this may reduce their, already limited, possibilities to use their 
affected arm-hand in daily activities.  
 
The aim of the present study is to investigate the added-value of reduction of early 
signs of spasticity on improving arm-hand function (AHF) and functional arm-hand skill 
performance (AHSP) in sub-acute stroke patients with either a severely or moderately 
affected arm-hand (Utrecht Arm-hand Test (UAT) [45] score 1-3) and moderate to 
severe grades of spasticity, i.e. Modified Ashworth Scale (MAS) score 1+ to 3 [7] 
adjunct to therapy-as-usual. The latter consisted of the concise arm-hand rehabilitation 
approach in stroke (CARAS) [44].  
The research question is:  
To what extent does reduction of spasticity in the shoulder, arm and hand muscles, 
adjuvant to a concise arm-hand rehabilitation approach (CARAS), improve arm-hand 
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function and arm-hand skill performance in sub-acute post-stroke patients with a 
moderately to severely affected arm-hand (UAT score 1-3) and moderate to severe 
grades of spasticity? 
 
 
Methods 
 
The present study featured 1) a multiple baseline single case experimental design [49] 
involving 10 individuals in the sub-acute phase after a stroke, and 2) a meta-analysis 
or group analysis of the data of all these 10 single cases. To correct for improvements 
caused by e.g. spontaneous recovery and/or other treatment received, all-time series 
per subject were linearly detrended for any baseline trends. As presented in Figure 1, 
the study covered three phases (A, B and C) in which each participant underwent 
sequential observations and measurements, generating a time series per patient per 
outcome measure.  
Measurements were repeatedly performed at baseline, with a time interval of one 
week. Baseline length randomly varied between 3-6 weeks across subjects during the 
first training period, i.e. phase A, in which CARAS was applied, the rationale of which 
has been reported by Franck et al. [44]. Consecutive to phase A, phase B started once 
the Abobotulinum toxin-A (ABoNt-A) was injected, which was administered adjunct to 
CARAS. Both phases together encompassed 12 weeks. Measurements were 
continued using the 1-week intervals until the end of the second 6-weeks training 
period (phase B). Finally, measurements performed during the ensuing 3 months 
follow-up (phase C) were interspaced by two weeks. A detailed description of this study 
protocol has been presented by Franck et al. [50] 
 
This study received ethical approval from the Medical Ethics Committee of Maxima 
Medical Centre in Veldhoven, the Netherlands (METC reference number: W16.027; 
CCMO code: 56494.015.16). This study was conducted according to the principles of 
the Declaration of Helsinki (version October 2013) and in accordance with the Dutch 
Medical Research Involving Human Subjects Act (Wet medisch-wetenschappelijk 
onderzoek met mensen (WMO) [51]. 
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Figure 1.      Schematic representation of the study design. 
ABoNt-A = application of ABoNt-A. Phase A = 3 - 6 weeks of training in CARAS, program 2. Phase B = CARAS 
training in program 2 after ABoNt-A injections. Phase C = Measurement moments from 2 till 12 weeks after CARAS. 
Dotted line: experimental stimulus or intervention. Dark dots: measurements of outcome variable X. 
Study population
First, sub-acute stroke patients admitted to the department of Brain Injury 
Rehabilitation at Adelante rehabilitation centre in Hoensbroek, the Netherlands, were 
informed about the content and purpose of the study. Subsequently, they were asked 
to participate in this study. Written informed consent was obtained from all participants 
prior to the start of their participation in this study. 
Patients with a moderately to severely affected arm-hand (UAT score; 1-3) who 
developed early signs of spasticity in the arm and/or hand, i.e. within 5 weeks after 
start of arm-hand treatment (CARAS), remained in the study. In patients who had a 
severe paretic arm and hand (UAT score 1-3) at admission to the rehabilitation centre, 
but who did not develop early signs of spasticity within 5 weeks after start of arm-hand 
treatment (thereby not being in the target group), were excluded from the study and 
measurements used in the study ceased. However, they continued their arm-hand 
rehabilitation in program 2 as ‘therapy-as-usual’ combined with their regular therapy-
related measurements. Any research data of the latter patient group recorded for the 
sole purpose of the research was discarded. 
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Inclusion criteria  
In order to be eligible to participate in this study, a subject had to meet all of the 
following criteria: Age >=18 years; stroke; sub-acute phase after stroke, i.e. between 2 
weeks and 3 months post-stroke; moderate to severe paretic arm and hand (UAT score 
1-3); functional disabling spasticity in the upper extremity: Modified Ashworth Scale 
(MAS) score 1+ to 3 (developing within 5 weeks after the start of arm-hand treatment); 
Eligible to participate in the CARAS program for a period of 12 weeks; Able to 
understand the questionnaires and measurement instructions. 
 
Exclusion criteria  
A subject who met any of the following criteria was excluded from participation in this 
study: severe non-stroke related co-morbidity that may interfere with arm-hand 
function; additional complaints that may interfere with the execution of the 
measurements; no informed consent. 
 
Procedures 
Patients with a moderately to severely affected arm-hand were asked to participate in 
the study before the start of the arm-hand treatment regime, i.e. program 2 (gross 
motor grip performance training) of CARAS [44]. Once admitted, measurements 
started according to the study protocol [50].  
The training duration of CARAS’ program 2 contained 2x6 weeks. A single week of 
training consisted of 3 days of 1.5 hours training time. All training sessions contained 
the following structure: Patients started with training on a personal goal for 5 - 10 
minutes, followed by 45 minutes of training fitted to arm-hand motor control issues, 
sub-goals and the patient’s current performance level, which was determined by 
therapists prior to admission. After these 45 minutes of training, the patient worked 5 - 
10 minutes towards his or her personal goal again. CARAS is the standard therapy 
(therapy-as-usual) provided by physiotherapists and occupational therapists to stroke 
patients with arm-hand problems who are admitted to Adelante rehabilitation centre for 
treatment. Once enrolled in CARAS’ program 2, the patient’s level of impairment and 
personal needs were determined, and tailored interventions were applied [44].   
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Patients who showed early signs of spasticity (MAS score 1+ to 3) within the first 5 
weeks of training episode 1 of CARAS were treated with ABoNt-A. The latter occurred 
within 1 week after the severity of spasticity was determined. Target muscles in the 
shoulder, arm and forearm were identified using echography. In order to avoid muscles 
getting excessively weakened, thereby losing their ability to facilitate movements, 
ABoNt-A dosages were limited to 50% of the prescribed amount related to the target 
muscle. [52 , 53, 54].  
In patients who had a moderately to severely affected arm and hand at point of 
admission but who did not develop spasticity (MAS score 1+ to 3) within 5 weeks after 
the start of the arm-hand treatment (thereby not being in the target group), 
measurements ceased.  
 
Outcome measures 
 
Primary outcome measures 
Changes in patient’ arm-hand skill performance capacity was measured using the 
Action Research Arm test (ARAT). The ARAT is a valid and reliable instrument, 
sensitive to change in measuring upper limb capacity at activity level in patients with 
stroke [55-57]. The 19 items are scored on a 4-point scale, with a total score ranging 
from 0 to 57.  
 
Secondary outcome measures 
Perceived performance was measured by the ABILHAND, a Rasch-analyzed test, 
which measures the level of manual ability in terms of the difficulty perceived by 
patients with hand impairments in their daily life [58]. It focuses on 23 bimanual 
activities that are representative for a person’s daily activities [59, 60], using a 3-level 
ordinal rating scale: impossible (0), difficult (1), and easy (2) to perform. The 
ABILHAND is valid, responsive and clinically useful [58, 59].  
 
At function level, the Fugl-Meyer Motor Assessment (FMA), Motricity Index (MI) [61] 
and JAMAR hand-held dynamometer (grip strength) were used. The FMA (part upper 
extremity) is a reliable and valid instrument to measure AHF in stroke patients [62, 63], 
with a score ranging from 0 to 66. The JAMAR hand-held dynamometer was used to 
measure grip strength of the hand (in kgf) [64].  
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Data processing and statistical analysis 
 
Handling of missing values 
 
When 1 or 2 (temporally adjacent) value(s) in a time series of data were missing, these 
missing value(s) were estimated by linear interpolation using the two valid adjacent 
values in the time series. In case of the final time series’ observation missing, the ‘last-
observation-carried-forward’ principle was used.In case of 3 or more missing values, 
the whole case was discarded.  
 
Data analysis 
An in-depth overview of the different data analyses techniques used in this study as 
well as their rationale have been reported by Franck et al [50]. 
First, all-time series per subject were linearly detrended for any baseline trends, using 
a least squares method, to (partially) compensate for improvements caused by e.g. 
spontaneous recovery and/or other treatment received. This was done for the time 
series of the ARAT, ABILHAND, FMA, JAMAR and MI. The residuals, i.e. the 
detrended (and thereby rendered mutually independent) data, were subsequently 
analysed for each participant. Furthermore, mean residual data per subject per 
measure (FMA, MI, grip strength, ARAT and ABILHAND) were calculated for the 
baseline phase (Phase A), for the treatment phase after application of the spasticity 
reducing therapy (Phase B), and for the follow-up period (Phase C). These data were 
analysed at group level. 
 
Group level data 
At group level, first, mean data per subject per measure (FMA, MI, grip strength, ARAT 
and ABILHAND) were calculated for the baseline phase (Phase A), for the treatment 
phase after application of the spasticity reducing therapy (Phase B), and for the follow-
up period (Phase C). Statistical (within-group) analysis of these data included 
Friedman two-way analysis of variance by ranks, followed by multiple comparison 
using Wilcoxon signed ranks tests in a Bonferroni approach. The latter was done to 
compensate for spurious false positive findings [65]. 
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Next, all-time series per subject were linearly detrended for any baseline trends, using 
a least squares method, to (partially) compensate for improvements caused by e.g. 
spontaneous recovery and/or other treatment received. This was done for the ARAT, 
ABILHAND, FMA, JAMAR and MI. The residuals, i.e. the detrended (and thereby 
rendered mutually independent) data, were subsequently analysed at group level. 
Statistical (within-group) analysis of these data included Kruskal-Wallis one-way 
analysis of variance tests and multiple comparison involving Mann-Whitney U-tests, 
again in a Bonferroni approach. 
 
Individual level data 
At individual level, mean baseline trend-corrected data, i.e. the residuals, per subject 
per measure (FMA, MI, grip strength, ARAT and ABILHAND) for all three phases were 
used in the statistical analyses. The latter included Kruskal-Wallis one-way analysis of 
variance tests and multiple comparison involving Mann-Whitney U-tests in a Bonferroni 
approach. 
MAS results are reported descriptively. 
 
 
Results 
 
Patient characteristics and error analysis 
 
Thirteen patients entered the study. According to the protocol, three participants left the 
study within the first 5 weeks because they did not develop spasticity in the shoulder, arm 
or hand. No further drop-outs of study participants occurred. Ten patients (all males) 
completed the study. No baseline values or final follow-up values were missing. Missing 
values were minimal (0.37%) and these data were estimated using linear interpolation 
based on the two valid adjacent values in the time series.  
Two serious adverse events were reported. One patient underwent a one-day admission 
to the hospital because of low blood sugar levels. One patient experienced a recurrent 
(minor) stroke during the follow-up phase, between the 3rd and the 4th measurement point 
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during the follow-up phase. None of these events were in any way related to the study. 
Due to logistical reasons, one patient was treated with ABoNt-A on the Monday of week 
7, instead of the originally planned Friday of week 6 of Phase A. 
 
Demographic and clinical baseline data of all participants are presented in Table 1. 
Table 2 provides details of the muscles treated with ABoNt-A and the dosage of ABoNt-
A per target muscle, expressed in Units. Table 2 also presents the patients’ level of 
spasticity as measured using the Modified Ashworth Scale in phase A, phase B and 
phase C. 
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Group level data: General improvement over time 
Mean group values of the ARAT, ABILHAND, FMA, grip strength and MI for all three 
phases, i.e. phase A, phase B and phase C are presented below.   
Action Research Arm Test 
Overall, on average, all patients improved over time on the ARAT (p=0.002) across all 
three phases. Furthermore, a multiple comparison analysis revealed that mean ARAT 
values were significantly improved in phase B, relative to the baseline data, i.e. phase 
A (p = 0.005).  Also, the mean ARAT values calculated in phase C were significantly 
higher compared to the baseline data (p= 0.013). No statistical differences were found 
for the mean ARAT data between phase B and C (p = 0.221). Boxplots of ARAT results 
are presented in Figure 2. 
Figure 2.    Boxplots of Action Research Arm Test mean values (2A) and residuals mean values (2B). ARAT =  
Action Research Arm Test; Circles = outlier value. 7 = measurement point
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ABILHAND 
Overall, on average, patients improved over time on the ABILHAND (p=0.001). Multiple 
comparison revealed that ABILHAND results were higher both in phase B and phase 
C, relative to baseline data (p=0.017 and p=0.005 respectively). No significant 
differences were found between phase B and C (p = 0.047). Boxplots of ABILHAND 
results are presented in Figure 3. 
Figure 3.      Boxplots of ABILHAND mean values (3A) and residuals mean values (3B). Circles = outlier value.  
Fugl-Meyer Motor Assessment 
Overall, on average, patients improved over time on the FMA (p=0.001). Multiple 
comparison showed significant changes between two of the three phases; between 
phase A and phase B (p = 0.008), and phase A and C (p = 0.005). No significant 
differences were found between phase B and C (p = 0.037). Boxplots of FMA results 
are presented in Figure 4. 
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Figure 4.  Boxplots of FMA mean values (4A) and residuals mean values (4B). FMA = Fugl Meyer Motor 
Assessment. 
Grip strength 
Overall, on average, patients changed significantly over time regarding grip strength 
(p=0.001). Multiple comparison showed substantial changes between phase B and 
phase C (p=0.007) and phase A and phase C (p=0.037). No statistical differences were 
found between phase A and phase B (p=0.093). Boxplots of grip-strength results are 
presented in Figure 5. 
Figure 5.      Boxplots of Grip strength mean values (5A) and residuals mean values (5B). Circles = outlier value.  
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Motricity Index 
Overall, on average, patients improved over time on strength measured using the 
Motricity Index (p=0.014). Multiple comparison showed significant improvements 
between all three phases; phase A and B (p=0.013), phase B and phase C (p=0.028) 
and phase A and phase C (p=0.013). Boxplots of MI results are presented in Figure 6. 
Figure 6.  Boxplots of MI mean values (6A) and residuals mean values (6B). Group level data: Changes over 
time, corrected for baseline trends 
Mean group values of the linearly baseline detrended data of the ARAT, ABILHAND, 
FMA, grip strength and MI, are presented above. 
Boxplots of the mean linearly baseline trend-corrected ARAT, ABILHAND, FMA, grip 
strength and MI values for all 10 participants, for all three phases, are presented in 
Figure 2B, 3B, 4B, 5B and 6B respectively. No significant differences in the residuals 
values of the ARAT, ABILHAND, FMA, grip strength and MI were found between either 
one of the three phases (p>=0.419).  
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Individual level data: Baseline trend corrected time series for individual participants 
 
Single case time series 
Regarding changes in arm-hand capacity, for each participant, boxplots of ARAT time 
series residuals for phase A, B and C are presented in Figure 7. 
In three patients (P1, P3 and P7) overall mean ARAT residuals were higher in the 
follow-up phase relative to the baseline phase (p<=0.012). In the remaining seven 
patients (P6, P8, P9, P10, P12 and P13) no statistically significant improvements in 
mean ARAT residuals across phases were observed. In one patient (P5) a statistically 
significant decrease in mean ARAT residuals was observed between phase A and 
phase C (p=0.002). 
 
P1 and P3 showed improvements over time across phase A, B and C: Residuals from 
phase B were higher compared to phase A, although this difference did not attain 
statistical significance. In phase C a significant improvement was observed relative to 
phase B (p<=0.004). ARAT residuals calculated in phase C were significantly higher 
than those in phase A (p<=0.006). In P7 results were statistically significantly different 
between phase A and C (p<=0.010). No significant differences were observed between 
phase A and B (p<=0.025). In phase C, in three participants, P1, P9 and P10 a return 
of spasticity in wrist-and hand muscles was observed. 
 
With respect to perceived arm-hand capacity (ABILHAND) and to arm-hand function 
(FMA, grip strength, MI) median and interquartile range of the within-subject results of 
all measurements are shown in Table 3a. Both the Kruskal-Wallis p-values and the 
subsequent multiple comparison p-values regarding phase A, B and C are presented 
in Table 3b.  
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Discussion 
 
The aim of the present study was to investigate the added-value of the reduction of 
early signs of spasticity on improving arm-hand function and functional arm-hand skill 
performance in sub-acute stroke patients with either a severely or moderately affected 
arm-hand (UAT score 1-3) and moderate to severe grades of spasticity, i.e. MAS 
scores between 1+ to 3 adjunct to a concise arm-hand rehabilitation approach [44]. 
To discern between spontaneous recovery and therapy-as-usual effects on the one 
hand, and the spasticity reducing treatment on the other hand, two methodological 
approaches were used. Firstly, a ‘multiple baseline single experimental design’ was 
used. Secondly, the time series of each subject were ‘detrended’ for any baseline 
trends to investigate the added-value of BoNt-A on changes in arm-hand function 
(AHF) and arm-hand skill performance (AHSP) in sub-acute stroke patients with a 
moderate to severely affected arm-hand.  
 
At group level, on average, participants improved significantly regarding both AHF and 
AHSP in phase B and C, relative to phase A, except for grip strength. In contrast, after 
baseline trend correction, data at group level did not confirm that the application of 
ABoNt-A resulted in an additional improvement of AHF and AHSP adjunct to therapy-
as-usual, i.e. CARAS. However, the application of linear detrending using the within-
subject data baseline values measured in phase A of the study may have led in some 
cases to a) an overestimation of spontaneous recovery and therapy-as-usual effects 
in phase B and C, and could therefore have led to an underestimation of any unique 
effect of the ABoNt-A as applied in phase B (administration of ABoNt-A). 
 
At individual level, as to each individual patient’s baseline detrended time series, data 
showed that the injection of ABoNt-A in three out of the ten participants resulted in 
significant additional improvements in arm-hand capacity, as measured with the ARAT. 
Five patients improved at the level of self-perceived performance, as measured with 
the ABILHAND. Seven out of ten patients demonstrated significant improvements in 
arm-hand function (AHF). Four patients improved on motor function measured with the 
FMA, the Motricity Index and six patients improved on (grip)-strength. In three patients 
no beneficial effects from the contribution of ABoNt-A during arm-hand rehabilitation 
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were observed. In one patient a decrease in ARAT residuals was observed between 
the trainings phase and follow-up phase. 
 
To achieve the desired effect, i.e. a long lasting improvement of AHF and AHSP in 
stroke patients who suffer from spasticity, many authors recommend to apply a person-
tailored approach using a distinct arm-hand rehabilitation intervention in conjunction 
with botulinum toxin, coupled to relevant AHF and AHSP outcome measures [2, 13, 
22, 26, 28, 33, 39, 66]. However, only a minority of studies actually did combine 
rehabilitation and the application of botulinum toxin including an arm-hand 
rehabilitation program which is tailored to the patients’ individual characteristics and 
adaptable to changes in AHF and AHSP level throughout the study period. For 
example, Devier and colleagues combined botulinum toxin during a well described, 
patient-tailored arm-hand rehabilitation program. They observed AHF improvements 
in chronic stroke patients with a mildly affected hand [26].  
 
Despite the fact that at group level no significant results as to the added value of 
ABoNt-A adjunct to therapy-as-usual were found, the individual data show that several 
individuals showed significant improvements on AHSP and even more on AHF. With 
respect to these findings some remarks have to be made. First, the study participants 
who demonstrated higher baseline values on the Fugl Meyer wrist and hand section 
improved significantly at arm-hand skill capacity level during phase B and/or C, in 
contrast to participants with lower initial FMA values. FMA outcome values are 
associated with cortico-spinal tract integrity and recovery of the affected arm-hand [67]. 
Our results suggest that the former subgroup may have benefitted more from 
spontaneous recovery in the distal part of the arm during phase A, compared to the 
latter subgroup and therefore may have obtained higher levels of arm-hand capacity 
during phase B and C. Maybe especially in the group of patients who displayed 
significant improvements, the application of botulinum toxin may have facilitated the 
re-occurrence of voluntary movements that were hampered by spasticity before.  
Secondly, the application of the linear baseline detrending of the time series may have 
led to an underestimation of the potential effects of the botulinum toxin in three study 
participants regarding both AHSP and AHF level during and after their treatment. Due 
to the rapidity with which spontaneous recovery combined with arm-hand training 
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interventions occurred during the first (baseline) phase of rehabilitation, the linear 
detrending may have caused the aforementioned underestimation of any singular 
added value of the botulinum toxin application.  
Three patients did not attain a significant arm-hand capacity level because they 
showed MAS scores between 1+ and 2 in the wrist and hand combined with a low level 
of motor recovery in the distal part of the arm, as measured with the FMA. The 
combination of both a lack of strength in the wrist/hand and the presence of spasticity 
in wrist and hand muscles may have hampered progression at the level of arm-hand 
capacity.  
In these three patients, who coped with a very low level of motor output in the distal 
part of their arm, the flexor muscles of the wrist and/or fingers were treated with ABoNt-
A. However, patients who received ABoNt-A in the wrist muscles and/or hand muscles 
may experience a temporarily delay in regaining hand function and the course of re-
learning how to use the affected hand. This is caused by the combination of reduced 
muscle tone, changes in spasticity and changes in muscle function of the already 
weakened wrist-and hand muscles [29, 40]. This phenomenon, i.e. the loss of muscle 
function, may explain the lack of significant grip strength improvement between the 
baseline phase and the intervention phase in these three patients. Ultimately, this 
could have led to no statistically significant differences regarding arm-hand capacity 
being found, as a certain level of grip strength is required to observe any progression 
at arm-hand capacity level as measured with the ARAT.  
 
Progression in AHF and AHSP may be hampered by co-morbidity, especially in stroke 
survivors with a moderately to severely affected arm-hand. Early post-stroke spasticity 
is highly correlated with a low motor ability level due to severe muscle weakness [29], 
and a high level of ADL dependency [9, 10, 68-70], shoulder pain [71, 72] or edema 
[73]. These symptoms were also present in the majority of the patients who participated 
in the present study. In order to regain control over goal-directed voluntary movements 
of the hand as efficiently as possible, depending on underlying sensory, motor or 
cognitive deficits, the aforementioned symptoms were tackled using a set-up of 
interventions aimed to the specific needs and abilities of each participant. However, 
the multitude of symptoms within a single subject affecting AHF and AHSP outcome 
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to a certain extent, may have obscured the unique contribution of ABoNt-A applied in 
this study.  
 
The application of botulinum toxin is considered an adjunct intervention with temporary 
effects [74] that provides a window of opportunity by temporarily reducing spasticity 
[13]. In the follow-up phase of this study, a minority of the participants experienced a 
return of spasticity in muscles who were previously treated with ABoNt-A, a 
phenomenon that negatively influenced progression regarding AHF and AHSP. 
Besides the temporary effect of botulinum toxin, patients with a low motor ability level 
experience more spasticity and associated reactions [75]. These associated reactions 
often appear and increase when patients become more mobile when, for example, 
they get out of their wheelchair and start walking longer distances. This may have led 
to an increase in tone and, eventually, in biomechanical and (neuro-)physiological 
changes of the different tissues in the affected arm-hand [17] during the training phase, 
thus negatively influencing AHF and AHSP.  
 
The overall results at group level of this study are in line with Baker et al. who found 
significant improvements in AHSP as measured by the ARAT in sub-acute and chronic 
stroke patients with an affected arm-hand who received BoNT in conjunction with arm 
hand training [1]. Furthermore, the studies of Turner Stokes et al. (2013) and Demetrios 
et al. (2015) reported substantial improvements in AHF in moderately to mildly 
impaired chronic stroke patients who participated in an unspecified (high intensity) 
arm-hand rehabilitation program [13, 18]. However, at group level, the baseline trend-
corrected data of our study did not confirm that the application of ABoNt-A leads to an 
additional improvement in moderately to severely impaired sub-acute stroke patients.  
This is in contrast with Cousins et al. (2010) who showed a significant positive change 
in AHSP after applying botulinum toxin in stroke individuals with no arm function [76].  
However, in that study an undefined form of arm-hand training and botulinum toxin was 
provided simultaneously. This may have led to difficulties to ascertain the added-value 
of the botulinum toxin. 
A recently published systematic review found no evidence that BoNT is effective in 
regaining arm-hand use [35]. The major part of this meta-analysis included studies 
containing chronic stroke patients. Multiple studies included in review did not offer 
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adjunctive rehabilitation therapies after botulinum toxin has been applied in order to 
optimize voluntary control. Also information with respect to the content and dose of 
arm-hand therapy offered adjunctive to botulinum toxin was not clearly described. 
These aforementioned factors make it difficult to compare their results with our study, 
involving stroke patients in the sub-acute phase, who received ABoNt-A and 
participated in a defined high-intensity arm-hand therapy regime.  
 
Research concerning sub-acute stroke patients who suffer from a non-functional hand 
(UAT 0 -3) is scarce in literature [77, 78]. From a clinical point of view, exploring the 
possibilities for training methods for this particular group, especially in early post-stroke 
phase, is of utmost importance because this could make the difference between either 
no dexterity or regaining and maintaining dexterity in patients. A further study with more 
focus on why some individuals respond well to the combined intervention of arm-hand 
therapy and ABoNt-A in terms of AHF and AHSP progressions, while others do not 
respond well to the combined intervention, is warranted.    
 
 
Limitations of the study 
 
The present study is not without limitations. The application of linear detrending may 
probably have led to an underestimation of effects of the ABoNt-A applied within the 
arm-hand training provided in phase B. The latter may have been the case in at least 
three participants. Future research should also focus on identifying other, non-linear 
models that may be used to describe effects of spontaneous recovery and therapy-as-
usual in stroke patients, that may then be used to gauge the added value of adjunct 
interventions like the use of ABoNt-A. 
Using the single case experimental design is a valid and efficient way to capture 
clinically relevant clinical questions rapidly and convert them into a research format. 
However, creating baseline stability regarding the dependent variables before the 
intervention to be investigated is applied, is difficult due to, among others, spontaneous 
recovery processes and therapy-as-usual offered during the baseline phase.  
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Abstract 
 
Purpose: To investigate the usability and effectiveness of a functional hand orthosis, 
combined with electrical stimulation adjunct to therapy-as-usual, on functional use of 
the moderately/severely impaired hand in sub-acute stroke patients. 
Materials and Methods: Single case experiment (A-B-A’-design) involving eight sub-
acute stroke patients. The functional hand orthosis and electrical stimulation were used 
for six weeks, four days/week, 45’/day. Outcome measures: Action Research Arm 
Test, Intrinsic Motivation Inventory. 
 
Results: At group level, patients improved 19.2 points (median value) (interquartile 
range: [8.8 , 29.5] points) on the Action Research Arm Test (p=0.001). After correcting 
for spontaneous recovery and/or therapy-as-usual effects Action Research Arm Test 
scores still improved significantly (median: 17.2 points; interquartile range: [5.1, 29.2] 
points) (p=0.002). At individual level, six patients had improved as to arm-hand skill 
performance at follow-up (p<=0.010). In one patient arm-hand skill performance 
improvement did not attain statistical significance. In another patient no arm-hand skill 
performance improvement was observed. Average Intrinsic Motivation Inventory sub-
scores were between 4.6 and 6.3 (maximum: 7), except for ‘perceived 
pressure/tension’ (3.3).  
 
Conclusion: Sub-acute stroke patients who display only little/modest improvement on 
their capacity to perform daily activities, seem to benefit from training with a dynamic 
arm orthosis in combination with electrical stimulation. Patients’ perceived intrinsic 
motivation and sense of self-regulation was high. 
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Introduction 
 
Stroke leaves approximately 50% of its survivors disabled with regard to arm–hand 
performance, often for the rest of their lives [1, 2]. An important treatment aim in stroke 
rehabilitation is to achieve and maintain dexterity, i.e. a clinically relevant improvement 
in both arm-hand function and arm-hand skill performance. The term ‘arm-hand 
function’ (AHF) refers to the ‘body function and structure level’ of the International 
Classification of Functioning, Disability and Health (ICF) [3]. The term ‘arm-hand skilled 
performance’ (AHSP) refers to the ICF activity level, covering both capacity and 
performance’ [4]. Selecting the optimal therapy from a wide range of arm-hand 
interventions is challenging and depends on, among others, the severity of the AHF 
impairment and the potential (spontaneous) recovery of the affected arm-hand. These 
aspects may vary considerably among patients [5, 6]. In order to simplify this 
heterogeneity problem concerning arm-hand impairment, a stratification may be used 
in which dexterity can be roughly classified into three levels, i.e. a mildly, moderately 
or severely impaired arm-hand, [7, 8]. For this classification, the Utrecht Arm hand Test 
(UAT) can be used [9]. 
The present study is focused on patients who suffer from a moderately to severely 
affected arm-hand (UAT score 1 or 2). These patients are insufficiently able to generate 
voluntary movements to participate in regular arm-hand skill training at the start of 
rehabilitation [10, 11], and are often excluded from clinical effectiveness studies. 
Especially in the early sub-acute phase after stroke, i.e. between 24 hours till 3 months 
post-stroke [12], this inability to participate in regular arm-hand skill training may 
hamper improvement in AHF and AHSP. Within this timespan patients with a severely 
impaired arm-hand show an uncertain, non-linear trend as to recovery [13, 14] and are 
often labeled beforehand as having ‘low potential’ regarding recovery of arm-hand 
function. 
Next to traditional treatment methods for patients with a moderate to severe arm-hand 
paresis [5, 15], training applications also incorporating assistive devices, like robot 
assisted therapy with electrical stimulation [16] or dynamic orthoses fitted to the 
affected arm-hand to facilitate participation in task-oriented training, are emerging [17, 
18]. In contrast to the growing body of evidence regarding the effectiveness of such 
specific interventions in persons with a moderately to mildly affected arm-hand [5, 19, 
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20], studies into the effectiveness of interventions featuring combinations of task-
oriented training methods and assistive devices for the most severely affected group 
of sub-acute stroke patients are still scarce [21], and the effectiveness of many 
assistive devices in stroke rehabilitation is still equivocal [22, 23]. However, modest 
results as to the use of dynamic hand orthoses combined with task-oriented training in 
moderately to severely affected stroke patients have been reported [17, 24-26]. Stroke 
patients who are able to regain wrist and finger extension have sufficient residual 
voluntary movement ability to work independently with these types of orthoses. 
However, due to absence of voluntary muscle contraction towards extension and 
flexion of the wrist and fingers, patients will be unable to execute grasp movements 
independently.  
The application of electrical stimulation, adjuvant to a dynamic orthosis, to provoke 
normal muscle activation of the fingers while the orthosis keeps the paretic wrist and 
hand in an optimal position, has already been considered by others [18, 20]. It is 
assumed that these devices may assist patients with a moderately to severely affected 
hand in executing a functional grasp independently, even in the presence of minimal 
voluntary finger flexion. This, in turn, may enable them to participate in task-oriented 
training interventions [17, 21, 27-29]. However, evidence on the effectiveness of the 
aforementioned approaches remains sparse. 
 
As patients’ motivation to train/exercise is correlated to therapy outcome [30], next to 
studying the effectiveness of a dynamic orthosis combined with electrical stimulation, 
it is important to investigate whether patients are motivated to work with this 
combination embedded in a task-oriented training program. Applying multiple devices 
may demand extra efforts as to time to 1) calibrate the orthosis to fit the 
anthropometrics of the affected forearm, wrist and hand, and 2) fine-tune the electrical 
stimulation prior to the task-oriented intervention. Furthermore, results as to regaining 
AHF and AHSP dexterity may be uncertain for the patient. Therefore, user experience 
(i.e. usability), perceived competences and motivational aspects from the patient’s 
perspective (like values and beliefs related to task-oriented training combined with the 
orthosis and electrical stimulation) should be investigated.  
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The aim of the present study was:  
a) to evaluate to what extent arm-hand skill performance may improve in patients with 
a moderately to severely affected arm-hand (UAT score 1 - 2) in the sub-acute 
stage after a stroke who use a dynamic hand orthosis in combination with electrical 
stimulation, adjunct to therapy-as-usual, and  
b) to assess the clinical usability of a dynamic hand orthosis combined with electrical 
stimulation, adjunct to therapy-as-usual, in patients with a moderately to severely 
affected arm-hand (UAT score 1-2) in the sub-acute phase after a stroke.  
 
The following research questions were posed: 
1) In which order of magnitude does a six-week training with a dynamic hand orthosis 
combined with electrical stimulation, adjunct to therapy-as-usual, improve arm-
hand skill performance in patients with a moderately to severely affected arm-hand 
(UAT score 1-2) in the sub-acute stage after a stroke? 
 
2) To what extent is a dynamic hand orthosis combined with electrical stimulation, 
adjunct to therapy-as-usual, usable in stroke patients with a moderately to severely 
affected arm-hand (UAT score 1 or- 2) in the sub-acute phase after a stroke? 
 
 
Methods 
 
Study design 
This study featured a multiple baseline single case experimental design (A-B-A’ 
design) [31] involving multiple single cases. From each individual subject many 
sequential measurements were recorded. After a baseline (A) period, an experimental 
intervention (B) was applied. In the subsequent time phase (A’) the effect of this 
experimental stimulus or intervention relative to baseline values was investigated. The 
number of measurements during baseline was varied between 3 and 6 (range: 12 – 30 
days). Three measurements were performed during the intervention phase (B) and five 
during the follow-up phase (A’). Measurements performed in the intervention and 
follow-up phase were interspaced by two weeks, thus generating a time series per 
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single case data were also performed.
Figure 1.     Example of linear detrending of the Action Research Arm Test time series of 1 subject.
ARAT: Action Research Arm Test; BL: Baseline; TR: Training; FU: Follow- up.
Subjects
The study population consisted of eight sub-acute, first-ever stroke patients. All 
patients were clinically diagnosed with a moderately to severely impaired arm-hand, 
according to the Utrecht Arm-hand Test (UAT) [9], with an UAT score of 1 or 2. All 
patients were admitted to the inpatient stroke ward of Adelante Rehabilitation Centre 
in Hoensbroek, The Netherlands. Additional inclusion criteria were: age >= 18 years; 
patients’ post-stroke time less than three months; a fair cognitive level, i.e. being able 
to understand the questionnaires and measurement instructions; ability to control 
sitting posture; optimal passive wrist extension of  >5° (with a minimum of -5°) as 
measured with the metacarpophalangeal, proximal interphalangeal and distal 
interphalangeal joints in extension; the distal part of the affected arm-hand impeded 
due to hypotonic muscles. Exclusion criteria were: serious problems regarding vision, 
leading to limited possibilities in object location and object recognition during goal-
directed reach and grasp performance; severe problems of the shoulder, arm or hand 
on the paretic side, like edema and/or inflammation in the shoulder joint which hamper 
the execution of voluntary movements and/or the intensity of training; intolerance 
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regarding the application of electrical stimulation; insufficient understanding of the 
Dutch language, no informed consent. 
Participants were asked for their cooperation, and, after having received adequate 
information about the study, were enrolled after having given their consent. 
 
Apparatus 
A dynamic hand orthosis (Saeboglove, Saebo Inc, Charlotte, NC) was used. It consists 
of two parts, 1) a soft Lycra glove and 2) a plastic spiraled forearm shell. The glove 
assists in finger and thumb extension via tensioners located at all interphalangeal joints 
of each finger. The plastic forearm shell positions the wrist in a neutral, i.e. functional, 
position. The hand is maintained in an optimal position while grasping. Releasing is 
facilitated through finger extension just after the grasp movement has ended. The 
support of hand opening can be adjusted by therapist or the patient, depending on the 
amount of assistance needed to accomplish tasks. As the patient progresses, the 
tensioners can be removed individually as needed. When properly fitted, patients 
should be able to grasp and release different objects sized approximately 2 inches.  
 
An electrical stimulation device, the Microstim 2(v2) (Odstock Medical Limited, 
Salisbury, Wiltshire) was used additional to the hand orthosis. The electrical stimulation 
was applied by placing two surface electrodes sized 2 x 2 inch. The anode was placed 
in the forearm midline at approximately one third of the muscle belly length of the 
musculus flexor digitorum profundus measured from the belly’s proximal end [32].  
The cathode was positioned on the muscle belly 5 cm distally from the anode [33]. The 
stimulator parameters were adjusted to time phases of 10 sec with 200 usec pulses of 
40 Hz, with 10 – 20 sec silent period between the stimulation epochs. The current 
intensity was modulated till a tangible contraction of both muscles was present and 
fingers were flexed in order to produce a grasp movement.  
An overview of the training set-up is presented in Figure 2 
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Figure 2.      Overview of the treatment set-up. 
 
 
Intervention 
During the baseline assessment phase (A), patients received a protocolized arm-hand 
rehabilitation program (therapy-as-usual), i.e. program 1 of CARAS [34]. This program 
is designed to teach patients how to cope with a severely impaired, i.e. non-functional, 
arm-hand that cannot be used in daily activities. In this program patients learn 
strategies to avoid discomfort, to maintain joint mobility and to maintain their 
muscles/tendons in an optimal condition. Also, they learn strategies as to what to do 
when discomfort arises, and, during two times 30 minutes/week, they learn how to 
perform basic exercises to elicit voluntary movement where possible. Furthermore, 
patients learn how to maintain their affected arm-hand in an optimal condition and 
optimal position during different circumstances. Patients also receive training in the 
use of supportive tools like static or dynamic splints, braces and/or slings. 
 
Prior to the intervention phase, the orthosis was fitted by a senior occupational 
therapist or a senior physical therapist. Concomitant with the orthosis, all patients 
received electrical stimulation. As soon as the patient experienced a comfortable fit of 
the orthosis, practice conditions were tested in a session, lasting 30 minutes, to 
observe if the patient was capable to perform various gross motor grip, grasp and 
release exercises independently. Once the patient succeeded, (s)he then entered the 
intervention phase.  
HAND ORTHOSIS COMBINED WITH ELECTRICAL STIMULATION TO IMPROVE ARM-HAND CAPACITY
7
 197
 
 
During the intervention phase (B), patients followed a task-oriented training program, 
i.e. a gross motor grip performance program (program 2 of CARAS) [34] in conjunction 
with a dynamic hand orthosis (Saeboglove) and electrical stimulation. In this phase 
patients learned to integrate their affected arm in daily pursuits. Individual goal-setting 
and principles of self-efficacy were integrated to enable patients’ maximum 
involvement during training. The duration of the training was 1.5 hours per day, 3 days 
per week for 6 weeks. Training sessions were tailored as follows: Patients started with 
training on a personal goal for 5 - 10 minutes, followed by 45 minutes of training with 
the dynamic orthosis, executing various grasp and release exercises. After these 45 
minutes of training the patient worked 5 – 10 minutes towards a personal goal again. 
Prior to the training sessions, a therapist facilitated the patient with setting up exercises 
fitting the patient’s goals and current performance level.  
 
During the final (A’) phase patients continued by following a second and final 6-week 
task- oriented training program, i.e. program 2 of CARAS) [34]. In this phase, neither 
the orthosis nor the electrical stimulation or any other supporting technology was used 
during arm-hand training. 
No other, separate rehabilitation intervention involving the affected arm and hand was 
applied in the patients during this final phase.  
 
 
Measures  
 
Utrecht Arm/Hand Test 
The Utrecht Arm-hand Test (UAT) is a simple bedside test measuring arm-hand motor 
impairment after stroke. Evaluation criteria are comparable to stages of motor recovery 
after stroke. The ordinal scale represents eight stages, ranging from 0 (non-functional 
arm) to 7 (‘clumsy hand’) [9]. In the present study the UAT was used as a classification 
measure at baseline. 
 
Action Research Arm Test 
The Action Research Arm Test (ARAT) is a capacity test [4] regarding upper extremity 
activity. It consists of four subtests comprising 16 grasp movements and three reaching 
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movements to be performed by the patient. Items are scored on a 4-point scale, its 
sum score ranging from 0 to 57. The test is valid [35], reliable [36] and sensitive to 
change [37] in patients with stroke. The ARAT is suitable for the evaluation of changes 
in arm-hand skills capacity in clinical trials [38]. The minimum clinically important 
differences (MCID) of the ARAT were 12 points (affected dominant arm-hand) and 17 
points (affected non-dominant arm-hand [39]. 
 
Intrinsic Motivation Inventory 
The Intrinsic Motivation Inventory (IMI) assesses participants’ subjective experience 
related to a target activity. It has been used in several experiments related to intrinsic 
motivation and self-regulation [40, 41]. In this study, 35 items extracted from the 
original 45 items of the IMI have been used (see appendix). The subscale ‘Perceived 
choice’ and 3 questions from the last subscale, i.e. ‘Relatedness’, have been excluded, 
since no single participant was able to elicit voluntary hand movements at the initial 
phase of this study and they all chose to participate in the intervention prior to the start 
of the study. The three questions removed from the last section, Relatedness, were 
aimed at interactions between persons, and therefore were less relevant to the 
research question. The 7-point Likert scale instrument was administered at the end of 
the follow-up phase to assess participants’ interest/enjoyment, perceived competence, 
effort, value/usefulness, pressure/tension and relatedness felt while training with the 
dynamic spring-loaded hand orthosis. Please note that the item “pressure/tension felt” 
is scored inversely, relative to all other items of the IMI [40, 41]. The reliability of the 
IMI was found to be good [42]. 
 
Data analysis and statistics 
The intervention (phase B) started at different time periods post-stroke due to the 
baseline lengths (phase A) differing between individual subjects (= multiple baseline 
design) [31]. 
This was done to methodologically ensure that the possible temporal causal 
relationship between the start of the intervention (phase B) and the occurrence of an 
effect of this intervention may become clear relative to any effects that may be 
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observed during baseline (phase A) caused by e.g. spontaneous recovery and/or 
conventional therapy received.  
 
In a first data analysis step, baseline data stability and any baseline trends regarding 
the ARAT, i.e. the average change between consecutive baseline measurement dates, 
were calculated per subject. Within-group differences between mean baseline data, 
mean training phase data and mean follow-up data were analysed using a Friedman 
two-way analysis of variance by ranks. Subsequent multiple comparison involved 
Wilcoxon signed ranks tests in a Bonferroni approach, thus correcting for spurious 
false positive findings.  
Secondly, by using a least squares method, all ARAT data in the time series were 
linearly adjusted for baseline trends per subject to compensate for improvements 
caused by e.g. spontaneous recovery and/or conventional therapy received. The 
residuals, i.e. the detrended (and thereby rendered mutually independent) data, were 
subsequently analysed for the whole group using a Kruskal-Wallis one-way analysis 
of variance test, and, where applicable, followed by multiple comparison involving 
Mann-Whitney U-test.  
Thirdly, the linear detrended ARAT time series (i.e. series of residuals) of each 
individual patient was analysed separately, i.e. per subject, the residual baseline 
measurement results were compared to the residual follow-up measurement results 
using Mann-Whitney U-tests.  
Patients’ experience and motivation are reported descriptively. 
Linear detrending of the ARAT data was performed using MATLAB software (The 
MathWorks Inc, Natick, MA). All data were statistically analysed using IBM SPSS 
software version 23 (IBM Inc, Houston, TX).  
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Results 
Error analysis 
Eight patients participated in this study. No data were missed during data acquisition. 
No adverse events were reported during the study.  
Participants’ characteristics 
All patients were in the early sub-acute phase after stroke, i.e. between 24 hours till 3 
months post-stroke. Patients’ characteristics at entry in the study are presented in 
Table I.  
Baseline data stability 
Three (P3, P7 and P8) of the eight patients showed small improvements (i.e. one point) 
on the UAT during the baseline phase, whereas only one patient (P5) improved on the 
ARAT (by 6 points) during the baseline phase. Further improvements at baseline level 
were not present. 
ARAT results 
General improvement over time 
Boxplots of ARAT mean results are presented in Figure 3A. Overall, patients improved 
over time regarding the ARAT (p=0.001). Furthermore, significant improvements were 
found between baseline phase (BL) and follow-up phase (FU) (p=0.012), baseline 
phase and training phase (TR) (p=0.012), and between TR and FU (p=0.017).
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Improvement over time, corrected for baseline trends 
 
Representing data of the whole group (n=8), boxplots of the within-subject averaged 
ARAT time series data for all three phases, i.e. baseline, training and follow-up phase, 
linearly detrended for the baseline trends, are presented in Figure 3B.  
 
An overall improvement was found for the ARAT results (p=0.002). Multiple 
comparisons revealed that ARAT residuals were higher in FU relative to those obtained 
from BL (p=0.010) and higher in TR relative to those obtained from BL (p<0.000). No 
statistical differences in ARAT data were found between TR and FU (p=0.293).  
 
 
Time series for individual participants 
 
In Figure 4 the baseline trend-corrected time series concerning the ARAT data per 
patient are depicted.  
Furthermore, boxplots of ARAT time series residuals for the baseline (BL), training 
phase (TR) and follow-up phase (FU) are presented in Figure 5A and 5B.  
 
In six of the eight patients (P1- P4, P6 - P7) mean (and median) ARAT residuals were 
higher (p<= 0.010) in the FU relative to the BL. One patient (P8) also improved in the 
FU relative to the BL, but this improvement did not attain the level of statistical 
significance (p= 0.020). In one patient (P5) a decrease, though not statistically 
significant, in mean (and median) ARAT residuals was observed between the baseline 
phase and follow-up phase (p=0.251).
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Six of the eight patients (P1 - P4, P6 - P7) also showed a statistically significant 
improvement between BL and TR (p<= 0.019). One patient (P8) improved over time, 
although this improvement did not attain significance level (p=0.034). One patient (P5) 
did not improve between BL and TR (p=0.101). Between the TR and FU phase no 
statistically significant improvements in ARAT residuals were observed. 
 
With respect to the non-dominant and dominant hand, minimal clinically important 
difference (MCID) values differ. Three out of the eight patients who participated in this 
study exceeded the MCID threshold regarding the ARAT scores. 
 
In Table 2 mean IMI results are displayed. 
Intrinsic motivation and self-regulation values, as measured by the IMI, were relatively high 
for 3 of the 6 the IMI‘ sub items, i.e. ‘value/usefulness’ (6.3 / 7.0), ‘effort/importance’ (5.1 / 
7.0) and ‘relatedness’ (4.9 / 7.0). The sub-item ’ Experienced Pressure and Tension’ was 
scored relatively low (3.3 / 7.0). 
 
 
Table 2: Overview of Intrinsic Motivation Inventory scores 
Intrinisc Motivation Inventory Item  Mean           (sd) 
   
Interest / Enjoyment  4.6               (0.9) 
Perceived competence  4.6               (1.1) 
Effort / Importance  5.1               (0.5) 
Pressure / Tension  3.3               (0.5) 
Value / Usefulness  6.3               (0.9) 
Relatedness  4.9               (1.4) 
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Discussion 
 
The aim of this study was A) to evaluate in which order of magnitude arm-hand skill 
performance (AHSP) may improve in sub-acute stroke patients with an moderately to 
severely affected arm-hand (UAT score of 1 or 2), who use a dynamic hand orthosis 
in combination with electrical stimulation within a six-week task-oriented training 
program, and B) to assess the clinical usability of the dynamic hand orthosis combined 
with electrical stimulation, adjunct to therapy-as-usual, in patients with a moderately to 
severely affected arm-hand in the sub-acute phase after stroke.  
 
As a result of the arm-hand training featuring the dynamic hand orthosis in combination 
with electrical stimulation, 75% of the sub-acute stroke patients improved on their 
capacity to use their affected arm in daily activities between the start of the training and 
follow-up. However, as all eight participants were included during the sub-acute phase 
after stroke, the improvements in arm-hand skill performance may also be attributable 
to other factors, i.e. a) spontaneous recovery, b) received therapy-as-usual, c) the 
application of the dynamic orthosis in combination with electrical stimulation or d) a 
combination of these factors.  
In order to reduce the influence of spontaneous recovery and possible therapy-as-
usual  effects on the data obtained, two methodological approaches were used. First, 
a ‘multiple baseline across subjects’ design was used. Secondly, data series were 
detrended for any baseline trend for each subject in order to identify the unique 
contribution of the applied intervention. 
 
 As to differences between baseline and follow-up phase, the trend-corrected ARAT 
data (or ‘ARAT residuals’) showed that, at group level, significant improvement in arm-
hand skills capacity occurred. This suggests that patients with a moderately to severely 
impaired hand function at the initial start of the intervention can regain a certain level 
of dexterity at follow-up that may be attributed to the use of the dynamic orthosis in 
combination with electrical stimulation embedded in a task-oriented training program.  
As to each individual patient’s baseline detrended time series, six out of the eight 
patients demonstrated significant improvements in arm-hand skills capacity, indicating 
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that they had benefitted from the orthosis in combination with electrical stimulation. In 
three out of these six patients arm-hand skills capacity improved to such an extent that 
it enabled them to routinely perform grasp and displace tasks as well as bimanual 
activities. The other three patients  improved to a level which enabled them to perform 
gross motor grip function, i.e. being able to use their affected arm-hand for passive and 
active stabilization tasks like fixating bread while making a sandwich. However, one 
patient did not benefit from the orthosis in combination with the electrical stimulation at 
all. During the first two weeks of training this patient experienced an increase in muscle 
tone and spasticity in the forearm and finger flexors, hampering him in the task-oriented 
training. Finally, one patient showed clinically relevant, though statistically non-
significant improvements in arm-hand skill capacity. The overall results of the present 
study are in line with Barry et al. [43] and Franck et al. [24] who found that stroke 
survivors with a moderately to severely affected arm-hand improved significantly on 
the ARAT after they received arm-hand training in conjunction with a dynamic orthosis.  
 
The present study showed that, at group level, improvements in arm-hand skills 
capacity between the training phase and follow-up phase were considerable, though 
not statistically significant. The latter was mainly due to large inter-individual 
differences as gauged by the ARAT. From our finding, one might conclude that the 
majority of patients who improved during the training phase were able to at least 
maintain their arm-hand skill capacity level during the follow-up phase. Some of these 
patients even improved further as to arm-hand capacity during the follow-up phase.   
In general, patients were motivated to work with the orthosis and electrical stimulation 
within the task-oriented training program that lasted 6 weeks. The relative high score 
regarding ‘value’ and ‘usefulness’ may indicate that patients were capable to work 
actively and independently with their affected arm and hand during training sessions. 
Most patients became more competent in the orthosis fitting procedure and 
(re)adjustments of the orthosis, leading to the device being more useful to them. The 
patients’ growing belief in their own capabilities to become more skilled in the orthosis’ 
fitting procedure and the use of the orthosis within arm-hand therapy may have 
positively influenced their general sense of self-efficacy [44]. This, in turn, may 
stimulate each patient to engage even more in his own rehabilitation program and in 
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the use of his affected arm in daily pursuits, thus also preventing ‘learned non-use’ 
once he has returned to his home environment.  
 
In this study, the application of the Saeboglove dynamic hand orthosis was combined 
with electrical stimulation and task-oriented training (CARAS) [34], in which patients 
were encouraged to work as independently as possible. Studies into the effectiveness 
of assistive arm-hand devices applied in arm-hand rehabilitation are upcoming [18, 23, 
45, 46].  
The majority of these orthoses are actuated devices tested in acute, sub-acute and 
chronic stroke patients, but mainly in research conditions [18, 45]. The randomized 
controlled trial of Kutner et al. indicated that robot-assisted rehabilitation combined with 
task – oriented training enhances distal motor function of the wrist and fingers [28]. 
However, study participants had some voluntary hand movements, i.e. ≥ 10 degrees 
of wrist/finger extension. The Rehand [47] is a dynamic hand orthosis which can be 
used easily during arm-hand skill performance tasks within rehabilitation practice. Due 
to its actuated finger-flexion and extension movements it may assist stroke survivors 
with no discernible voluntary motion in using their affected hand. However, as a grasp 
and release motion is generated by forearm and (intrinsic) hand muscle groups [47], 
some cortical connectivity between these muscles and the affected side of the brain 
should be present.  
In stroke survivors with a severely affected arm-hand the application of electrical 
stimulation to improve arm-hand function has been proven to be non-beneficial [48]. In 
a case-report, Chin et al. combined functional electrical stimulation with a neuro-
prosthesis to restore AHF and AHSP in a severely affected stroke patient. Clinical 
relevant changes were observed at arm function level, but not at the level of dexterity 
of the severely affected hand [49]. 
In the present study the use of a non-actuated orthotic device in combination with 
electrical stimulation was found to be a valuable addition in arm-hand rehabilitation in 
6 out of 8 patients with a severely affected hand in the sub-acute phase post stroke. 
This is in line with a study by Popovic et al. who combined orthotic systems with 
electrical stimulation to assist movements coupled to task-oriented training, and with 
Carpaneto et al [20, 50].  
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Somatosensory dysfunction, expressed as lack of voluntary finger movements, 
prevents arm-hand recovery [51]. Despite upcoming clinically useful prediction models 
[6, 7, 14, 52] it remains difficult to reliably characterize those patients with a severe 
arm disability who will achieve a clinically important change during arm-hand training 
and those who will not [53, 54]. Systematic monitoring during the first 8 to 12 weeks 
post-stroke onset has been advocated to identify subgroups of patients who might 
achieve dexterity in this limited time-window [51, 55].  
The average time that the eight patients in our study entered the training phase was 
7.6 weeks post-stroke onset. Prior to this intervention, all patients coped with a 
moderately to severely affected arm-hand, i.e. they did not show any arm-hand 
dexterity. Only voluntary movements in flexion synergy in the proximal and/or distal 
part of the arm (UAT 1-2) were observed. Once patients left the training phase, 75% 
of these patients had regained and maintained a certain level of arm-hand dexterity. 
The present study shows that combining the orthosis with electrical stimulation allows 
patients to shift from a training condition in which they learn how to cope with a non-
functional hand, i.e. program 1 of CARAS [34], towards participating within a task-
oriented environment, i.e. program 2 of CARAS. This combination of therapy 
interventions may be a solution for patients with a moderately to severely affected arm-
hand who otherwise might not recover functionally, as described in literature [51]. 
Where normally these patients had to cope with an uncertain prognosis as to attaining 
a certain level of arm-hand capacity or dexterity, we now should work on the early 
identification of the subgroup of patients that may have the potential to regain arm-
hand dexterity within the sub-acute phase post-stroke, who might benefit from the 
therapy approach investigated in the present study. This, in turn, may lead to innovative 
insights to develop novel therapy methods or to adjust and combine existing therapy 
methods.  
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Considerations and future research 
 
Measuring changes in arm-hand skill performance of moderately and severely 
impaired stroke patients is important. However, it would also have been interesting to 
investigate how these results may be associated with outcome at the ‘body and 
structure level’ and the ‘participation’ level of the International Classification of 
Functioning (ICF) [56]. Another consideration is that generalizability of the results from 
a single case experimental design, as used in the present study, towards larger groups 
of patients, is limited.  
The fact that one of the eight patients, i.e. patient P8, showed clinically relevant 
progressions that did not attain a statistical significance level, may possibly have been 
due to a lower number of baseline measurements (i.e. n=3) in this individual.In future 
research in this domain, it is advocated that baseline length should include at least four 
measurement points. 
 
Future research should focus on: 1) optimizing arm-hand recovery models in order to 
assist therapists in identifying, at an early stage post-stroke, which patients might 
benefit from the application of assistive devices within arm-hand rehabilitation, and 2) 
larger scale clinical research (e.g. randomized clinical trials) into the effectiveness of 
assistive devices in stroke survivors in the sub-acute phase with a moderately to 
severely impaired arm-hand associated with loss of dexterity.  
 
Implications for rehabilitation 
 
• Arm-hand training featuring the dynamic hand orthosis in combination with 
electrical stimulation shows a shift from no dexterity to dexterity. 
• As to the users’ experience regarding the dynamic hand orthosis, patients perceive 
a high intrinsic motivation and sense of self-regulation. 
• Combining the orthosis with electrical stimulation creates opportunities for a non-
functional hand towards task-oriented training. 
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Aim of this thesis 
The overall aim of the work presented in this thesis was to develop and evaluate a 
systematic arm-hand rehabilitation approach in order to offer clinicians knowledge and 
tools in systematically coaching sub-acute stroke patients who suffer from a 
moderately to severely affected arm and hand. To achieve this aim, the present thesis 
addressed three relevant topics in arm-hand rehabilitation in stroke. Firstly, a Concise 
Arm-hand Rehabilitation Approach in Stroke (acronym: CARAS) was presented as an 
in detail-described form of ‘therapy-as-usual’ for arm-hand rehabilitation aimed at a 
heterogeneous group of sub-acute stroke patients typically seen in day-to-day stroke 
rehabilitation. Secondly, results regarding the rate of improvement of arm-hand 
function (AHF), arm-hand capacity, self-perceived arm-hand skill performance (AHSP) 
and actual arm-hand use in patients from the aforementioned group, who received 
CARAS, were presented. Thirdly, two non-actuated dynamic hand-orthoses as well as 
the application of botulinum-toxin adjunct to ‘therapy-as-usual’, all applied to facilitate 
the functional use of the moderately to severely impaired hand during and after 
rehabilitation, were systematically evaluated. In this chapter the main research findings 
are discussed, as are a number of methodological considerations. In the final 
paragraph, future perspectives and directions are discussed from both a clinical and a 
research perspective.  
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Main findings and results 
 
CARAS 
Rationale behind the development of CARAS 
Solving arm-hand deficits in stroke survivors necessitates stepwise clinical procedures 
and is considered to be challenging. Unfortunately, comprehensive descriptions of 
arm-hand interventions, offered in stroke rehabilitation, often are lacking. Sufficiently 
detailed information regarding therapy content (activities, therapy approaches), 
settings and intensity often is not provided and/or may vary highly [1-3], which makes 
these interventions to be considered ‘black boxes’ [4-6]. Apart from information 
regarding therapy time, expressed in terms of duration and frequency, studies rarely 
provide details of arm-hand rehabilitation programmes used, making study replication 
difficult and obscuring causality as to (e.g.) therapy effectiveness.  
In literature, the majority of arm-hand rehabilitation programs is presented as fixed 
intervention protocols [7, 8] without sufficiently taking into account the patient’s 
individual possibilities and needs. These intervention protocols frequently target 
specific (study) sub-populations and thus, are less applicable in heterogeneous patient 
populations commonly seen in contemporary stroke rehabilitation practice. Most 
protocols lack information about how therapy content relates to the patient’s goals, and 
what actually occurs in patients admitted to arm-hand rehabilitation [4, 5, 9-11]. 
Besides, to allow quick adaptations to novel and effective innovations without 
disturbing clinical routines, this demands an easy-to-organise modular therapy regime 
[12]. However, most arm-hand treatment protocols as presented in the literature, are 
not organized in a way that allows content of training to be easily replaced by other, 
often novel, training methods without disturbing routines in daily treatment planning.  
 
The aforementioned shortcomings in therapy descriptions have led to the development 
of CARAS. It is based on a number of principles, discussed below, in order to guide 
therapists in organizing and structuring arm-hand treatment in sub-acute stroke 
survivors admitted to a rehabilitation setting. CARAS has been designed as a group-
based, yet individually adjustable, training program and has been implemented as a 
substitute for conventional individual arm-hand therapy [13].  
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CARAS’ main constructs 
 
Accommodating patient group heterogeneity  
During therapy, sub-acute stroke patients with severe, moderate or mild arm-hand 
impairments are stratified according to the Utrecht Arm Hand Test (UAT) [14], an 8 – 
point ordinal scale, based on the stages of recovery as described by Brunnstrom [15]. 
The UAT objectively differentiates between the presence of distal (hand-wrist) 
selectivity ((UAT score: 2 -7, i.e. moderately impaired (UAT score 2-3) and mildly (UAT 
score 4-7) impaired)), and the absence of selectivity, i.e. severely impaired (UAT score: 
0-1). In contrast to persons with a severely affected arm-hand, moderately and mildly 
impaired persons are allocated to a highly intensive, task-oriented training regime, i.e. 
Part 2 of CARAS. This means that also patients with a moderately impaired arm-hand 
are exposed to task-oriented and functional arm-hand training in order to regain 
dexterity, despite the fact that a substantial part of them lack finger extension at the 
initial phase of training. This is done for two reasons: 1) Sub-acute stroke patients who 
enter CARAS are still in the 8 – 12 weeks post-stroke onset phase and regaining 
dexterity is possible within this (limited) time window [16]; 2) Being actively engaged 
during therapy provides the patient with valuable insights into any progress made in 
his attempts to regain dexterity, which, in turn may stimulate patient’s motivation and 
fuel his sense of ‘being in control again’.   
If in patients with a severely affected arm-hand (UAT 0-1) no neurophysiological 
recovery takes place, no functional gain is foreseen, and they will be unable to use 
their affected arm-hand in daily activities. It is not useful to train these patients under 
the same practice conditions and as intensively as patients admitted to program 2 and 
3. In program 1, i.e. Part 1 of CARAS, these patients receive training which consists of 
education, exercises on how to position the arm-hand, exercises to avoid discomfort, 
maintain joint mobility, and maintain muscles/tendons in an optimal condition, 
exercises to provoke voluntary movement where possible, and training how to use 
supportive tools. 
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Principles of motor learning  
Task-oriented training, based on motor learning principles, is the gold standard for 
post-stroke rehabilitation, both in current therapeutic approaches and in clinical 
research [17].Theoretical constructs of the task-oriented training part of CARAS 
encompass a clinical reasoning model combined with a hypothetico-deductive clinical 
reasoning method [18, 19] to define relevant motor control problems. The training part 
consists of re-learning motor abilities of the affected arm-hand, by applying suitable 
training conditions, learning approaches [20] and self-efficacy principles [21], tailored 
to a patient’s needs and specified to the goals set. 
The clinical reasoning model is applied in order to guide therapists in:1) Identifying in 
a systematic way the nature and cause of abnormal movements, as well as factors 
affecting motor learning and recovery of arm-hand function; 2) Establishing and 
implementing an intervention plan, tailored to the health condition of the individual, in 
order to facilitate motor learning in the most optimal way. If both steps are performed 
correctly, patients with a moderately or mildly impaired arm-hand and a substantial part 
of patients with a severely affected arm-hand may feel more confident in their ability to 
perform a task. The hypothetico-deductive clinical reasoning method is used to assist 
clinicians in their analysis on how arm-hand impairments are related to functional 
deficits and how to distinguish between interventions designed to improve AHF and 
AHSP, and reduce underlying disabilities [19]. 
 
 
Application of self-efficacy principles 
Self-efficacy principles are applied to stimulate the patient’s awareness of the capacity 
of the affected arm and hand in a positive way. Creating perspective on how and when 
to use the affected hand in daily performance at an early stage during rehabilitation 
may encourage patients to push their limits by exploring actual arm-hand use [21-23]. 
Ultimately, patients facilitate themselves in creating an optimal retention of learning to 
use the full potential of the affected hand post-rehabilitation. For this reason, patients 
are exposed to therapy sessions in which they work as independently as possible, and 
therapeutic assistance during therapy sessions is gradually phased out. 
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Swift systematic incorporation of technology and new evidence-based training 
elements  
During arm-hand rehabilitation interventions, patients are enabled to practice tasks 
which are important to them. Setting and updating of realistic goals is done within the 
boundaries of residual voluntary (neural) control of their affected arm-hand. Once 
admitted to an arm-hand rehabilitation regime, patients have to work towards daily 
skills of progressive difficulty and intensity. To deliver the most appropriate and 
effective treatment necessitates an overview of current practice and regular updates 
of treatment as new insight or new evidence emerges.  
Interesting developments encompass, amongst others, pharmacological interventions 
like botulinum toxin [2, 24], virtual reality [25], brain-machine interfaces [26], electrical 
stimulation [27, 28]  and technology-assisted devices like rehabilitation robots [29, 30] 
or dynamic hand orthoses [31], applied to complement conventional arm-hand 
rehabilitation therapy in stroke patients. 
 
In daily practice, arm-hand rehabilitation interventions may be combined and may be 
used synergistically in order to speed up functional recovery of the affected arm-hand. 
For instance, assistive technologies, in conjunction with electrical stimulation, may be 
applied in a task-oriented training regime [32, 33]. The application of these hybrid forms 
of therapy are upcoming in day-to-day clinical practice [34], and, depending on 
progressions in AHF and/or AHSP achieved, such combinations may change during 
the rehabilitation process. 
 
Incorporating new insights in clinical practice remains limited [12] due to several factors 
like: 1) Difficulties to change daily care routines which demands flexibility from 
therapists and care delivery structures [35]; 2) The unknown superiority over standard 
care; 3) The (dis-) comfort of therapists with the use of novel technologies [36]; 4) The 
speed of developments in e.g. technology, and 5) The increasing workload in 
healthcare [35].  
Other recent developments encompass pharmacological agents like, for instance, 
botulinum toxin [2, 24] and assistive technologies [29, 30, 37]  as applications to 
complement conventional arm-hand rehabilitation therapy in stroke patients. Botulinum 
toxin is frequently applied adjunct to arm-hand rehabilitation in order to reduce pain or 
to create motor improvements [38-41]. Nevertheless, uncertainty exists regarding its 
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role in improving motor dysfunction after stroke [42], and for which type of stroke 
patients it may be beneficial. This may lead to disagreement among clinicians 
regarding when and where botulinum toxin should be applied [43].  
 
Application of assistive technologies adjunct to conventional arm-hand rehabilitation 
may support the therapist in increasing therapy intensity and dosage, and may reduce 
the physical burden on therapists [44, 45]. However, despite rapid advances in the 
development of assistive technologies, there is a lack towards implementing these 
devices in rehabilitation due to several factors like, for instance, their added-value 
regarding therapeutic effectiveness [46], cost-effectiveness, fun to use and robustness 
[45].  
 
To investigate the added-value of novel insights before they are implemented in 
rehabilitation would be the most optimal situation to support high quality care. However, 
to keep up with the latest evidence, and to systematically evaluate novel insights 
swiftly, is difficult given the speed of developments in e.g. technology [35, 47] and the 
evaluation methodology necessary to assess the effectiveness of new developments 
[48, 49]. Furthermore, once a development has been proven effective, an 
implementation strategy must be used to facilitate its actual application in the clinic. In 
order to respond to new developments adequately, CARAS’ time table consists of easy 
to replace schedules fitted in time blocks in which the type of training is defined. The 
training content and therapy time can be adjusted without the therapist having to 
rearrange treatment time schedules.  
CARAS’ modularity and monitoring procedures can also facilitate the use of (parts of) 
other arm-hand therapy protocols, like Constrained-Induced Movement Therapy 
(CIMT) [50], to be integrated in CARAS. Depending on the patient’s needs, a (modified 
form of) CIMT can be implemented on a regular basis without having to resort to major 
(systemic) alterations in daily routines as for instance therapy time.  
The use of mobility aids, like the application of dynamic hand orthoses or the 
application of pharmacological interventions can be easily applied in CARAS’ part 2. 
Especially when these interventions assist sub-acute stroke patients with no or minimal 
voluntary finger flexion to execute a functional grasp independently in such a way that 
they are facilitated to train as independently as possible. Also, several variations of 
hybrid forms of therapy may be applied and evaluated, like the application of electrical 
GENERAL DISCUSSION
9
 251 
stimulation adjuvant to a dynamic orthosis to provoke gross motor grasp-and-release 
tasks in moderately to severely affected patients admitted to the task-oriented training 
part of CARAS.  
 
Intensity of arm-hand training 
Stroke patients who do not regain voluntary finger extension early post-stroke may 
have a poor prognosis regarding the improvement of arm-hand capacity [51]. The 
proportional functional recovery from motor impairments in the affected arm-hand 
depends on the process of neurophysiological recovery [52-54] and may depend more 
on corticomotor tract integrity than on the amount of time spent on arm-hand therapy 
[55, 56]. However, proponents of high intensity training suggest that the dose of 
activity-related arm-hand training is a critical factor contributing to successful 
rehabilitation [1, 57, 58]. Ward et al.  
even recommended to invest in much higher doses of treatment than currently 
attempted [59].  
 
In the general debate about the most appropriate dosage of arm-hand rehabilitation, 
moderate-quality evidence was provided towards a beneficial effect for greater doses 
(57 hours of therapy) compared to smaller doses (24 hours of therapy) [1, 60]  in 
repetitive practice training interventions. In patients with a mildly impaired arm-hand 
who are admitted to CARAS, the total therapy time is almost equivalent to other arm-
hand rehabilitation programs applied in stroke patients with a mildly impaired arm-hand 
[62-64]. Patients with a moderately affected arm admitted to the CARAS gross motor 
grip performance program receive at least three sessions of 90 minutes weekly for 
twelve consecutive weeks (54 hours of therapy)[13]. They receive less therapy time 
compared training regimes presented in two recently published studies by Ward et al 
[59] and by Daly et al. [57]. Ward et al. reported a total of 90 hours of therapy for 
patients with a moderately affected arm-hand [59]. However, their classification of a 
moderately impaired arm-hand differs from the classification used in CARAS. The 
median values at admission of the Action Research Arm Test (ARAT) ARAT and Fugl 
Meyer Motor Assessment (FMA) of the total group of patients who participated in their 
study were 18 points and 26 points, respectively. Daly and colleagues provided 300 
hours of treatment, divided over 12 weeks [57]. The median value of the FMA 
presented in their study was 21.8 points, which, from a motor recovery perspective, is 
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comparable to the data from the moderately affected group of patients admitted to 
CARAS, with a median score on the ARAT of 4 points and a FMA score of 22 points 
[61]. Unfortunately, given the diversity between the aforementioned studies regarding 
content, intensity and patient populations, it remains difficult to infer on the exact 
differences in effectiveness between these studies. 
 
The search for the most optimal dosage of therapy time for patients remains difficult 
[1], especially when interventions (and time required to perform these interventions) 
used in most studies are not tailored to individual patient’s needs. Depending on the 
status of the individual patient, the optimal dose of therapy time and therapy intensity 
may fluctuate during the course of the arm-hand rehabilitation program.  
 
 
Arm-hand performance during and after CARAS 
 
Whereas arm-hand rehabilitation may reduce arm-hand impairments and enhance a 
person’s functional ability to use the hand in daily practice [59, 65], it is known that in 
some patients arm-hand performance may deteriorate once they have left the training 
program [66-70]. However, it is not well understood at which rate any deterioration (or 
improvement) occurs post-rehabilitation, nor in which patient categories, i.e. patients 
with a certain level of arm-hand impairment severity, this is most prominent.  
In view of the evaluation of CARAS, which was implemented in regular care as a form 
of therapy-as-usual, it was important to identify and objectively quantify any changes 
in the course of arm-hand performance during and after the rehabilitation phase. 
A second question was to what extent the rate of improvement or deterioration (over 
time) of AHF, AHSP and actual arm-hand use differed between three subgroups of 
stroke patients, i.e. patients with either a severely, moderately or mildly impaired arm-
hand during and after their rehabilitation phase involving CARAS.  
 
As has been outlined in chapter 1, AHF has been measured using the Fugl-Meyer 
Motor Assessment (FMA) [71] and grip strength by using dynamometry [72]. AHSP, 
encompassing both capacity and perceived performance, has been evaluated with the 
Action Research Arm test (ARAT) [73] and ABILHAND [74]. Actual arm-hand use, as 
part of AHSP, has been measured using accelerometry. 
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When comparing rate of progression among stroke sub-groups, the smallest gains as 
to AHF, AHSP and actual arm use were observed in the severely affected part of the 
study population [61, 75]. Due to the absence of any voluntary dexterity (UAT 0-1) at 
approximately 30 days post-stroke, it was not feasible to admit these patients to the 
high-intensive task-oriented training (part 2 of CARAS). Instead, they were admitted to 
the ‘Taking care and prevention’ (part 1 of CARAS) to learn to keep their severely 
affected arm-hand in an optimal condition. From a functional perspective, 
improvements made in this low functional group were less relevant, as the functional 
benefits, i.e. integrating the affected hand in daily task performance, were minimal. 
Although not clinically relevant, significant improvements at AHF and AHSP capacity 
and self-perceived performance level were observed during and after the rehabilitation 
phase, except for grip strength. In contrast, intensity of unimanual arm-hand use on 
the affected side sharply dropped during the rehabilitation phase and remained low in 
the post-rehabilitation phase. Intensity during bimanual use as well the duration of arm-
hand use improved during the rehabilitation period and remained stable, yet remained 
relatively low in post-clinical phase, compared to moderately and mildly affected 
patients. Improvements in Intensity during bimanual arm-hand-use may have been 
caused by patients performing exercises to keep the affected arm and hand supple 
and pain free. In order to perform these exercises correctly, the non-affected hand 
guides the affected arm and hand.   
  
Both sub-acute stroke patients with a mildly or moderately impaired hand, admitted to 
CARAS’ part 2, task-oriented training program, improved significantly at AHF and 
AHSP level during the rehabilitation phase. Also their level of Intensity-of-arm-hand-
use during bimanual activities improved significantly during rehabilitation and these 
levels were maintained during the post-rehabilitation phase. During the training phase 
intensity to use the affected hand in unimanual activities dropped in both the mildly and 
moderately affected group. In exact the same time, during bimanual activities, the 
Intensity-of-arm-and-hand-use on the affected side increased. This phenomenon could 
be explained by the fact that patients learn to co-use their affected arm-hand more 
during bimanual performance instead of predominantly using the non-affected arm-
hand. Largest gains as to AHF and AHSP and actual arm use, both during and after 
the rehabilitation phase, were observed in stroke survivors with an initially moderately 
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affected arm-hand. This means that patients who lack any dexterity, i.e. finger 
extension at the time of admission to the task-oriented training program, still have an 
ability to generate and maintain significant improvements in AHF, AHSP and actual 
arm-hand-use, as also has been observed by others [76]. 
Duration-of-use of the affected hand improved in both the moderately and mildly 
impaired groups during exact the same period of time and results were maintained in 
the post-clinical phase. In both these groups the ratio of Intensity-of-arm-hand-use 
between the affected and non-affected side during bimanual activities increased 
significantly during the rehabilitation period and remained unchanged in the post-
rehabilitation phase. 
 
Although in all three subgroups most people improved as to AHF and AHSP capacity 
in the post-clinical phase, a small proportion of people showed a deterioration, though 
this was only a minor change. In all groups the number of patients who experienced a 
deterioration regarding perceived performance in the post-clinical phase was higher 
relative to the number of patients who showed a deterioration on the objectively 
quantified performance measures like the ARAT, FM, and grip-strength. This implies 
that patients’ ability to overcome difficulties during daily arm-hand performance tasks 
is not always experienced as being present. It also must be taken into account that, 
whereas the ABILHAND captures patients’ perceived performance at general activity 
level, patients often train activities that are very specific to them, which may not be well 
represented in the more general domain of the ABILHAND. When perceived ability is 
rated as being low, this may also reflect a low level of self-efficacy as was also reported 
by Korpershoek et al. [77],  which implies that a patient may not be encouraged to use 
his affected arm-hand in exploring certain hobbies or activities  to the same extent as 
persons with a higher level of self-efficacy [22, 78]. Post- stroke depression, pain, or 
socio-cultural factors may also have a negative impact on the patients’ sense of self-
efficacy and may influence perceived performance negatively [79].  
 
The course of long-term motor function and functional recovery of the affected arm-
hand in post-stroke phase is described by several authors [80-83]. Also, outcomes 
expressed in AHF, AHSP and/or actual arm-hand-use, during and after the 
rehabilitation phase, of sub-acute stroke survivors who followed a specific arm-hand 
intervention program during the rehabilitation phase have been described elsewhere 
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[17, 63, 64, 66, 84, 85]. In most cases, results with respect to outcomes on arm-hand 
improvement are described in moderate to mildly impaired patients using narrow 
inclusions and are often inconclusive. Meyer et al. (2015) revealed a significant 
deterioration in arm function between 6 months and 5 years after stroke [70]. Doman 
and Rand observed a significant improvement in motor and functional ability of sub-
acute stroke survivors with a moderately to mildly affected hand, but no significant 
increase of daily arm-hand use in post-rehabilitation phase [80, 86]. Some authors 
stated that the non-affected hand is used predominantly while the affected hand is 
disregarded, developing so-called learned non-use [87], and thereby prolonging the 
inability to perform (certain) meaningful activities and reducing participation in society, 
especially in patients with a severely to moderately affected hand. In view of the 
aforementioned inconclusive evidence provided in literature, the AMUSE study was 
performed, gauging patients’ arm-hand performance at all levels of the ICF, both during 
and after the rehabilitation phase [61, 75]. Based on the results of the comprehensive 
longitudinal database compiled during the AMUSE study, it can be stated that sub-
acute stroke patients who participated in an arm-hand training regime featuring 
CARAS, program 2 and program 3, improved on AHF, AHSP and actual arm-hand use 
during the rehabilitation phase. Patients with a mildly impaired arm-hand maintained 
these levels during the post-rehabilitation phase, while moderately impaired patients 
even increased further during the post-rehabilitation period.  
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Interventions adjunct to CARAS 
 
Adjunct to CARAS, the added-value of two dynamic hand orthoses, the Saeboflex and 
Saeboglove, respectively, and one pharmacological intervention involving the use of 
Abotulinum toxin-A, have been investigated. All three interventions were applied in 
order to facilitate voluntary movements of the moderate to severely affected hand 
towards grasp-and-release tasks during task-oriented training. In the following 
paragraph, results of these additional interventions are discussed. 
 
Dynamic hand orthoses 
In two separate studies, the added-value of two non-actuated dynamic hand orthoses, 
i.e. the Saeboflex, a spring-loaded hand orthosis (study 1), and the Saeboglove, a 
tensioner-assisted hand orthosis, combined with electrical stimulation (ES) (study 2) 
was investigated in conjunction with CARAS’ program 2, gross motor grip performance 
program [32, 33]. The study participants who participated in these studies were all sub-
acute stroke patients with a moderately to severely affected hand. ARAT values, as 
primary outcome measure taken at baseline in both studies showed that in a 
substantial part (88%) of the participants no dexterity was observed. These studies 
featured a so-called single case experimental design with a baseline phase, an 
intervention phase and a follow-up phase. At point of admission, this particular group 
of patients was not able to work actively and independently with their affected arm and 
hand during training sessions. Prior to the intervention phase, patients from both 
studies were equipped with either one of the two dynamic hand orthoses.  
At group level, patients in both studies showed significant improvements at arm-hand 
capacity during and after the training, as measured with the ARAT. In study 1, the post-
training phase showed a decline of arm-hand capacity in a major part of the study 
participants. In study 2, at group level, improvements between the intervention phase 
and follow-up phase were considerable, but not significant.  
Both studies show that combining a dynamic hand orthosis (study 1), or a dynamic 
hand orthosis with ES (study 2) in conjunction with CARAS’ task-oriented training 
program create training conditions which lead to improvements, although not always 
statistically significant and sustainable, in arm-hand capacity in patients with an 
uncertain prognosis regarding regaining dexterity.  
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Botulinum Toxin 
The presence of spasticity in stroke patients with a moderately or severely affected 
arm-hand may limits the development of voluntary movements in the affected arm and 
hand during rehabilitation and functional recovery may be delayed [2, 88]. To 
determine the added-value of early spasticity reduction to improve AHF and AHSP in 
sub-acute stroke patients with a moderately to severely affected hand, all study 
participants who developed early signs of spasticity were treated with abobotulinum 
toxin-A (ABoNt-A) in the first 5 weeks of CARAS’ gross motor grip performance 
program. After baseline trend correction, adjusting for spontaneous recovery and 
therapy-as-usual effects, group level data did not provide statistically significant results 
with respect to the application of ABoNt-A as an additional improvement of AHF and 
AHSP adjunct to therapy-as-usual, i.e. CARAS. However, at individual level, after 
baseline trend correction, 7 out of 10 patients improved on AHF, whereas 6/10 patients 
improved on AHSP. For sub-acute stroke patients who suffer from spasticity and 
display no dexterity at point of admission to CARAS’ task-oriented training part, 
spasticity reduction may lead to improvements in arm-hand performance. 
 
 
Clinical implications 
 
As observed in regular stroke rehabilitation, up to 30% of the patients copes with a 
severely impaired arm-hand [89, 90] and 33 to 66% of stroke patients with a paretic 
arm-hand does not show any recovery on AHF six months after stroke [90]. 
Furthermore, it has been suggested that stroke patients who do not show any voluntary 
motor control after 5-9 days post-stroke have a low probability of achieving dexterity 
[91].  
From a clinical point of view, it is of utmost importance to achieve a sufficient level of 
actual arm-hand performance in home-based situations. Currently, existing evidence-
based arm-hand rehabilitation interventions (e.g. constraint-induced movement 
therapy, robot-assisted therapy) are foremost aimed at stroke patients with a mildly 
affected arm-hand [8, 92, 93]. For patients who cope with a moderately to severely 
affected arm-hand, evidence based interventions to improve AHF and AHSP and to 
maintain a sufficient level of AHF and AHSP post-rehabilitation are still scarce [8, 76, 
94-96]. A reason for this may be that many studies aimed at ascertaining the 
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effectiveness of arm-hand interventions in stroke patients, strict inclusion criteria were 
set in order to reduce, for example, within-group variance. This led to a well-defined, 
yet narrow bandwidth in terms of level of (arm-hand) impairment severity, most often 
limited to mildly affected stroke patients. From a methodological point of view this may 
be wise. However, the other (clinical) side of the story is that the development of novel 
treatments and the study of the efficacy of such treatments in patients with a 
moderately to severely affected arm-hand, and those that have more complex (co-
)morbidity, is slow. Perhaps the most urgent problem is that patients with moderate to 
severe arm-hand impairments are limited, or even unable to execute a functional grasp 
independently due to insufficient voluntary force generation. For them to participate in 
regular arm-hand skill training at the start of rehabilitation, working actively and 
independently with the affected arm-hand, is difficult or even impossible [97, 98]. The 
challenge lies in developing and implementing novel treatments for this patient 
category. CARAS has explicitly been designed and shown, to accommodate the 
heterogeneity of patients presented to rehabilitation centers, yet be specific enough to 
allow patients with different levels of impairment severity to be able to participate in 
meaningful arm-hand training. 
 
The vast majority of a heterogonous group of stroke patients with an affected hand 
who were admitted to CARAS’ gross motor grip performance program, improved 
considerably on AHF and AHSP (arm-hand capacity, self-perceived performance and 
actual arm-hand use) during rehabilitation. In addition, they were able to maintain these 
high levels during the post-rehabilitation phase [61, 75]. Largest gains with respect to 
improvements in AHF and AHSP occurred in moderately and partly in severely 
impaired patients. It is most likely that the majority of these patients were able to (re-
)use their affected arm-hand in home-based situations. Furthermore, the application of 
an intensive arm-hand rehabilitation in conjunction with assistive devices in moderate 
to severely affected patients showed that it may be of added-value regarding 
improvements in AHF and AHSP. It was also shown that a part of moderately to 
severely affected patients responded well to the combined intervention of arm-hand 
therapy and ABoNt-A in terms of AHF and AHSP progression. 
 
  
GENERAL DISCUSSION
9
 259 
From a clinical perspective there are several important aspects to discuss.  
Firstly, CARAS can be used as a form of therapy-as-usual applied to a heterogeneous 
group of stroke patients with a moderately to severely affected arm-hand, typically seen 
in a regular stroke rehabilitation centre. Patients admitted to CARAS received a well-
documented form of ‘therapy-as-usual’. Its theoretical framework will assist clinicians 
in the clinical management of motor control problems and set-up of training conditions 
and concomitant motor learning principles. CARAS accommodates appropriate 
evaluation methods from both the clinical perspective and patient’s perspective. Data 
obtained from our single-armed prospective cohort study using CARAS may be used 
as reference data both in clinical practice and in future research as a reference 
database to contrast newly developed training interventions. This is especially 
important since  clearly defining ‘therapy-as-usual’ (TAU) is a problem in AHSP 
research in stroke patients. In many studies evaluating newly developed training 
protocols, each of these new training approaches is contrasted to some kind of TAU, 
the latter of which may vary widely between clinics and institutes. Even worse, often 
TAU is not clearly defined at all.  
Secondly, in order to deliver effective arm-hand therapy it is important to stratify 
patients based on their capacity regarding neural organization and recovery [3, 99]. 
However, recovery profiles of patients with a severely affected arm-hand do not fit in 
current existing proportional recovery models [53]. It is important to realize that a 
number of these so-called “non-fitters” may regain dexterity, although this is not 
mentioned by the authors [100].  
The results of this thesis underline the importance of gaining insight in how (dis-)similar 
arm-hand severity levels, i.e. severely, moderately and mildly affected, are determined 
by different authors across literature [101-103], and how these levels are used in 
clinical practice. It is particularly important to realise that these levels are predominantly 
determined from a research point of view, and hardly ever from the perspective of the 
(individual) patient’s perception. For example, a pianist, diagnosed with a mildly 
impaired arm and hand referred to CARAS’ functional performance program, will most 
certainly perceive his arm-hand condition as being severely impaired. 
The FMA is often used to determine the level of motor impairment of the affected arm 
and hand [104, 105]. To determine the level of arm-hand capacity, or so-called 
dexterity, the ARAT is often considered [104]. Some authors have argued that a low 
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score (e.g., 10/57 on the Action Research Arm Test) may not reflect a meaningful arm 
function [90, 91]. Based on this arbitrary view, patients are artificially allocated to one 
of two groups: patients who have no dexterity, and patients who have dexterity, leaving 
little room for nuances. From a clinical point of view, it is important to note that dexterity 
is a perquisite for arm-hand performance. However, in some patients who have no 
dexterity in the initial phase of arm-hand rehabilitation, training may still lead to 
improved AHF and AHSP levels, and possibly to meaningful daily arm-hand 
performance.  
Easy applicable and valid outcome prediction models for moderately to severely 
affected stroke patients that may be commonly usable in stroke rehabilitation practice, 
are still under development [106-108]. Earlier prediction models use rather strict 
inclusion and exclusion criteria, and predominantly target first-ever mildly to 
moderately impaired stroke patients [52, 91, 100]. To identify individuals with potential 
for recovery among those patients who cope with severe (motor) impairments in the 
sub-acute phase post-stroke is challenging [106, 107]. This is especially true in clinical 
rehabilitation settings as clinical outcome measures add little to the ability to predict 
expected recovery in severely affected patients [55].  
The substantial amount of variability in characteristics between stroke patients typically 
seen in stroke rehabilitation leads to large variability in recovery patterns [100], 
especially among the more severely impaired patients [109]. This leaves us with the 
question how to provide the best possible care with respect to arm-hand rehabilitation 
for sub-acute stroke patients who lack any dexterity at point of admission to 
rehabilitation. Hoonhorst et al. and Woytowicz et al. suggested to use four distinct arm-
hand impairment classification levels, i.e. severe, severe-moderate, moderate-mild 
and mild, based on the FMA [101, 102] and ARAT [101].  From a clinical point of view, 
these four levels allow for more nuances in both the content and set-up of training 
between the severe and severe-moderate sub-groups. This allows for the 
accommodation a more differentiated treatment of those who have no dexterity but 
who, at the initial phase of rehabilitation, have the prospect to regain (some) dexterity. 
Once admitted to CARAS, patients are stratified based on the severity of their arm–
hand impairment for which the Utrecht Arm-hand Test (UAT) is used [14]. Looking 
back, it can be stated that this UAT-based classification adequately classified the 
moderately (UAT score: 2 - 3) and mildly affected patients (UAT score: 4 – 7). In 
patients with a severely impaired hand, originally classified with an UAT score of 0-1 
GENERAL DISCUSSION
9
 261 
at baseline, 25% (7 out of 28) showed more than the expected average progression in 
the affected arm-hand. Pending valid (novel) prediction models for the severely 
affected patients, the aforementioned findings show that stratification of the patient 
population based on the severity of arm–hand impairment, i.e. the UAT score, seems 
to be a viable, pragmatic and practical solution to the allocation of patients to an arm-
hand rehabilitation regime, adjusted to their needs and possibilities.  
 
Thirdly, one of the major challenges in stroke rehabilitation services is to deal with the 
absent  or limited spontaneous use of the affected arm-hand in the patient’s natural 
environment, i.e. at home [110]. The focus of arm-hand rehabilitation is to achieve and 
maintain actual arm-hand performance, outside the therapeutic environment. The 
ultimate goal is that the patient’s affected arm and hand can be (and is) used to assist 
in the successful completion of a meaningful task.  
Actual arm hand use of the affected arm-hand and what persons actually do with their 
affected hand is not necessarily correlated with AHF and AHSP measures currently 
applied in the clinic [111, 112]. In essence, arm-hand therapy is not about regaining or 
maintaining motor improvements or dexterity, neither it is about ‘forcing’ patients to 
perform tasks with their paretic hand using behavioural contracts or immobilising the 
unaffected arm [113]. Arm-hand therapy is about recognizing improvements in AHF 
and/or AHSP, which may encourage stroke patients to push their limits and create 
perspectives to re-use their affected hand more quickly in daily tasks. Once 
encouraged, patients will facilitate themselves to re-explore their motor capabilities in 
relation to real life skills and tasks. Ultimately, they create an optimal retention of 
learning to use the full potential of the affected hand outside therapeutic situations as 
quickly as possible and, eventually, in post-rehabilitation.  
 
Nevertheless, compared to the rehabilitation regime of stroke survivors with an initially 
mildly impaired hand, the course towards regaining control over goal-directed voluntary 
movements of the moderately to severely affected hand and how to organize day-to-
day arm-hand rehabilitation is more difficult. One of the main reasons for this is the 
variances in (motor) recovery patterns [90], and comorbidity [76] among these patients. 
To choose the most appropriate approach towards improvements in AHF and AHSP 
in the latter group demands extensive knowledge with respect to clinical management 
of motor control problems, training conditions and motor learning principles. It also 
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demands extensively more therapy time and therapeutic effort. The design and content 
of arm-hand training for the moderately to severely affected patient is not ‘one-size-
fits-all’. It has to be patient-tailored. In the first week of CARAS’ gross motor grip 
performance program, a stepwise clinical management procedure, in conjunction with 
self-efficacy-enhancing interventions [114, 115], is applied. This is done in order to 
assist the patient in choosing his most efficient strategy, leading to the patient 
experiencing improvements in task performance. If done properly, already in the first 
two weeks of arm-hand training the vast majority of moderately affected patients learn 
to recognize and to monitor improvements made in AHF and AHSP. 
 
 
Methodological considerations  
 
Intention-to-treat procedure 
A study to evaluate the course of the affected arm-hand during and after rehabilitation 
was performed (dossier number NL35681.068.11). This study was divided in two parts: 
In the first part, the course of AHF and AHSP capacity has been evaluated [61], and in 
the second part actual arm-hand use has been evaluated [75]. A single-armed 
prospective cohort study was conducted in order to collect the necessary data. Based 
on their level of arm-hand impairment, stroke survivors were stratified into three 
different subgroups; severely, moderately and mildly impaired before being admitted 
to a training program fitted to their initial arm-hand impairment level [13]. This was done 
using the Utrecht Arm-hand Test [14].  
Approximately one fourth of patients in the severely affected subgroup (subgroup 1) 
showed more than expected progressions measured at AHF level, AHSP level and 
actual arm-hand use level. One could argue that a part of these patients may have 
been allocated to the wrong subgroup and thereby to the wrong intervention, due to 
misclassification. However, this was not the case. Up to 30% of stroke patients cope 
with a severely impaired arm-hand [89, 90]. This severely affected sub-acute stroke 
group consists of patients who have roughly a 50% chance of (some) recovery of 
function versus no recovery at all [51]. Furthermore, currently used clinical measures 
may not be able to adequately predict expected recovery in patients with a severely 
impaired arm-hand [55, 116].  
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In both our studies, all data with respect to AHF, AHSP and actual arm-hand-use in 
the subgroups was analyzed according to the intention-to-treat principle. All subjects 
were analyzed according to the subgroups they were assigned to in the first place. The 
intention-to-treat procedure performed in this study provides an optimal reflection of 
treatment as provided in daily practice, and retains the initial comparison between the 
three subgroups [117]. As this could have led to a higher within-group variance and a 
lower between-group contrast regarding the outcome measures used, in the second 
study, also a per-protocol analysis of the data was performed, i.e. leaving out patients 
who, in view of their speed of progress, switched to another program of CARAS, to 
check if results regarding actual-arm-hand use differed significantly from the results 
obtained in the intention-to-treat analysis. However, no significant differences in 
outcomes were found between the intention-to-treat analyses and the per-protocol 
analyses.  
 
 
Ceiling effects in patients with a mildly affected hand 
With respect to between-group differences, largest gains in AHF and AHSP were 
observed in patients with an initially moderately affected hand. However, patients with 
an initially mildly impaired hand may have improved even further as to their AHF and 
AHSP which may not have been detected due to ceiling effects in the measures used. 
In two clinical scales encompassing arm-hand function and arm-hand capacity, i.e. the 
Fugl-Meyer Motor Assessment (FMA) and the Action Research Arm test (ARAT), the 
maximum of the scale was reached in some patients, thus constituting ceiling effects 
[71].  
In order to measure the quality of motor performance, core clinical measures like the 
FMA and ARAT may be complemented by technological devices involving sensor 
technology. The application of sensor technology to monitor kinematics and kinetics 
can be used as additional parameters to objectively assessing arm-hand performance 
and the quality of arm-hand use in stroke trials, without being hampered by floor or 
ceiling effects [118-120]. Furthermore, kinematic assessments are assumed to provide 
information about physiologically relevant changes during the neurophysiological 
recovery episode. In the long term, this could lead to a better understanding of 
neurological mechanisms of sensorimotor recovery post-stroke [121]. Additionally, the 
use of multiple sensors may be useful in recognizing arm-hand activities which are 
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performed by patients in their home environment [122], and for assessing the quality 
of arm-hand use in daily tasks, which may be incorporated as important outcome 
measures in arm-hand assessment procedures [123].  
 
Within-group variations 
In both AMUSE studies large within-group variations across time regarding AHF and 
AHSP both during and after rehabilitation were observed in all three subgroups. The 
purpose of the AMUSE study was to evaluate the course of AHF and AHSP in a 
heterogeneous group of stroke survivors in the sub-acute phase, typically seen in 
stroke rehabilitation. This entails that a) The study population covered a broad 
spectrum of hand severity levels (as measured at entry of the study), and contained a 
large heterogeneity as to recovery patterns of the affected arm-hand; b) Only a few 
inclusion and exclusion criteria were used, leading to a broad spectrum of patient 
characteristics, and co-morbidities; and c) As measures were taken at fixed, pre-
determined time points post-stroke, and patients’ individual neurophysiological 
progressions differed, within-group variance may have increased as time post-stroke 
progressed. Pragmatically, in the CARAS program, this clinical variation in patients’ 
status has been taken into account by introducing three distinct, yet cohesive training 
programs, keeping patients’ variability clinically manageable. 
 
 
Measuring self-perceived performance  
Patients may fail to experience the positive impact of their arm-hand improvements 
due to e.g. problems regarding their mood and social participation, especially in the 
post-rehabilitation phase [21, 124]. In a percentage of our study population, the level 
of self-perceived performance, as measured with the ABILHAND, deteriorated or 
remained the same over time. This percentage was higher relative to those concerning 
outcomes on more objectively measured outcomes at the level of AFH and AHSP 
capacity. The aforementioned mood and social participation levels may play a role 
here. Another plausible reason may be that the ABILHAND does not cover all aspects 
of self-perceived performance. For example, a patient may improve on a personally 
relevant (daily) skill, which is not covered by the ABILHAND. An alternative for the 
ABILHAND with respect to self-perceived performance may be the DASH (Disabilities 
of the Arm, Shoulder and Hand) [125]. This questionnaire helps to describe and rate 
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the disability experienced by people with upper-limb disorders and also helps to 
monitor changes in symptoms and function over time. 
 
Single case experimental design versus randomized controlled trial  
In a number of the studies reported in this thesis, a single case experimental design 
(SCED) has been used to evaluate the added-value of new therapy elements added 
to CARAS, and to deal with multiple sources of variability in sub-acute stroke patients 
with a moderately to severely affected arm-hand [126]. Randomized controlled trails 
(RCTs) are considered the gold standard for evaluating efficacy in clinical research to 
constitute evidence for medical treatment [127, 128]. Nevertheless, to translate RCT 
data stemming from (heterogeneous) group averages into individual patient-specific 
clinical practice is considered difficult [127, 129, 130]. Given the individual patient’s 
characteristics, clinicians (and also patients) want to know / predict the extent to which 
(arm-hand) interventions may improve the individual patient’s performance. The SCED 
methodology provides a solution in determining the effectiveness of rehabilitation 
interventions in the individual patient, which is coherent to personalized evidence-
based medicine. However, the generalizability of SCED results towards larger 
populations is low. The SCED allows training of the individual patient in clinical practice 
while observing and recording his (behavioral) changes [131]. Observed changes, like 
for instance improvements in arm-hand capacity, are directly applicable to the patient’s 
situation and thus easily interpretable. Consequently, the application of SCED studies 
have the potential to make a substantial contribution to the development of evidence 
based interventions [132].  
Some specific threats to the internal validity make the SCED methodologically 
challenging [126, 132]. Featuring a within-subject design, participants serve as their 
own controls over the pre- and post-experimental phase. Main outcomes are to be 
measured systematically and frequently within and across all phases, in order to 
assess individual change across different conditions. Stability of the dependent 
variable during baseline conditions, or at least being able to adequately correct for 
effects of other treatment and effects of spontaneous recovery during baseline, is 
essential, because otherwise the detection of specific treatment effects will not be 
feasible [133].  
Also, in order to adequately quantify baseline variability, the number of measurements 
taken during the baseline period should be extensive [134]. However, in some cases 
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lengthening the baseline phase is undesirable, especially in conditions where changes 
in the “natural” course of recovery are to be expected, like in the sub-acute phase after 
a stroke. Furthermore, extensive repetition of measurements can also have an 
exhausting and demotivating effect on patients.  
 
Detrending for baseline trends 
In our SCED studies, linear de-trending has been applied for any (baseline) trend for 
each single subject in order to identify the unique contribution of the applied 
intervention. Nevertheless, the application of linear detrending may have led in some 
cases to a) An overestimation of spontaneous recovery and effects of therapy-as-
usual, especially in the long term post-training, thereby underestimating the effects of 
the experimental stimulus, i.e. the added-value of the application of a dynamic hand 
orthosis or botulinum toxin in the follow-up phase. For sub-acute stroke patients, an S-
shaped (non-linear) model or at least a model ‘levelling off over time’ might have better 
fitted the reality of spontaneous recovery. However, gathering enough data to 
adequately fit such a model would have necessitated a much longer baseline phase, 
which, in turn, would inevitably have compromised the sub-acuteness of the patients’ 
status during the ensuing intervention phase. Future research should focus on 
optimizing this model to better contrast spontaneous recovery with intermediate and 
long-term effects of (adjunct) therapy. 
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Future perspectives  
 
Apart from answering a number of clinical questions, this thesis has also raised a 
number of new questions that need attention. 
 
Future rehabilitation of patients with a moderately to severely affected arm-hand 
A large number of studies on rehabilitation treatment outcomes aimed at the impaired 
arm-hand reported in literature has and still is focusing on sharply delineated 
subgroups of stroke patients of homogeneous composition, and have been only 
limiting taking the wider spectrum of co-morbidities associated with stroke into account 
[135]. This has led, among others, to less scientific attention for patients with a 
moderately to severely impaired arm-hand who typically experience high (between-
subject) variances in comorbidity, and, therefore, to less development of novel, 
efficacious arm-hand training interventions for these subgroups. What is needed is an 
integrated approach in which clinicians and researchers co-develop new arm-hand 
training interventions for these subgroups, and novel (statistical) methodologies that 
accommodate the between-subject versatility typically seen in (daily) clinical stroke 
rehabilitation practice in general, and in moderately to severely impaired stroke patient 
specifically. Such an approach would necessitate the set-up of an academic specialty, 
or network, thus facilitating the interaction of experts in different fields of rehabilitation, 
methodology, movement/health sciences, and technology.  
  
Early identification of recovery potential in patients with a severely affected arm-hand 
The identification of severely impaired patients’ eligibility to motor recovery at an early 
stage post-stroke is important for tailoring neuro-rehabilitation interventions. I.e., it is 
essential to be able to differentiate between severely impaired individuals, who have 
no prospect on arm-hand recovery, and those that may attain partial or even complete 
recovery of arm function. Current prediction models need optimisation as to this 
feature. There is a growing interest in using biomarkers to predict patients’ motor 
recovery at AHF and AHSP level in severely affected patients. Further research into 
supporting biomarker-based arm-hand outcome prediction modeling is necessary. 
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Appropriate allocation of patients to dedicated technology-assisted arm-hand rehabilitation 
In order to optimally exploit both training-induced and endogenous post-stroke 
neuroplasticity, typically seen in a limited time window, an early start of treatment is 
essential, even when no voluntary activity of the hand muscles has been observed yet. 
However, to participate in regular arm-hand skill training at the start of rehabilitation is 
difficult for these patients due to their insufficient ability to voluntarily generate force. 
The application of technological assistive devices, like, for instance, actuated dynamic 
hand-orthoses, may assist them in performing grasp and release movements 
independently. Once equipped with an actuated dynamic orthosis, they may engage 
in CARAS’ gross motor grip training interventions early. Working actively with their non-
functional arm-hand, using an actuated dynamic hand orthosis, may provide 
meaningful tactile and proprioceptive feedback associated with motor commands, 
enhancing sensorimotor learning. Patients with a severely affected hand who, 
potentially due to more precise biomarker-based recovery models, are properly 
admitted to a well-defined, task-oriented training method, equipped with assistive 
technology devices, may obtain substantial improvements in terms of AHF, AHSP 
capacity and actual arm-hand-use. Future research should focus on investigating the 
efficacy of such newly developed care pathways and training interventions. In order to 
contrast these (novel) interventions, the longitudinal database on the development of 
AHF and AHSP, as outlined in this thesis, can be used as a reference database. 
  
Synergistic use of a task-oriented approach and technology in arm-hand treatment 
Given the sheer volume of stroke patients experiencing arm-hand problems and the 
decreasing (financial) means [136, 137] to provide adequate treatment to them, new 
solutions must be sought to maintain, optimize and improve treatment outcome. The 
use of technology as part of regular treatment definitively is a solution here. However, 
there are several challenges, ranging from “What works for whom?” and “How to 
adequately incorporate technology in assisting treatment?” to “How (cost-)effective is 
the use of technology incorporated in (daily) rehabilitation treatment?”. It is advocated 
to start investigating how low-cost, non-actuated technology can be used in mildly 
affected stroke patients to free up therapist-assisted treatment time that can then be 
spent on patients with a moderately to severely affected arm-hand. Furthermore, 
technology-assistance for the latter groups to be developed, may also lead to further 
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improvement of AHF and AHSP. Here, identifying/predicting, at an early stage post-
stroke, which kind of technology-assistance, e.g. robot-based or sensor-based 
technology, may work best for which kind of arm-hand severity subgroup is of 
paramount importance. For an adequate implementation of technology in regular 
treatment, implementation strategies should be developed. Also, in order to assess the 
(cost-)effectiveness of newly developed technology-assisted treatment regimes, health 
technology assessment studies should be performed. 
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In stroke, the loss of the ability to move the arm and hand  is a very common, and often 
persistent and disabling symptom [1]. Stroke patients who have a prospect on recovery 
of arm-hand function should be facilitated in creating an optimal retention of how to 
use the full potential of their affected hand in their own daily life pursuits. Organizing 
and structuring clinical treatment supporting stroke patients with a moderately or 
severely affected hand in regaining an optimal level of arm-hand function and arm-
hand skill performance is difficult. 
 
This thesis provides a perspective on how to clinically manage sub-acute stroke 
patients with a moderately to severely affected arm-hand, regularly seen in stroke 
rehabilitation settings.  
The findings of this thesis may contribute to an increase in quality, efficacy and 
efficiency of treatment from both the perspective of health care professionals and 
patients. Furthermore, this research also provides some suggestions how to 
systematically implement novel insights in daily clinical practice.   
Most important deliverables of this thesis are:  
1) a clearly defined clinical pathway, aimed at the moderately to severely affected 
arm-hand of subacute stroke patients, which may lead to a more efficient way 
of communication between clinicians and patients, as well as between clinicians 
and scientists with respect to how therapy content relates to the patients’ goals, 
and to clearly describe and communicate the treatment steps that are actually 
taken during arm-hand therapy [2];  
2) reference data, obtained from the single-armed prospective cohort study, 
describing how stroke patients, who were admitted to CARAS, actually perform 
during and after rehabilitation;  
3) suggestions on how to incorporate and systematically investigate technological 
and/or pharmacological interventions within the existing CARAS treatment, 
which may facilitate patients and/or clinicians during arm-hand rehabilitation in 
improving patients’ performance. In addition, the information on how 
technological and/or pharmaceutical interventions that are used in conjunction 
with the designed clinical care pathway can be assessed, may also be beneficial 
to other stakeholders like innovative companies and knowledge institutes.  
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Valorization potential towards clinical experts and scientists 
The multitude and complexity of information regarding the treatment of the patients’ 
affected  arm and hand in the post-stroke phase requires an efficient treatment policy. 
Facilitating knowledge exchange among clinical experts and between scientists is an 
important first step to take [3]. Here, four steps for further valorisation are proposed: 
Step 1: Setting a reference frame 
CARAS contains a well-defined form of therapy-as-usual, substantiated with outcome 
data at AHF and AHSP level [4, 5]. CARAS’ transparent nature and related data may 
be used to, 1) strengthen insight into effects and changes at outcome level, process 
level and structure level, and 2) provide insight into complex arm-hand impairments 
and concomitant interventions. In summary, information obtained can be used as a 
frame of reference for clinicians and scientists to discuss clinical and scientific 
questions with respect to this field. Sharing knowledge and experiences may 
accelerate consensus on how to develop and/or improve knowledge, skills and 
outcomes with respect to arm-hand interventions that are currently offered in stroke 
rehabilitation practice. Experiences acquired in the stroke population may also be 
applicable in rehabilitation of patients who experience arm-hand problems due to other 
forms of central neurologic disorders. 
Step 2: Combining expertise across disciplines 
Strengthening the connection between care and research, and creating an on-going 
interaction between clinical experts and researchers is critical in order to facilitate the 
exchange of relevant knowledge with respect to the field [6]. To develop and adjust 
arm-hand interventions to the patient’s individual needs, and to design the set-up of 
evaluation studies with respect to novel arm-hand interventions in moderately to 
severely affected patients is considered to be complex. This complexity reflects the 
importance and need for clinicians and (clinical) scientists to formalize exchange of 
knowledge and learning, which would necessitate the development of a (so-called) 
Specialty, focused on bringing together expertise on arm-hand rehabilitation in patients 
with a central nervous system disorder.  
Step 3: Education program 
Following chapter 2 of this thesis, in which CARAS has been described, an education 
and training program of arm-hand rehabilitation has been developed (in Dutch: “ 
Opleidingsplan arm-hand revalidatie na centraal neurologisch letsel” (unpublished)). 
The training program has primarily been built to support clinical experts in their clinical 
VALORIZATION
10
 287 
decision-making process in patients with different levels of arm-hand impairment after 
stroke. The main part of the training program contains 1) a module with respect to the 
analysis and observation of arm-hand skill performance, 2) a module containing the 
development of interventions in arm-hand skill performance training, and 3) a toolbox 
with supportive information, including various documents, such as the actual treatment 
program, a patient workbook, assignments and a  manual.  
Furthermore, throughout the Netherlands, the majority of the stroke survivors are 
discharged from the hospital to their home situation or are admitted to a nursing home 
[7]. Part of these patients also has to cope with a moderately to severely affected arm 
hand. Therefore, it is also relevant for clinical experts, who work in hospitals, nursing 
homes and/or home-based health-care centers to exchange and structure information 
with respect to the clinical management of the affected arm and hand in post-stroke 
phase. In fact, based on the complex nature of arm-hand rehabilitation, creating a 
network for arm-hand rehabilitation in central neurological disorders involving clinicians 
from a broad spectrum of rehabilitation care delivery organisations may optimize the 
quality of treatment, research and guidance of patients with an affected arm and hand. 
The description of CARAS and scientific output, as has been outlined in this thesis, 
may be used as supportive information in conjunction with the training course, thus 
valorizing the knowledge gathered in our research as presented in this thesis. 
Step 4: Consortium building 
Between 2014 and 2019 CARAS has been implemented in a number of stroke 
rehabilitation units in the Netherlands which now are united in a consortium (see Figure 
1). The consortium provides a platform for discussion and learning methods with 
respect to topics related to arm-hand rehabilitation in post-stroke phase. 
Internationally, several stroke rehabilitation centers have implemented parts of 
CARAS. A step-wise implementation plan was developed in order to facilitate the 
implementation process of CARAS in other rehabilitation centers. An example of this 
implementation process is outlined in Figure 2. 
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Figure 1.    Rehabilitation centers in the Netherlands who joined the CARAS Consortium between 2014 and 2019
Figure 2.   Example of an implementation schedule of CARAS. 
VALORIZATION
10
 289 
Valorization regarding technological innovations 
 
The use of (rehabilitation) technology as part of regular treatment may be a solution in 
optimizing and improving treatment outcome in AHF and AHSP during rehabilitation 
[8, 9]. From the perspective of manufacturers and distributors of technological and 
medical devices, there are several challenges with respect to the incorporation of 
technology in (daily) rehabilitation treatment. Many innovations do not mature and are 
not implemented in rehabilitation care. Also, impact assessments with respect to (cost-
) effectiveness often are missing and technology can be used erroneously.  
To exchange knowledge and intensifying the collaboration between the development 
and manufacturing of technological devices with rehabilitation experts may lead to a 
more optimal use of a device and could even accelerate the approval process of a 
medical device.  
A substantial part of technological devices, developed with the purpose to be used as 
a medical device are subject to a systematic clinical evaluation, according to the 
Medical Device Regulation (MDR) [10]. This procedure is required before the product 
is provided with a (CE) certificate. Only once the product is certified, it can be 
distributed to end-users, as for instance healthcare providers or patients. These 
regulatory requirements and obtaining the approval process, is likely to make the 
transition to stroke rehabilitation services a complicated and time-consuming process. 
Data with respect to the development of arm-hand function and arm-hand skill 
performance of patients who were allocated to CARAS can be used as a reference 
database and can be used as a route to (systematically) assess and evaluate new 
technological innovations with respect to arm-hand rehabilitation in post-stroke phase.  
An example of an international initiative in which the reference data of this thesis will 
be used for further (technological) developments is the European Interreg EMR project 
“Innovation and Implementation acceleration of Complex Rehabilitation Technology” 
(acronym: i2-CoRT) (https://www.i2-CoRT.eu/). For example, the CARAS program is 
being used in conjunction with a novel, ‘remote handling concept’-based, task-oriented 
arm-hand skill performance training approach (ReHab-TOAT) for patients with a 
moderately to severely impaired arm-hand in the subacute and chronic stage after a 
stroke. Results from this combination of existing treatment (CARAS) and novel, 
technology-assisted training aspects may be used by companies developing new 
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technologies in improving their product, bringing it in alignment with current training 
principles, thus valorising the (clinical) knowledge gathered.  
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Patients, suffering a stroke, rate improving their arm-hand function and incorporating 
their paretic hand in daily activities as a top priority in their rehabilitation. Nevertheless, 
even when stroke survivors experience some return of arm-hand function, it remains a 
common and significant source of long-term disability. For this reason, a wide range of 
different exercises or training methods, the use of equipment or techniques, and/or 
pharmacological interventions have been developed aimed at maximizing arm-hand 
recovery in order to improve functional ability and quality of life in post-stroke phase. 
 
The set-up of most evaluation studies with respect to arm-hand interventions is 
protocol-based to serve a narrow band of well-described patients, and is less 
adaptable to accommodate patients with different levels of arm-hand impairment after 
stroke and/or patients with specific needs, as commonly seen in regular stroke 
rehabilitation centers.   
Evidence-based interventions to improve and to maintain a sufficient level arm-hand 
function (AHF) and arm-hand skill performance (AHSP) in moderately or severely 
affected patients are scarce. Nevertheless, once associated with the prospect to 
dexterity, the opportunity to learn to use the full potential of their affected hand must 
be explored. In order to achieve this potential, patients have to be admitted to 
(intensive) arm-hand training interventions in the limited time window of maximum 
post-stroke neuroplasticity.  
 
CARAS 
The Concise Arm and hand Rehabilitation Approach in Stroke (CARAS) is designed 
for clinicians to structure and implement training of AHF and AHSP in stroke patients 
typically seen in every day clinical practice. Stratified based on the basis of their arm-
hand severity level, i.e. mildly, moderately or severely impaired, patients are allocated 
to one of the three group-based training programs of CARAS. Severely affected 
patients are admitted to the program ‘Taking care of the limb and prevention of 
complications’ (program 1). Moderately affected patients were allocated to the ‘Task-
oriented gross motor grip performance program’ (program 2), were they learn to use 
their affected hand to assist the non-paretic arm-hand during bimanual activities in 
daily life. Mildly affected patients admitted to the ‘Functional AHSP training program’ 
(program 3) participate in a task-oriented training program working immediately using 
more complex functional tasks. CARAS incorporates a stepwise clinical management 
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procedure to elicit motor control problems and self-efficacy principles to assist patients 
to recognize and monitor improvements made in arm-hand performance. All three 
programs are well-documented and exist of time-delimited building blocks in order to 
systematically incorporate (new) technology and new evidence-based training 
elements swiftly. 
 
Changes in AHF and AHSP 
Once admitted to CARAS it was not well understood at what rate improvement (or 
deterioration) in AHF, AHSP and actual arm-hand use (as part of AHSP) occurred in 
sub-acute stroke patients with either a severely, moderately or mildly affected 
functional arm-hand, during and after their rehabilitation period. Nor was clear in which 
way AHF and AHSP differed between patients with a different levels of arm-hand 
severity.  
The vast majority of patients admitted to CARAS’ task-oriented training part, program 
2 and program 3 respectively, improved considerably on AHF and AHSP. In addition, 
they were able to maintain these high levels during the post-rehabilitation phase. 
Largest gains with respect to AHF and AHSP occurred in moderately impaired patients. 
This means that also patients who lack any dexterity, i.e. finger extension at the start 
of program 2, are able to generate and maintain significant progressions in AHF and 
AHSP.  
With respect to actual arm-hand-use it could be concluded that a vast majority of 
patients admitted to CARAS program 2 and program 3, improved on Intensity-of-use 
and Duration-of-use of their moderately or mildly affected arm-hand during 
rehabilitation. These results were also maintained across the post-rehabilitation phase. 
With respect to the ratio of Intensity-of-use between the affected and non-affected 
hand it can be stated that in mildly impaired patients the non-affected hand is used 
about one and a half times more than the affected hand in the post-rehabilitation 
period. Patients with a moderately affected hand use their non-affected hand about 
two and a half times more than their affected hand.  
A minority of the severely affected patients, initially diagnosed with a severely impaired 
arm-hand, also improved considerably in terms of AHF and AHSP during and after the 
rehabilitation phase.  Due to their progressions, these patients switched from program 
1 to program 2, the task-oriented gross motor grip performance program in order to 
learn to use their affected arm-hand in daily performance tasks. 
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Interventions adjunct to CARAS 
In sub-acute stroke patients in who no or little dexterity in the initial phase of arm-hand 
rehabilitation was observed, arm-hand training led to improvements in AHF and AHSP. 
These improvements enlarged their possibilities to regain a sufficient level of dexterity 
in order to perform gross motor grip tasks and assist the non-paretic hand during 
simple bimanual activities in daily life. 
In order to create an optimal retention of learning to use the full potential of the affected 
hand, patients’ needs to push their limits by exploring actual arm-hand use. For this 
reason, patients have to work as independently as possible during therapy sessions, 
encouraged to use an efficient problem-solving strategy leading to an easier 
performance of a given task. To work actively and as independent as possible with the 
affected arm-hand in an (intensive) arm-hand skill training regime, these patients 
needed to be facilitated in generating sufficient voluntary force generation to execute 
a functional (gross motor) grasp.  
 
In order to facilitate voluntary grasp-and-release movements in moderately to severely 
affected patients and to augment existing (intensive) therapies, the use and added-
value of Abobotulinum toxin-A (ABoNt-A) and two non-actuated dynamic hand 
orthoses has been investigated. All three interventions were applied in conjunction with 
CARAS’ gross motor grip performance program.  
Besides a low motor ability level due to weakness, stroke survivors with a moderately 
to severely affected arm-hand may be hampered by post-stroke spasticity, which also 
may limit progressions in AHF and AHSP. A spasticity reduced treatment ABoNt-A was 
applied in the training phase in conjunction with CARAS’ gross motor grip performance 
program, tailored to the patients’ individual characteristics. At group level, the added-
value of ABoNt-A on AHF and AHSP could not be confirmed. Results of the study 
showed that a minority of all study participants achieved significant additional 
improvements in arm-hand capacity. Half of the participants improved at the level of 
self-perceived performance. A majority of the participants demonstrated significant 
improvements in AHF. In a minority of patients, no beneficial effects from the 
contribution of ABoNt-A during arm-hand rehabilitation was observed. Patients who 
displayed improvements in the distal part of the arm before ABoNt-A was applied, may 
have obtained higher levels of arm-hand capacity, compared to the more severely 
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affected subgroup. The application of botulinum toxin may have facilitated the re-
occurrence of voluntary movements that were hampered by spasticity before. 
 
In two separate studies, the added-value of two non-actuated dynamic hand orthoses, 
i.e. the Saeboglove, a tensioners-assisted hand orthosis, combined with electrical 
stimulation (ES) and the Saeboflex, a spring-loaded hand orthosis has been evaluated. 
The first study targeted moderately to severely sub-acute stroke patients who did not 
show any arm-hand dexterity prior to the intervention. Equipped with the orthosis and 
ES they were admitted to CARAS’ program 2, gross motor grip performance program. 
Once they left the training phase, a vast majority of patients improved significantly on 
arm-hand capacity and maintained a certain level of arm-hand dexterity post-
rehabilitation.   
In the second study, the majority of moderately to severely sub-acute stroke patients 
improved on arm-hand capacity. However, only half of the patients admitted to this 
study improved as to their self- perceived performance, relative to their baseline 
performance. Patients who showed little to no arm-hand improvements at an early 
stage post-stroke seemed to have benefitted more from the Saeboflex in conjunction 
with CARAS than those patients who showed clear improvements during the baseline 
phase. In both studies, patients’ felt highly motivated to work with the orthosis in 
conjunction with a high-intensive task-oriented training regime. Also, the rated their 
sense of self-regulation as high. 
 
Conclusion 
Stroke patients with prospect regarding arm-hand recovery should be facilitated in 
creating an optimal retention in how to use the full potential of their affected hand 
outside therapeutic situations, i.e. in their own daily life pursuits as quickly as possible. 
CARAS has explicitly been designed to allow a heterogeneous group of stroke patients 
with a broad spectrum of arm-hand severity levels to participate in task-oriented 
practice, including patients with a moderately to severely affected arm-hand who 
display little or no dexterity the initial phase of rehabilitation. In the vast majority of 
mildly and moderately affected patients the training resulted in significantly improved 
AHF and AHSP levels, and possibly to meaningful daily arm-hand performance, also 
in post-rehabilitation. In addition, moderately to severely affected patients appeared to 
be facilitated by dynamic hand orthoses or botulinum toxin in conjunction with CARAS’ 
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gross motor program in order to provide functional grasp-and-release movements 
while reducing therapeutic assistance. 
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Samenvatting 
 
Revalidanten die, ten gevolge van een CVA, beperkingen ondervinden in een arm en 
hand beoordelen het verbeteren van de arm-handfunctie en het kunnen inzetten van 
de aangedane arm-hand in dagelijkse activiteiten als een topprioriteit.  
Hoewel een deel van de revalidanten een bepaalde mate van herstel van de arm- en 
handfunctie ervaart, blijft de niet-inzetbare of beperkt inzetbare hand een belangrijke 
en frequent voorkomende oorzaak van handicap. Wereldwijd zijn inmiddels een 
aanzienlijke hoeveelheid trainingsmethoden en technologische en farmacologische 
interventies ontwikkeld die bedoeld zijn om het herstel van de aangedane arm-hand 
en de daarmee gepaard gaande kwaliteit van leven na een CVA te verbeteren. 
De meeste evaluatiestudies met betrekking tot het beoordelen van de effectiviteit van 
arm-handinterventies zijn geprotocolleerd en gericht op een afgebakende populatie 
waarbij strikte inclusiecriteria worden gehanteerd. Dit bemoeilijkt de generalisatie van 
dergelijk trainingsprotocollen naar meer heterogene doelgroepen, zoals revalidanten 
met verschillende niveaus van arm-handfunctie en co-morbiditeit, frequent gezien in 
de reguliere revalidatie. 
 
Evidence-based interventies, gericht op het verbeteren én het behouden van een 
voldoende niveau van arm-handfunctie en arm-handvaardigheid bij patiënten met een 
gemiddeld tot ernstig aangedane arm en hand, zijn schaars. Desalniettemin, eenmaal 
geassocieerd met het vooruitzicht tot enig herstel van de aangedane arm-hand, dienen 
ook revalidanten met een gemiddeld tot ernstig aangedane arm-hand de kans te 
krijgen om het volledig potentieel van de aangedane arm en hand te benutten. Door 
het toegankelijk maken van arm-hand trainingsinterventies voor deze specifieke 
doelgroep kan het volledig potentieel van arm-handfunctie en armhandvaardigheid 
eerder aangesproken worden, binnen de begrensde tijdsperiode waarin ook de 
plasticiteit van het brein optimaal benut kan worden.   
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CARAS 
De ‘Concise Arm and hand Rehabilitation Approach in Stroke’ (acroniem: CARAS) is 
ontwikkeld met als doel een brede doelgroep van revalidanten met een beperkte arm-
handfunctie ten gevolge van een CVA, optimaal te begeleiden tijdens het 
revalidatieproces. Binnen CARAS staat enerzijds het structureren van interventies, 
gericht op het behoud of het verbeteren van de aangedane arm-hand en anderzijds 
het implementeren van nieuwe trainingsmethodieken, die een bijdrage kunnen leveren 
aan het bespoedigen van het al dan niet partiële herstel van de arm-handfunctie en 
arm-handvaardigheid, centraal.  
 
Eens verwezen naar CARAS, worden revalidanten, op basis van de ernst van de 
beperking van de aangedane arm en hand, gestratificeerd naar mild, matig of ernstig 
beperkte handfunctie. Vervolgens worden ze toegewezen aan één van de drie 
trainingsprogramma’s in CARAS. 
Patiënten met een ernstig aangedane arm-hand worden verwezen naar het 
programma waarin het verzorgen van de aangedane arm-hand en het voorkomen van 
complicaties centraal staat (programma 1). Revalidanten, gediagnosticeerd met een 
matig aangedane arm-hand worden verwezen naar programma 2, een taak-
georiënteerd training programma waarin het accent ligt op het leren van grof-
motorische grijpvaardigheden. In programma 2 leren revalidanten de aangedane hand 
in te zetten als ondersteuning van de niet-aangedane arm-hand tijdens het uitvoeren 
van dagelijkse, veelal bimanuele, activiteiten. Revalidanten met een mild aangedane 
arm-hand doorlopen programma 3, een taak-georiënteerde training programma waarin 
geleerd wordt de aangedane arm-hand vrijwel direct in te zetten tijdens  het uitvoeren 
van complexe functionele taken. 
 
CARAS omvat een klinische procedure om de beperkte functionele inzetbaarheid van 
de aangedane arm-hand vast te stellen en vervolgens te trainen. Het structureel 
toepassen van self-efficacy principes ondersteunt patiënten tijdens de training in het 
tijdig (h)erkennen van de verbeterde functionele inzetbaarheid van de aangedane arm-
hand. De programma’s zijn duidelijk beschreven en bestaan uit in tijd afgebakende 
trainingsperiodes, hetgeen ook het implementeren van technologische, therapie-
ondersteunende middelen en vernieuwende, evidence-based trainingselementen 
vereenvoudigt.  
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Veranderingen in arm-handfunctie en arm-handvaardigheid 
Nadat CARAS ontwikkeld was en toegepast werd in de kliniek ontstond de vraag in 
welke mate CARAS leidde tot verbetering (of achteruitgang) in arm-handfunctie, arm-
handvaardigheid en de daadwerkelijke inzet van de aangedane arm-hand (als 
onderdeel van arm-handvaardigheid).Tevens was het onduidelijk in welke mate een 
verandering van arm-handfunctie en arm-handvaardigheid plaatsvond bij revalidanten 
met een ernstig, matig of een mild aangedane arm-hand, in de sub-acute fase na CVA. 
Ook bleek niet duidelijk in welke mate en op welk moment deze veranderingen 
optraden en in welke mate de arm-handfunctie en arm-handvaardigheid verschilde 
tussen revalidanten met een ernstig, matig of mild aangedane arm-hand. Om op deze 
vragen antwoord te kunnen geven, is een grote prospectieve cohort studie opgezet. 
De overgrote meerderheid van revalidanten die de taak-georiënteerde training van 
CARAS’ programma 2 en programma 3 hebben doorlopen, vertoonde een significante 
verbetering ten aanzien van zowel arm-handfunctie als arm-handvaardigheid. De grote 
meerderheid van deze revalidanten behielden dit verbeterde niveau van arm-
handfunctie en arm-handvaardigheid tijdens de post-revalidatiefase. Meeste 
progressies in arm-handfunctie en arm-handvaardigheid werden geobserveerd bij 
revalidanten met een matig aangedane arm-hand. Dit betekende dat ook revalidanten 
die tijdens de aanvang van programma 2 géén inzetbare hand hadden toch significant 
konden verbeteren wat betreft arm-handfunctie en arm-handvaardigheid, leidend tot 
een inzetbare arm-hand. 
 
Met betrekking tot de daadwerkelijk inzetbaarheid van de aangedane arm-hand tijdens 
de revalidatieperiode kan worden geconcludeerd dat het overgrote deel van de 
revalidanten die hebben deelgenomen aan programma 2 en programma 3 significant 
verbeterden met betrekking tot zowel de intensiteit als de duur van inzetbaarheid van 
de aangedane arm en hand. Deze resultaten bleven bestaan tijdens de post-
revalidatiefase. Tevens bleek dat in de mild aangedane groep revalidanten de niet-
aangedane arm-hand anderhalf keer meer werd ingezet dan de niet-aangedane arm-
hand. In revalidanten met een matig aangedane arm-hand bleek dat de niet-
aangedane arm-hand tweeënhalf keer meer werd ingezet vergeleken met de 
aangedane arm-hand.  
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Van de revalidanten die in de initiële fase van de revalidatie gediagnosticeerd waren 
met een ernstig aangedane arm-hand, vertoonde een minderheid een aanzienlijke 
verbetering in arm-handfunctie en arm-handvaardigheid tijdens het revalidatieproces. 
Vanwege de doorgemaakte progressies verwisselden deze revalidanten programma 
1 voor het intensieve taak-georiënteerde programma 2, met als doel de hand te leren 
inzetten tijdens de uitvoering van dagelijkse taken.   
 
 
Het toepassen van interventies, aanvullend op CARAS 
Bij een aantal revalidanten, waarbij in de initiële fase van de revalidatie nauwelijks tot 
geen handfunctie was vastgesteld, leidde deelname aan arm-hand training tot 
verbeteringen in zowel arm-handfunctie als arm-handvaardigheid. Deze opgedane 
verbeteringen leidden uiteindelijk tot de mogelijkheid om met de aangedane arm-hand 
grove motorische grijptaken uit te voeren, waardoor eenvoudige bimanuele activiteiten 
uitgevoerd konden worden.  
In het taak-georiënteerde gedeelte van CARAS werden de revalidanten uitgedaagd 
zelf de inzetbaarheid van de aangedane arm-hand te exploreren binnen dagelijkse 
activiteiten met als doel een optimaal leereffect te creëren.  
Tijdens de arm-hand therapiesessies leerden revalidanten zo onafhankelijk mogelijk 
te werken en werden ze aangemoedigd om een zo efficiënt mogelijke strategie te leren 
gebruiken, leidend tot een eenvoudige, comfortabele uitvoering van een bepaalde 
vaardigheid of activiteit. 
Om revalidanten te stimuleren om de aangedane arm-hand in een (intensief) arm-
handvaardigheid training regime zo zelfstandig mogelijk in te zetten, dienden zij te 
worden gefaciliteerd in het genereren van voldoende handkracht om een functionele 
greep herhaaldelijk uit te kunnen voeren. De toegevoegde waarde van Abotulinum 
Toxine A (ABoNt-A) en twee niet-geactueerde dynamische handorthesen in het 
vereenvoudigen van zowel het grijpen als het loslaten door de matig tot ernstig 
aangedane arm-hand, is geëvalueerd. Deze drie interventies zijn toegepast in 
combinatie met programma 2 van CARAS.   
 
Revalidanten met een gemiddeld tot ernstig aangedane arm-hand worden, naast het 
hebben van te weinig spierkracht, ook vaak belemmerd door een vorm van spasticiteit, 
hetgeen de progressie in arm-handfunctie of arm-handvaardigheid tijdens de arm-
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handtraining kan hinderen. Tijdens de trainingsfase is daarom, afgestemd op de 
specifieke eigenschappen van de revalidant, een spasticiteit regulerende behandeling, 
i.c. ABoNt-A, toegediend in combinatie met programma 2 van CARAS.  
Op groepsniveau kon de toegevoegde waarde van ABoNt-A op arm-handfunctie en 
arm-handvaardigheid niet worden bevestigd. Een minderheid van alle revalidanten die 
aan deze studie deelnamen, toonden een significante verbetering in arm-
handcapaciteit. De helft van de revalidanten liet significante verbeteringen zien met 
betrekking tot de eigen perceptie van de mate van inzetbaarheid van de aangedane 
arm-hand tijdens de uitvoering van dagelijkse, veelal bimanuele activiteiten.  
In de meerderheid van de revalidanten die deelnamen aan de studie werden 
significante verbeteringen met betrekking tot arm-handfunctie geobserveerd. Bij een 
minderheid van de revalidanten die deelnamen aan deze studie werden geen 
additionele effecten van ABoNt-A op de arm-handfunctie waargenomen. Revalidanten 
waarbij enig herstel in het distale gedeelte van de arm was geobserveerd alvorens 
ABoNt-A werd toegepast, hebben, uitgaand van de verbeterde arm-handcapaciteit, 
mogelijkerwijs meer geprofiteerd van de toegevoegde waarde van ABoNt-A in 
vergelijking met de subgroep die nauwelijks tot geen herstel vertoonden bij aanvang 
van deze studie. Het toevoegen van ABoNt-A bovenop de gebruikelijke therapie, i.c. 
CARAS, lijkt een faciliterend effect te hebben gehad op het genereren van vrijwillige 
bewegingen in de aangedane arm-hand die voorheen werden verhinderd door de 
spasticiteit.  
 
In twee onafhankelijke studies is de toegevoegde waarde van twee niet-geactueerde 
dynamische hand ortheses geëvalueerd.   
De eerste studie was gericht op revalidanten in de sub-acute fase waarbij geen 
handfunctie was geobserveerd vóór aanvang van de arm-handtraining. Revalidanten 
hebben deelgenomen aan CARAS’ programma 2, uitgerust met de Saeboglove 
orthese, een elastiek-ondersteunde handorthese, in combinatie met elektrostimulatie. 
In het merendeel van de deelnemers werd een significante verbetering ten aanzien 
van arm-handcapaciteit geobserveerd. Dit niveau werd behouden in de periode na de 
revalidatie. 
Ook de tweede studie betrof revalidanten met een gemiddeld tot ernstig arm-hand in 
de sub-acute fase na CVA die, uitgerust met de Saeboflex, een veer-ondersteunde 
hand orthese, deelnamen aan programma 2 van CARAS. Het merendeel van deze 
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groep ondervond een significante verbetering met betrekking tot arm-handcapaciteit. 
Echter bij slechts de helft van de deelnemers werd een significante verbetering 
waargenomen met betrekking tot hun eigen perceptie van de mate van inzetbaarheid 
van de aangedane arm-hand tijdens de uitvoering van dagelijkse, veelal bimanuele 
activiteiten. Revalidanten bij wie in een vroeg stadium na een beroerte weinig tot geen 
verbeteringen in de aangedane arm-hand was geobserveerd, leken meer baat gehad 
te hebben van de Saeboflex in combinatie met arm-handtraining dan revalidanten waar 
in de baselinefase wel duidelijke progressies in arm-handfunctie was waargenomen. 
In beide onderzoeken voelden revalidanten zich zeer gemotiveerd om met de orthese 
te werken in combinatie met het intensieve, taakgerichte trainingsprogramma. De 
mogelijkheid om de therapie naar eigen behoefte te kunnen aanpassen, gebaseerd op 
actuele en persoonlijke trainingsdoelen, werd door de deelnemers zeer positief 
beoordeeld. 
 
Conclusie 
Revalidanten die na het CVA enig vooruitzicht hebben op motorisch herstel van de 
aangedane arm-hand dienen te worden gefaciliteerd om het volledig potentieel van de  
aangedane arm-hand zo snel en zo optimaal mogelijk in te zetten tijdens de dagelijkse 
handelingen, buiten therapeutische situaties.  
CARAS is expliciet ontworpen om taak-georiënteerde training toegankelijk te maken 
voor een brede doelgroep van revalidanten die, ten gevolge van een CVA, een 
beperkte arm-handfunctie ondervinden. Ook revalidanten die nauwelijks handfunctie 
of zelfs geen handfunctie hebben, kunnen deelnemen aan CARAS.  
Bij het merendeel van de revalidanten met een mild tot matig aangedane arm-hand 
leidt de training tot een significante verbetering in zowel de arm-handfunctie als de 
arm-handvaardigheid. Ook leidt de training veelal tot een verbetering in het uitvoeren 
van betekenisvolle activiteiten in de fase na de revalidatie. Revalidanten met een matig 
tot ernstig aangedane arm-hand hebben in veel gevallen baat bij de ondersteuning 
door een dynamische hand-orthese of bij het toedienen van ABoNt-A ter vermindering 
van spasticiteit, in combinatie met programma 2 van CARAS. Deze combinatie 
faciliteert het zelfstandig kunnen grijpen en loslaten met de aangedane hand en leidt 
tevens tot een afname van de noodzaak voor therapeutische begeleiding. Het 
toepassen van de handortheses en ABoNt-A maakt taak-georiënteerde training 
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toegankelijk voor doelgroepen waarvan in eerste instantie wordt gedacht dat deze niet 
zouden kunnen deelnemen aan taak-georiënteerde arm-hand training.  
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Zowel uit de wetenschappelijke hoek als uit de revalidatiesector is er een behoorlijk aantal 
mensen betrokken geweest die mij door de jaren heen hebben geholpen om dit 
proefschrift succesvol af te ronden. Allereerst wil ik de mensen bedanken die 
gerevalideerd hebben op de afdeling CVA bij Adelante. In totaal hebben maar liefst 119 
revalidanten meegewerkt aan dit proefschrift. Niet alleen tijdens hun revalidatietraject, 
maar zelfs ook tot een jaar daarna, namen zij de moeite om een aantal keer per jaar naar 
Adelante af te reizen.  
Om in deze fase van het leven waarin je behoorlijk wat tegenslag moet verwerken, deel 
te nemen aan onderzoek is een teken van moed en doorzettingsvermogen. 
 
Mijn promotoren Henk Seelen en  Rob Smeets ben ik veel dank verschuldigd. Zij hebben 
in grote mate bijgedragen aan de inhoud van dit proefschrift. Henk, zonder jouw eindeloze 
geduld zou ik niet zo ver gekomen zijn. Dank voor je kritische houding en het stellen van 
de juiste vragen. Rob, je hebt me altijd heel goed ondersteund door me te helpen focussen 
wanneer dat nodig was en door mijn werk snel en van duidelijk commentaar te voorzien. 
Ook heb je me enorm geholpen met het werven van fondsen, zodat ik de laatste jaren 
door kon werken, zonder me daar heel druk over te hoeven maken. Yvan, ik wil jou graag 
bedanken voor de goede faciliteiten die het kenniscentrum mij heeft geboden. Jule en 
Leonie, dank jullie wel voor het regelen en uitvoeren van metingen en het bijhouden van 
het CRF in de laatste studie.   
 
Een andere belangrijke inspiratiebron voor mij waren, en zijn nog altijd mijn collega’s van 
Adelante. Jullie hebben allemaal op eigen wijze bijgedragen aan dit proefschrift. Een heel 
fijne bijdrage was het overnemen van metingen als ik verhinderd was. Milou, Inge, Renee, 
dank jullie wel hiervoor. Ondanks de werkdruk maakten jullie tijd om mij te ondersteunen. 
Ook ben ik veel collega’s dankbaar voor de vele ideeën en uitspraken met betrekking tot 
de ontwikkeling van arm-hand revalidatie. Ze motiveerden tot nadenken en vaak 
uiteindelijk ook tot het (door-) ontwikkelen van interventies.  
Jos en Will, jullie ervaring en tomeloze inzet voor deze groep revalidanten heeft mij vanaf 
het eerste uur enorm geïnspireerd. Jos, je hebt mij in die jaren meermaals geholpen in de 
zoektocht om het beste uit de revalidant en mijzelf te halen. Jij was het die mij in 2003 
parkeerde in het voormalig IRV gebouw met een uitdraai van Pubmed met de zin: ‘zoek 
eens uit of CIMT iets voor ons is’. Will, jouw respect voor deze doelgroep en jouw warme 
hart voor de revalidant was iets wat ik altijd veel van heb mogen leren.  
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Paul, jouw kalmte, hulp en humor op de momenten dat ik weer eens te veel hooi op mijn 
vork nam hebben me echt geholpen. We kunnen inmiddels samen nog wel een boekje 
schrijven of weer eens een cursus geven. Boeiende onderwerpen met betrekking tot 
centraal neurologisch letsel zijn er genoeg. We kunnen we ook gewoon weer bier gaan 
drinken in een ver land. Jolanda, jij was het die in 2004 tegen mij zei; ‘misschien moet 
iemand zich toeleggen op arm-hand training’. Dat idee heb ik toen met beide handen 
aangenomen. Huub, door alle jaren heen hebben we vaak samen revalidanten gezien. 
Het sparren met jou heeft mij geholpen om mijn eigen gedachten en acties beter af te 
stemmen op vragen en behoeftes vanuit het behandelteam. Dick, ook wij hebben samen 
in het verleden veel revalidanten samen begeleid. Jouw optimisme en jouw altijd positieve 
instelling is fantastisch.  
 
Kim, je stelde vertrouwen in mij als collega, en je gaf me de ruimte daar waar het nodig was. 
Wip, een gesprek met jou, je positief kritische vragen, het geeft me nog steeds veel 
energie. Ik hoop dat we nog een hele tijd samen kunnen werken. Martine, je pragmatische 
kijk op de revalidatie, ‘wat moet er geregeld worden’, vond ik altijd heel verfrissend. 
Peter, dank je wel voor je luisterend oor, de tijd die je nam om al filosoferend tegen de 
dagelijkse beslommeringen aan te kijken. Het gaf vaak een betere kijk op wat er nu toe 
doet, niet alleen in het werk, maar in het leven zelf. Karolien, pas in de laatste studie van 
dit proefschrift zijn we wat nauwer met elkaar gaan samenwerken. Ik hoop dat we nog 
jaren van onze samenwerking gebruik kunnen maken, zowel binnen de kliniek als binnen 
onderzoek.   
Melanie, onze gesprekken over motorisch leren en hoe we dat praktisch het beste konden 
vormgeven binnen de klinische setting heb ik als heel waardevol beschouwd. Sonja, 
Margareth, Veronique, Jolanda, John, dank jullie wel, voor de ondersteuning, een grap en 
een glimlach en de snelle acties als ik weer eens iets snel geregeld moest hebben.  
 
In het eerste uur van het consortium, opgericht in 2017, heb ik de gelegenheid gekregen 
om een aantal collega ergo- en fysiotherapeuten, eveneens werkzaam in de medisch 
specialistische revalidatie, beter te leren kennen. Eugenie, Martine, Cecile, Matthijs, 
Jolanda, Iris, Andreas, Lisaso, Ivanka, Yvonne, Paula, Sonja, Geert-Willem, Josta, Paula, 
Bart, Marlou, Simone, Anna, Elise, Emmy, Marike, Franny en Tilly. Ik wil jullie allemaal 
bedanken voor jullie positiviteit en het vertrouwen wat jullie in mij hebben gesteld de 
afgelopen jaren. Met het CARAS consortium hebben we de afgelopen jaren op een unieke 
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manier van elkaars kennis en ervaring gebruik mogen maken. Ik ben er van overtuigd dat 
onze kijk op arm-hand revalidatie na CVA in deze tijd op positieve wijze is veranderd.  
 
Tevens wil ik hierbij een aantal mensen bedanken die zowel vanuit een bedrijfstechnisch 
oogpunt, maar zeker ook als persoon betrokken zijn geweest bij de totstandkoming van 
dit proefschrift. Mary, Antoinette, Claudia (Ispen Pharmaceutica), ik dank jullie hartelijk 
voor alle ondersteuning de afgelopen drie jaar, jullie persoonlijke benadering en de fijne 
samenwerking. Freek, (Hankamp Revalidatie), dank je wel voor je snelle acties, je 
oprechte en duidelijke mening over therapie en de toepassing van technische middelen. 
Ook dank ik je voor je vertrouwen in mij. Ik hoop dat we in de toekomst nog een tijd samen 
mogen werken aan een aantal projecten. Gerrit, Desiree en Leon (Schwa-medico 
Nederland), dank jullie wel voor de hele fijne samenwerking de afgelopen jaren. Henry, 
(Saebo US) thanks for all your efforts, product delivery, our discussions and your 
hospitality in Charleston.  
 
Mam, pap, ik kan jullie helaas niet meer in de ogen kijken en het jullie zeggen, maar 
bedankt. Dank je wel dat ik van jullie een hoeveelheid creativiteit en doorzettingsvermogen 
heb meegekregen. Dat is me de afgelopen jaren goed van pas gekomen. Jongens, dank 
jullie wel voor alle afleiding, stomme grappen, het bier, slechte én goede jaren ’90-‘00 
muziek. We zijn er altijd voor elkaar, en jullie staan altijd voor me klaar. Anne-Claire, het 
laatst jaar was geen eenvoudig jaar voor mij. Dank je wel voor je liefde, je steun, geduld 
en je positieve kijk op het leven, waar ik (nog steeds) veel van kan leren. Florien en Elise, 
we hebben nu nog meer tijd om samen te stoeien, te knutselen, te koken, muziek te 
maken, muziek te luisteren of te sporten ☺. 
 
Dank jullie wel allemaal, 
 
Han 
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